{"title": "Mecanismos del COVID-19 en el cuerpo humano: Lo que sabemos hasta ahora", "author": "Ashutosh Kumar; Ravi K Narayan; Pranav Prasoon; Chiman Kumari; Gurjot Kaur; Santosh Kumar; Maheswari Kulandhasamy; Kishore Sesham; Vikas Pareek; Muneeb A Faiq; Sada N Pandey; Himanshu N Singh; Kamla Kant; Prakash S Shekhawat; Khursheed Raza; Sujeet Kumar", "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059041/", "hostname": "ncbi.nlm.nih.gov", "description": "Ha transcurrido m\u00e1s de un a\u00f1o y medio desde el inicio de la pandemia debida a la enfermedad por coronavirus 2019 (COVID-19), y el mundo se esfuerza por contenerla. Al ser causada por un virus hasta ahora desconocido, en el periodo inicial ...", "sitename": "PubMed Central (PMC)", "date": "2020-05-14", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Learn more:\n[PMC Disclaimer](/pmc/about/disclaimer/)| [PMC Copyright Notice](/pmc/about/copyright/) [10.1159/000521507](//doi.org/10.1159%2F000521507)\nLanguage:\n[Spanish](#) | [Portuguese](#)\nMecanismos del COVID-19 en el cuerpo humano: Lo que sabemos hasta ahora\nResumen\nHa transcurrido m\u00e1s de un a\u00f1o y medio desde el inicio de la pandemia debida a la enfermedad por coronavirus 2019 (COVID-19), y el mundo se esfuerza por contenerla. Al ser causada por un virus hasta ahora desconocido, en el periodo inicial hubo una escasez extrema de conocimientos sobre los mecanismos de la enfermedad, lo que dificult\u00f3 las medidas preventivas y terap\u00e9uticas contra el COVID-19. En un esfuerzo por comprender sus mecanismos patog\u00e9nicos, se han llevado a cabo extensos estudios experimentales en todo el mundo con experimentos basados en cultivos celulares, organoides de tejidos humanos y modelos animales, enfocados en varios aspectos de la enfermedad, como las propiedades del virus, su tropismo tisular y su patog\u00e9nesis espec\u00edfica en ciertos \u00f3rganos, la implicaci\u00f3n de los sistemas fisiol\u00f3gicos y la respuesta inmunitaria humana contra la infecci\u00f3n. El enorme conocimiento cient\u00edfico acumulado sobre todos los aspectos del COVID-19 cambi\u00f3 el escenario, de una gran desolaci\u00f3n, a la esperanza. A pesar de que se han producido avances espectaculares en todos estos aspectos, quedan m\u00faltiples lagunas de conocimiento que deben abordarse en futuros estudios. Adem\u00e1s, desde el inicio de la primera oleada de COVID-19 han surgido en todo el mundo m\u00faltiples variantes del coronavirus tipo 2 del s\u00edndrome respiratorio agudo severo (SARS-CoV-2), que parecen tener mayor transmisibilidad/virulencia y capacidad de escape inmunol\u00f3gico que la cepa de tipo salvaje. En esta revisi\u00f3n narramos los avances realizados desde el inicio de la pandemia en nuestros conocimientos sobre los mecanismos del COVID-19 en el cuerpo humano, incluyendo las interacciones virus-hu\u00e9sped, las manifestaciones pulmonares y sist\u00e9micas, las desregulaciones inmunol\u00f3gicas, las complicaciones, la vulnerabilidad espec\u00edfica del hu\u00e9sped y las consecuencias a largo plazo en los supervivientes. Adem\u00e1s, ofrecemos una breve revisi\u00f3n de las pruebas actuales que explican los mecanismos moleculares que confieren mayor transmisibilidad, virulencia y capacidad de escape inmunol\u00f3gico a las variantes emergentes del SARS-CoV-2.\nIntroducci\u00f3n\nLa actual pandemia de la enfermedad por coronavirus 2019 (COVID-19) ha cobrado un gran n\u00famero de vidas humanas en todo el mundo (\u223c4.8 millones hasta el 8 de octubre de 2021, seg\u00fan datos de la OMS). El COVID-19 es causado por el coronavirus tipo 2 del s\u00edndrome respiratorio agudo severo (SARS-CoV-2) [\n[1](#B1)], un virus envuelto, con ARN monocatenario de sentido positivo, que pertenece al g\u00e9nero de los betacoronavirus (BCoV). Existen otros BCoVs, como el SARS-CoV-1 y el coronavirus del s\u00edndrome respiratorio de Oriente Medio (MERS-CoV), que han causado las epidemias de s\u00edndrome respiratorio SARS-2002/2003 y MERS-2012, respectivamente [ [1](#B1)].\nLa extrema escasez de conocimientos, especialmente en el periodo inicial, sobre la interacci\u00f3n de la nueva cepa de coronavirus, el SARS-CoV-2, con el hu\u00e9sped dificult\u00f3 enormemente el manejo preventivo y terap\u00e9utico de la pandemia. Sin embargo, la gigantesca investigaci\u00f3n realizada en todo el mundo ha generado evidencias cient\u00edficas rigurosas sobre todos los aspectos del COVID-19 a una velocidad y una escala sin precedentes. Los hechos emergentes sobre los mecanismos patog\u00e9nicos del COVID-19 han ayudado a frenar la propagaci\u00f3n incontrolada de la pandemia mediante el desarrollo de varias medidas preventivas, incluyendo vacunas efectivas, y un mejor manejo terap\u00e9utico. Aunque a\u00fan no existe ning\u00fan f\u00e1rmaco eficaz para el COVID-19, el estado actual de la investigaci\u00f3n hace concebir esperanzas sobre el futuro. La aparici\u00f3n de m\u00faltiples variantes de SARS-CoV-2 con mayor transmisibilidad/virulencia y capacidad de escape inmunol\u00f3gico es un giro desafortunado en el curso actual (2020\u20132021) de la pandemia. Surgen evidencias que pueden explicar una mejor interacci\u00f3n entre el virus y el hu\u00e9sped y la mayor capacidad de escape inmunitario de las variantes [\n[2](#B2), [3](#B3), [4](#B4)]; sin embargo, a\u00fan se desconoce si las variantes han alterado su patog\u00e9nesis para un tipo de tejido u \u00f3rgano espec\u00edfico. En esta revisi\u00f3n, analizamos con precisi\u00f3n evidencias recientes sobre los mecanismos patog\u00e9nicos del COVID-19 en humanos, incluyendo las interacciones virus-hu\u00e9sped, manifestaciones pulmonares y sist\u00e9micas, desregulaciones inmunol\u00f3gicas, complicaciones, la vulnerabilidad espec\u00edfica del hu\u00e9sped y los problemas de salud a largo plazo en los supervivientes. El art\u00edculo tiene como objetivo ofrecer una comprensi\u00f3n completa de los mecanismos patog\u00e9nicos clave que conducen a las manifestaciones cl\u00ednicas y a la evoluci\u00f3n de los pacientes en el COVID-19, y destacar las lagunas en los conocimientos que pueden requerir mayor atenci\u00f3n de los investigadores. Adem\u00e1s, se analizan brevemente las evidencias actuales sobre los mecanismos moleculares que confieren mayor transmisibilidad, virulencia y capacidad de escape inmunol\u00f3gico a las variantes emergentes del SARS-CoV-2.\nSintomatolog\u00eda del COVID-19\nEl COVID-19 se ha descrito principalmente como una infecci\u00f3n causante del s\u00edndrome respiratorio agudo severo (SARS); sin embargo, son muy habituales las manifestaciones sist\u00e9micas que afectan a otros \u00f3rganos, incluido el sistema nervioso central (SNC) [\n[5](#B5)] (Tabla [(Tabla1).1](/pmc/articles/PMC9059041/table/T1/)). El inicio de los s\u00edntomas se produce en promedio 5\u20136 d\u00edas despu\u00e9s de la exposici\u00f3n; normalmente, quienes tienen s\u00edntomas leves se recuperan en dos semanas; sin embargo, en los casos graves, la recuperaci\u00f3n puede extenderse hasta seis semanas (Figura [(Figura1).1](/pmc/articles/PMC9059041/figure/F1/)). Cabe destacar que en algunos pacientes, independientemente de la gravedad de la enfermedad, los s\u00edntomas pueden persistir o reaparecer durante semanas o meses tras la recuperaci\u00f3n inicial [ [17](#B17)]. En muchos supervivientes se ha reportado la persistencia de la enfermedad o la aparici\u00f3n de nuevas dolencias tras la recuperaci\u00f3n completa, lo que se conoce como \u00abCOVID persistente\u00bb [ [17](#B17), [18](#B18), [19](#B19)] (Figura [(Figura1).1](/pmc/articles/PMC9059041/figure/F1/)). La presentaci\u00f3n de datos cl\u00ednicos en los pacientes con COVID-19 ha revelado algunos hechos interesantes; del total de casos, aproximadamente 80% son asintom\u00e1ticos o presentan s\u00edntomas leves, mientras que \u223c14% desarrollan s\u00edntomas graves, como neumon\u00eda, \u223c5% desarrollan s\u00edntomas cr\u00edticos, como shock s\u00e9ptico, insuficiencia respiratoria o falla multiorg\u00e1nica, y \u223c2% de los pacientes mueren a causa de la enfermedad [ [20](#B20)]. La mortalidad es comparativamente mucho mayor en las personas de edad avanzada y con comorbilidades [ [21](#B21), [22](#B22)].\nTable 1\n|Sistema||S\u00edntoma||Estudio|\n|General||Fiebre||[|[6](#B6), [7](#B7)] [8](#B1), [9](#B9), [10](#B10), [11](#B11)] [12](#B12)] [6](#B6), [7](#B7), [13](#B13)] [14](#B14)] [6](#B6)] [6](#B6), [15](#B15), [16](#B16)]\nDe acuerdo con la revisi\u00f3n de la literatura actual, el \u00abCOVID persistente\u00bb se caracteriza por s\u00edntomas de fatiga, dolor de cabeza, disnea y anosmia. Es m\u00e1s probable que se produzca ancianos, personas con alto \u00edndice de masa corporal y de sexo femenino, y los s\u00edntomas pueden persistir durante 4\u201312 semanas. Adem\u00e1s, los pacientes con COVID que experimentaron m\u00e1s de cinco s\u00edntomas durante la primera semana de la enfermedad podr\u00edan tener una probabilidad significativamente mayor de desarrollar \u00abCOVID persistente\u00bb (odds ratio = 3.53 (2.76\u20134.50)) [\n[17](#B17)]. Un estudio reciente indica que algunos s\u00edntomas del \u00abCOVID persistente\u00bb pueden prolongarse m\u00e1s all\u00e1 de un a\u00f1o, en particular la fatiga, la disnea y s\u00edntomas neurol\u00f3gicos como la ansiedad y la depresi\u00f3n [ [23](#B23)].\nInteracciones entre el virus y el hu\u00e9sped\nEntrada del SARS-CoV-2 en las c\u00e9lulas del hu\u00e9sped\nLa entrada del SARS-CoV-2 en las c\u00e9lulas humanas es mediada por un receptor de superficie celular, la enzima convertidora de angiotensina-2 (ACE2) [\n[24](#B24)] (Figura [(Figura2).2](/pmc/articles/PMC9059041/figure/F2/)). La ACE2 se une al dominio de uni\u00f3n al receptor (RBD) de la prote\u00edna spike (S) del SARS-CoV-2. Adem\u00e1s, para que el virus pueda entrar en la c\u00e9lula hu\u00e9sped, la imprimaci\u00f3n de la prote\u00edna SSC se considera esencial para su fusi\u00f3n con la membrana de la c\u00e9lula hu\u00e9sped, lo que implica la escisi\u00f3n de la prote\u00edna \u00abS\u00bb por serina proteasas como la llamada serina proteasa transmembrana 2 (TMPRSS2) o por la catepsina B o L (CTS-B o -L) y la furina presentes en la membrana de la c\u00e9lula hu\u00e9sped [ [1](#B1)] (Figura [(Figura2)2](/pmc/articles/PMC9059041/figure/F2/)) (revisado en [ [1](#B1)]).\nSe sabe que ACE2 es un receptor de entrada a la c\u00e9lula hu\u00e9sped para algunos otros CoV, como el SARS-CoV-1 y el HCoV-NL-63. Tambi\u00e9n se sabe que TMPRSS2 y CTS-L act\u00faan como v\u00eda de entrada para SARS-CoV-1 y otros virus relacionados con el SARS [\n[1](#B1)]. Sin embargo, la inclusi\u00f3n de la furina parece ser una adquisici\u00f3n evolutiva en el SARS-CoV-2 en comparaci\u00f3n con otros virus del SARS (revisado en [ [1](#B1)]). El corte por la furina requiere la inserci\u00f3n de un segmento pept\u00eddico, el sitio de corte de furina (FCS), que contiene amino\u00e1cidos multib\u00e1sicos (PRRAR) en la intersecci\u00f3n S1/S2 de la prote\u00edna \u00abS\u00bb, que no est\u00e1n presentes en el SARS-CoV-1 ni en otros virus relacionados con el SARS [ [25](#B25)]. En particular, se sabe que el FCS est\u00e1 presente en muchos otros CoV, como el MERS-CoV, el HKU1-CoV y el OC43-CoV [ [26](#B26)]. Se especula que la inclusi\u00f3n del FCS en el genoma del SARS-CoV-2 contribuye a su alta infectividad y transmisibilidad en comparaci\u00f3n con otros virus del SARS [ [25](#B25)]. El FCS tambi\u00e9n se ha observado en virus de la influenza y se considera que contribuye a su virulencia [ [27](#B27)]. En la actualidad, hay limitada evidencia de si la inclusi\u00f3n del FCS contribuye a la virulencia del SARS-CoV-2 (revisado en [ [1](#B1)]). En un estudio reciente, se descubri\u00f3 que un mutante del SARS-CoV-2 que carec\u00eda de FCS en la prote\u00edna \u00abS\u00bb presentaba una menor replicaci\u00f3n en las c\u00e9lulas Calu3 (una l\u00ednea celular respiratoria humana) y una progresi\u00f3n atenuada de la enfermedad en un modelo de patog\u00e9nesis del COVID-19 en h\u00e1mster [ [28](#B28)].\nAdem\u00e1s de la ACE2, estudios recientes han identificado evidencia concreta de un receptor de entrada de c\u00e9lulas hu\u00e9sped alternativo para el SARS-CoV-2: la neuropilina-1 (NRP1) [\n[25](#B25), [26](#B26)]. La NRP1 se expresa abundantemente en m\u00faltiples tipos de tejidos en todo el cuerpo, con una expresi\u00f3n muy alta en las c\u00e9lulas endoteliales y epiteliales, en particular en el epitelio respiratorio y olfativo. Cantuti-Castelvetri et al. [ [29](#B29)] demostraron que el NRP1 potencia la infectividad del SARS-CoV-2. Adem\u00e1s, Daly et al. [ [30](#B30)] demostraron que el fragmento S1 de la prote\u00edna spike, escindido por la furina, puede unirse directamente a la NRP1 de la superficie celular, y que el bloqueo de esta interacci\u00f3n mediante un inhibidor de mol\u00e9culas peque\u00f1as o anticuerpos monoclonales reduce eficazmente la infecci\u00f3n por el SARS-CoV-2.\nTropismo tisular y organotropismo\nLos factores de entrada del SARS-CoV-2 en la c\u00e9lula hu\u00e9sped se expresan ampliamente en todos los tipos de tejidos en humanos [\n[31](#B31), [32](#B32), [33](#B33)]. Adem\u00e1s, ACE2 se coexpresa junto con TMPRSS2/CTS-L en muchos tipos de tejidos, lo cual es esencial para la infecci\u00f3n por el SARS-CoV-2 [ [32](#B32), [33](#B33)]. El amplio tropismo tisular del SARS-CoV-2 se refleja en la diversidad de los s\u00edntomas observados en pacientes con COVID-19 [ [5](#B5)]. El tropismo multiorg\u00e1nico del SARS-CoV-2 tambi\u00e9n se ha confirmado en estudios con observaciones histopatol\u00f3gicas en muestras de tejido post mortem de pacientes infectados [ [34](#B34)] y mediante la infecci\u00f3n en laboratorio de organoides de tejido humano [ [35](#B35)]. En la Figura [Figura33](/pmc/articles/PMC9059041/figure/F3/) se describen los tipos de tejidos que pueden infectarse con SARS-CoV-2 en funci\u00f3n de la expresi\u00f3n de los receptores de entrada de las c\u00e9lulas del hu\u00e9sped y de las proteasas del hu\u00e9sped asociadas con su ingreso.\nSecuestro de la maquinaria de la c\u00e9lula hu\u00e9sped\nEstudios recientes han desentra\u00f1ado los mecanismos moleculares impulsados por el SARS-CoV-2 para secuestrar la maquinaria de la c\u00e9lula hu\u00e9sped, en particular, para la s\u00edntesis de prote\u00ednas y los mecanismos de producci\u00f3n de energ\u00eda [\n[36](#B36), [37](#B37)]. Los estudios in vitro han aportado evidencias s\u00f3lidas de una extensa fosforilaci\u00f3n de prote\u00ednas v\u00edricas del SARS-CoV-2 por parte del proteoma del hu\u00e9sped, implicada en la activaci\u00f3n de las quinasas de la c\u00e9lula hu\u00e9sped y la se\u00f1alizaci\u00f3n del receptor del factor de crecimiento (GFR), facilitando as\u00ed el secuestro de la maquinaria proteica del hu\u00e9sped. La primera evidencia de este tipo publicada por Bouhaddou et al. [ [38](#B38)] demostr\u00f3 que la infecci\u00f3n por SARS-CoV-2 de las c\u00e9lulas del hu\u00e9sped promueve la activaci\u00f3n de la case\u00edna quinasa II (CK2) y de la prote\u00edna quinasa activada por mit\u00f3genos (MAPK) p38, as\u00ed como la producci\u00f3n de diversas citocinas, lo que lleva a la desactivaci\u00f3n de la quinasa dependiente de ciclinas (CDK) 1/2/5 y a la detenci\u00f3n del ciclo celular [ [38](#B38)]. Los autores tambi\u00e9n observaron una caracter\u00edstica \u00fanica del SARS-CoV-2 que era la menos conocida para los virus respiratorios: la infecci\u00f3n viral indujo marcadamente la producci\u00f3n de protrusiones filopodiales distintivas que conten\u00edan CK2 y tambi\u00e9n part\u00edculas virales en desarrollo. Las protuberancias filopodiales parec\u00edan facilitar la transferencia del virus infeccioso a otras c\u00e9lulas del hu\u00e9sped. Este patr\u00f3n de activaci\u00f3n de la v\u00eda molecular por parte del SARS-CoV-2 podr\u00eda explicar potencialmente los rasgos distintivos de las lesiones en los tejidos del hu\u00e9sped durante el COVID-19 grave, como la inflamaci\u00f3n aguda, el da\u00f1o a las c\u00e9lulas epiteliales y la disfunci\u00f3n endotelial vascular. Otra evidencia destacada se debe a Klann et al. [ [37](#B37)], quienes demostraron que la infecci\u00f3n por SARS-CoV-2 de una l\u00ednea celular de epitelio col\u00f3nico humano \u2212 c\u00e9lulas Caco-2 \u2212 activaba la se\u00f1alizaci\u00f3n del GFR y sus v\u00edas descendentes. Estos autores tambi\u00e9n demostraron que una inhibici\u00f3n de la se\u00f1alizaci\u00f3n del GFR imped\u00eda la replicaci\u00f3n del SARS-CoV-2 en las c\u00e9lulas hu\u00e9sped [ [37](#B37)]. Asimismo, otro estudio reciente con un modelo murino de COVID-19 ha sugerido que la toxicidad sist\u00e9mica inducida por el SARS-CoV-2 provoca una regulaci\u00f3n a la baja en la expresi\u00f3n de los genes que afectan los mecanismos de producci\u00f3n de energ\u00eda en las c\u00e9lulas, como la fosforilaci\u00f3n oxidativa y el ciclo del \u00e1cido tricarbox\u00edlico (TCA), as\u00ed como cambios epigen\u00e9ticos (metilaci\u00f3n del ADN) en los \u00f3rganos vitales [ [38](#B38)].\nSe ha reportado que las prote\u00ednas no estructurales (NSPs) del SARS-CoV-2, m\u00e1s particularmente la NSP1, que se une a la subunidad ribosomal 40S de las c\u00e9lulas del hu\u00e9sped, causan la interrupci\u00f3n de la traducci\u00f3n del ARNm en las c\u00e9lulas del hu\u00e9sped [\n[36](#B36)]. Tambi\u00e9n se ha descubierto que NSP1 bloquea el gen I inducible por \u00e1cido retinoico (RIG-I) y los genes estimulados por interfer\u00f3n (ISG), que son mediadores clave de la respuesta inmune innata del hu\u00e9sped en caso de infecciones virales [ [39](#B39)]. Otra prote\u00edna del SARS-CoV-2, la NSP16, junto con la NSP10, protege al virus de la respuesta inmune innata del hu\u00e9sped mediante la metilaci\u00f3n del extremo 5\u2032 de los ARNm codificados por el virus (imitando as\u00ed los ARNm celulares del hu\u00e9sped) [ [40](#B40)].\nAdem\u00e1s de los mecanismos mencionados, recientemente se ha demostrado que la prote\u00edna spike del SARS-CoV-2 se mimetiza con un canal i\u00f3nico de c\u00e9lulas epiteliales humanas, con lo que se dificultan sus funciones fisiol\u00f3gicas. Anand et al. [\n[41](#B41)] han demostrado que el sitio de escisi\u00f3n S1/S2 de la prote\u00edna \u00abS\u00bb del SARS-CoV-2 tiene una sorprendente similitud en su secuencia proteica con el segmento del p\u00e9ptido que puede ser eliminado por la furina (FCS) en la subunidad \u03b1 del canal de sodio epitelial humano (ENaC-\u03b1). El mimetismo de la prote\u00edna viral \u00abS\u00bb con ENaC-\u03b1 en las c\u00e9lulas hu\u00e9sped indica que el virus puede competir por la furina disponible en las c\u00e9lulas hu\u00e9sped infectadas y, por tanto, puede bloquear la activaci\u00f3n proteol\u00edtica de ENaC-\u03b1. Se ha establecido que la ENaC-\u03b1 interviene en el desarrollo del s\u00edndrome de dificultad respiratoria aguda (SDRA) mediado por la activaci\u00f3n de las c\u00e9lulas inmunitarias y las citocinas/quimiocinas [ [42](#B42), [43](#B43)], lo que indica que este mecanismo puede tener un papel en la patog\u00e9nesis del SDRA en los pacientes graves de COVID-19.\nDesregulaci\u00f3n del sistema renina-angiotensina-aldosterona (SRAA): Un eje clave para mantener la homeostasis fisiol\u00f3gica\nLa desregulaci\u00f3n del sistema renina-angiotensina-aldosterona (SRAA) ha sido un rasgo caracter\u00edstico del COVID-19 [\n[44](#B44)]. El SRAA regula el equilibrio hemodin\u00e1mico fisiol\u00f3gico que afecta a todos los \u00f3rganos principales, principalmente el h\u00edgado, el pulm\u00f3n, el coraz\u00f3n y el ri\u00f1\u00f3n [ [22](#B22)], y tambi\u00e9n participa en el mantenimiento del equilibrio electrol\u00edtico y la resistencia vascular; por lo tanto, es un determinante crucial de la presi\u00f3n arterial sist\u00e9mica y, en consecuencia, de la salud cardiovascular. La desregulaci\u00f3n del SRAA inducida por el SARS-CoV-2 est\u00e1 mediada por su receptor de entrada en la c\u00e9lula hu\u00e9sped ACE2, un an\u00e1logo de la ACE que realiza un paso clave en la regulaci\u00f3n del SRAA: la conversi\u00f3n de angiotensina I en angiotensina II. El equilibrio ACE/ACE2 se considera un factor crucial para mantener el funcionamiento \u00f3ptimo del SRAA. Aparentemente, la infecci\u00f3n por SARS-CoV-2 regula a la baja la ACE2, pero no la ACE, y por lo tanto puede estar creando un desequilibrio de la relaci\u00f3n fisiol\u00f3gica ACE/ACE2 [ [9](#B9), [17](#B17)]. Por otra parte, la uni\u00f3n del SARS-CoV-2 provoca una regulaci\u00f3n a la baja de la ACE2 en los componentes del SRAA, lo que puede inducir la activaci\u00f3n y liberaci\u00f3n de marcadores proinflamatorios que causan lesiones tisulares [ [42](#B42)]. La desregulaci\u00f3n del SRAA mediada por la ACE es un paso clave en la patog\u00e9nesis del COVID-19 y contribuye significativamente a la mortalidad asociada con la comorbilidad, la trombosis vascular, la morbilidad espec\u00edfica de los \u00f3rganos y las fallas multiorg\u00e1nicas, que se discuten con detalle m\u00e1s adelante en las subsecciones relacionadas de este art\u00edculo. En la Figura [Figura44](/pmc/articles/PMC9059041/figure/F4/) se resume una representaci\u00f3n esquem\u00e1tica de las desregulaciones del SRAA mediadas por la ACE e inducidas por el virus en el COVID-19.\nAfectaci\u00f3n multisist\u00e9mica en el COVID-19: Comprensi\u00f3n de los mecanismos subyacentes\nLa amplia distribuci\u00f3n en el cuerpo humano de los factores de entrada a las c\u00e9lulas hu\u00e9sped del SARS-CoV-2 indica que el virus puede infectar la mayor\u00eda de los \u00f3rganos y tipos de tejidos. Inicialmente, se percib\u00eda que el principal \u00f3rgano implicado en la patog\u00e9nesis del COVID-19 era el pulm\u00f3n; sin embargo, la acumulaci\u00f3n de evidencias a lo largo del tiempo ha establecido que el COVID-19 es una enfermedad sist\u00e9mica con manifestaciones extremadamente diversas [\n[5](#B5)] (Tabla [(Tabla1).1](/pmc/articles/PMC9059041/table/T1/)). En muchos casos, los pacientes presentan sobre todo s\u00edntomas no-respiratorios que afectan a uno o varios \u00f3rganos, incluido el cerebro [ [5](#B5)]. Una revisi\u00f3n exhaustiva de la bibliograf\u00eda sugiere que la afectaci\u00f3n multisist\u00e9mica en el COVID-19 puede explicarse en gran medida por la distribuci\u00f3n generalizada de los receptores de entrada a las c\u00e9lulas hu\u00e9sped del SARS-CoV-2, la toxicidad viral directa, la respuesta inmunitaria desregulada del hu\u00e9sped, la participaci\u00f3n del SRAA y la respuesta hiperinflamatoria sist\u00e9mica contra la infecci\u00f3n, adem\u00e1s de la trombosis macro y microvascular. A continuaci\u00f3n se mencionan evidencias emp\u00edricas recientes sobre todos estos aspectos, implicados en la fisiopatolog\u00eda del COVID-19 sobre sistemas fisiol\u00f3gicos clave.\nSistema respiratorio\nLos receptores de entrada celular del SARS-CoV-2 se expresan en m\u00faltiples tipos de c\u00e9lulas a lo largo del tracto respiratorio. En el tracto respiratorio superior, las c\u00e9lulas epiteliales ciliadas secretoras nasales coexpresan ACE2 y TMPRSS2 en abundancia [\n[32](#B32)]. En el tracto respiratorio inferior, ACE2 y TMPRSS2 se coexpresan de forma m\u00e1s extensa en los neumocitos de tipo 2 que en los de tipo 1; adem\u00e1s, ambos receptores se expresan en las c\u00e9lulas caliciformes, de Clara, enteroendocrinas y bronquiales, as\u00ed como en las c\u00e9lulas endoteliales de la vasculatura pulmonar [ [32](#B32), [33](#B33), [44](#B44)]. Aunque los s\u00edntomas respiratorios leves pueden atribuirse a la infecci\u00f3n del tracto respiratorio superior, el SARS o SDRA caracter\u00edstico se produce cuando se infectan las c\u00e9lulas pulmonares, principalmente los neumocitos de tipo 2 y las c\u00e9lulas endoteliales vasculares pulmonares [ [45](#B45)]. La infecci\u00f3n de estas c\u00e9lulas puede provocar inflamaci\u00f3n pulmonar grave, primero por la participaci\u00f3n de los macr\u00f3fagos residentes y luego por el reclutamiento de macr\u00f3fagos perif\u00e9ricos y otras c\u00e9lulas inmunitarias, como neutr\u00f3filos y c\u00e9lulas T [ [20](#B20), [45](#B45)]. La producci\u00f3n reducida de surfactantes (por parte de los neumocitos de tipo 2) y la consolidaci\u00f3n de exudados acumulados provocan el colapso de los alveolos e inducen cambios neum\u00f3nicos [ [46](#B46)]. Si no se controla, la inflamaci\u00f3n inicial puede provocar la liberaci\u00f3n de m\u00e1s citocinas proinflamatorias y el reclutamiento de c\u00e9lulas inmunitarias perif\u00e9ricas, con lo que se produce un c\u00edrculo vicioso que induce mayores lesiones tisulares [ [20](#B20)]. La endotelitis vascular pulmonar y la posterior trombosis, principalmente de los microvasos, marcada por niveles sangu\u00edneos elevados de productos de degradaci\u00f3n de la fibrina (FDP), del d\u00edmero D y un mayor tiempo de protrombina (TP) tambi\u00e9n contribuyen en gran medida a la patolog\u00eda pulmonar [ [20](#B20), [45](#B45), [47](#B47)].\nSistemas cardiovascular y renal\nSe sabe que los miocitos cardiacos, el endotelio de los vasos coronarios y los fibrocitos muestran una expresi\u00f3n significativa de ACE2 y de serina proteasas, principalmente TMPRSS2 [\n[48](#B48)]. Los s\u00edntomas cardiacos pueden deberse a la lesi\u00f3n mioc\u00e1rdica directa causada por el virus [ [49](#B49), [50](#B50)]. Adem\u00e1s, la desregulaci\u00f3n del SRAA impulsada por el CoV-2 puede aumentar la incidencia de tromboembolismo, y los episodios hipertensivos pueden ser consecuencia de la constricci\u00f3n persistente de los vasos sist\u00e9micos y coronarios [ [51](#B51), [52](#B52)]. Por otra parte, la inflamaci\u00f3n de las arterias coronarias puede acelerar la formaci\u00f3n de placas, provocando obstrucci\u00f3n y, por tanto, cambios isqu\u00e9micos que conducen a la insuficiencia cardiaca [ [12](#B12), [53](#B53)]. El desequilibrio electrol\u00edtico inducido por la desregulaci\u00f3n del SRAA puede ser otro mecanismo que conduzca a enfermedades cardiacas; en particular, la hipopotasemia puede causar la hiperpolarizaci\u00f3n de los miocitos cardiacos y provocar arritmias [ [53](#B53)]. La hipopotasemia en el COVID-19 tambi\u00e9n puede ser consecuencia de una lesi\u00f3n mioc\u00e1rdica directa mediada por el virus, que provoca la reducci\u00f3n del gasto cardiaco, activando as\u00ed la excreci\u00f3n renal de iones de potasio mediada por la aldosterona [ [53](#B53), [54](#B54)].\nLa afectaci\u00f3n renal es muy indicativa en el COVID-19, teniendo en cuenta la significativa expresi\u00f3n del receptor de entrada a la c\u00e9lula hu\u00e9sped del SARS-CoV-2, ACE2, y de las proteasas asociadas, en particular TMPRSS2, en las c\u00e9lulas epiteliales de los t\u00fabulos renales y los podocitos de los glom\u00e9rulos [\n[33](#B33), [55](#B55)]. En este sentido, se ha reportado afectaci\u00f3n renal aguda y evidencia de lesi\u00f3n inducida por el virus, incluyendo la presencia de part\u00edculas virales en los t\u00fabulos renales en el examen histopatol\u00f3gico post mortem [ [34](#B34)]. Sin embargo, la prevalencia de la afectaci\u00f3n renal directa en el COVID-19 es baja si se compara con la de otros sistemas/\u00f3rganos clave [ [56](#B56)]. La lesi\u00f3n renal tambi\u00e9n puede ser secundaria al ARDS y a la sepsis inducida por la tormenta de citocinas. Tambi\u00e9n puede deberse a la desregulaci\u00f3n del SRAA mediada por la ACE2 o a m\u00faltiples causas iatrog\u00e9nicas, como consecuencia del manejo en la unidad de cuidados intensivos o la ventilaci\u00f3n mec\u00e1nica y los efectos nefrot\u00f3xicos de los f\u00e1rmacos [ [57](#B57)].\nSistema digestivo\nSe han observado s\u00edntomas digestivos prominentes en muchos pacientes con COVID-19 [\n[6](#B6), [13](#B13)], y se han detectado part\u00edculas de SARS-CoV-2 en las c\u00e9lulas, con evidencia de lesiones inflamatorias, en los tejidos gastrointestinales, en m\u00faltiples estudios post mortem [ [34](#B34), [58](#B58)]. Los factores de entrada del SARS-CoV-2 en las c\u00e9lulas del hu\u00e9sped (ACE2 y TMPRSS2) se encuentran enriquecidos en el tejido intestinal [ [13](#B13)], y se ha demostrado el \u00e9xito de la invasi\u00f3n viral en organoides intestinales humanos [ [59](#B59), [60](#B60)] y en estudios de modelos animales, incluso en primates [ [61](#B61), [62](#B62)].\nAunque actualmente hay suficientes evidencias de que el SARS-CoV-2 puede infectar el tracto gastrointestinal (TGI), todav\u00eda no se sabe bien c\u00f3mo llega el virus a \u00e9ste. La v\u00eda fecal-oral de entrada del virus es la explicaci\u00f3n m\u00e1s plausible [\n[62](#B62)]. En algunos pacientes de COVID-19 se ha detectado la excreci\u00f3n de SARS-CoV-2 infeccioso en las heces, aunque no ha sido un hallazgo regular [ [62](#B62)]. Es intrigante c\u00f3mo el SARS-CoV-2 sobrevive a los extremos de pH en el medio del sistema digestivo (g\u00e1strico, 1,5\u20133,5; pancre\u00e1tico, 7,5; \u00e1cido biliar, 7\u20138) mientras atraviesa el TGI. Se sabe que el SARS-CoV-2 sobrevive en un amplio rango de valores de pH a temperatura ambiente (pH 3\u201310) [ [13](#B13)]. Los ARN virus como el de la influenza A y B (cuando se ingieren) pueden sobrevivir a los extremos de pH y mantener su infectividad con ayuda de la capa de moco que recubre el tracto gastrointestinal, lo que permite su paso seguro e incluso su excreci\u00f3n en las heces [ [63](#B63)]. Como las c\u00e9lulas mucosas son abundantes en todo el TGI, pueden contribuir al transporte y la supervivencia del SARS-CoV-2 [ [13](#B13)].\nCabe destacar que la mucosa intestinal sana podr\u00eda no favorecer la entrada del virus debido a la presencia de un sistema de barrera multicapa \u00fanico, aunque la presencia de una condici\u00f3n inflamatoria previa que altere la barrera de la mucosa puede volverla permisiva [\n[13](#B13), [64](#B64)]. Adem\u00e1s, una condici\u00f3n inflamatoria en el TGI puede favorecer la entrada del virus, al inducir la expresi\u00f3n de ACE2 en el epitelio de la mucosa [ [13](#B13)]. As\u00ed, una condici\u00f3n inflamatoria intestinal previa, como la enfermedad inflamatoria intestinal (EII), puede aumentar la susceptibilidad a la infecci\u00f3n por SARS-CoV-2 por v\u00eda fecal-oral [ [13](#B13)]. La composici\u00f3n del microbioma intestinal del sujeto es otro factor importante que influye en la contractibilidad y la gravedad de los s\u00edntomas [ [65](#B65)] (esto se analiza m\u00e1s a fondo en la subsecci\u00f3n Microbioma intestinal en la secci\u00f3n Factores del hu\u00e9sped que afectan la transmisibilidad, la gravedad y la evoluci\u00f3n de los pacientes).\nAdem\u00e1s de la v\u00eda fecal-oral, una ruta alternativa de entrada del virus a las c\u00e9lulas del TGI es a trav\u00e9s de la microvasculatura tisular [\n[13](#B13)]. La evidencia actual indica que la sangre transporta y transmite el SARS-CoV-2, y el endotelio vascular expresa abundantemente la ACE2 y la TMPRSS2 [ [45](#B45), [66](#B66)]. La inflamaci\u00f3n y la lesi\u00f3n tisular inducidas por la infecci\u00f3n viral, incluida la ruptura de los complejos de uni\u00f3n intercelular, pueden hacer que los peque\u00f1os vasos sean permeables para el paso del virus [ [67](#B67)].\nAdem\u00e1s del TGI, se han observado lesiones tisulares en otros componentes del sistema digestivo, como el h\u00edgado, las v\u00edas biliares y el p\u00e1ncreas [\n[34](#B34), [68](#B68)]. La elevaci\u00f3n de las enzimas hep\u00e1ticas ha sido un hallazgo frecuente en los casos graves de COVID-19 [ [68](#B68)]. Parad\u00f3jicamente, no ha habido evidencias claras de una invasi\u00f3n viral directa al tejido hep\u00e1tico [ [34](#B34)]; sin embargo, los estudios en modelos de organoides de tejidos humanos han demostrado que el SARS-CoV-2 puede infectar los hepatocitos, as\u00ed como los colangiocitos del epitelio ductal biliar [ [35](#B35)]. Cabe destacar que los estudios prote\u00f3micos y transcript\u00f3micos sugieren que la expresi\u00f3n del receptor de entrada de la c\u00e9lula hu\u00e9sped viral ACE2 se reduce principalmente a los colangiocitos [ [69](#B69)]. Al observar la limitada expresi\u00f3n de ACE2 en el tejido hep\u00e1tico, queda la posibilidad de que cualquier deterioro hep\u00e1tico en el COVID-19 pueda deberse principalmente no a una lesi\u00f3n v\u00edrica directa, sino a razones indirectas, como la hiperinflamaci\u00f3n sist\u00e9mica, la respuesta inmunitaria desregulada y la trombosis de los microvasos. La afectaci\u00f3n del p\u00e1ncreas en el COVID-19 es intrigante, porque se ha observado en los pacientes una grave alteraci\u00f3n de la glicemia, incluida la nueva aparici\u00f3n de diabetes (como se analiza m\u00e1s adelante en la subsecci\u00f3n Comorbilidades) [ [70](#B70), [71](#B71)]; sin embargo, a\u00fan no hay evidencias claras de que el COVID-19 pueda hacer esto por s\u00ed solo (revisado en [ [72](#B72)]). Aunque ha habido indicios vagos en estudios prote\u00f3micos y transcript\u00f3micos de alto rendimiento sobre la secreci\u00f3n de ACE2 por los componentes pancre\u00e1ticos [ [13](#B13)], los estudios de secuenciaci\u00f3n de ARN unicelular mostraron claramente una expresi\u00f3n significativa de ACE2 en las c\u00e9lulas beta secretoras de insulina, y se demostr\u00f3 que el SARS-CoV-2 es capaz de infectar las c\u00e9lulas endocrinas (alfa y beta) en organoides pancre\u00e1ticos humanos [ [35](#B35)].\nSistema nervioso\nSe han reportado s\u00edntomas neurol\u00f3gicos, leves en la mayor\u00eda de los casos, como cefalea, n\u00e1useas, v\u00f3mito, mareo y p\u00e9rdida de los sentidos (olfato y gusto), y en ciertos casos signos graves como ataxia, convulsiones, alteraci\u00f3n de la conciencia, accidente cerebrovascular isqu\u00e9mico o hemorr\u00e1gico, encefalomielitis aguda diseminada (ADEM), meningitis, encefalitis y, raramente, variantes del s\u00edndrome de Guillain-Barr\u00e9 (s\u00edndrome de Miller Fisher y polineuritis craneal) [\n[8](#B8), [73](#B73), [74](#B74), [75](#B75), [76](#B76)], as\u00ed como la aparici\u00f3n de s\u00edntomas psic\u00f3ticos [ [77](#B77)] en el COVID-19. Estudios de autopsia en fallecidos por COVID-19 han mostrado lesiones cerebrales generalizadas (que reflejan sobre todo una lesi\u00f3n hip\u00f3xico-isqu\u00e9mica aguda) [ [78](#B78)]. Aunque es poco frecuente, el ARN viral tambi\u00e9n se detecta en el tejido cerebral (78) y en el l\u00edquido cefalorraqu\u00eddeo (LCR) [ [74](#B74), [79](#B79)] de los fallecidos por COVID-19.\nLa forma como el SARS-CoV-2 entra en el sistema nervioso central y media en la patog\u00e9nesis de los s\u00edntomas neurol\u00f3gicos en pacientes con COVID-19 empieza a explicarse a la luz de nuevos datos [\n[80](#B80)]. La ruta m\u00e1s probable de diseminaci\u00f3n viral al cerebro es la propagaci\u00f3n transneuronal a trav\u00e9s de los nervios olfatorios. Tambi\u00e9n es posible la v\u00eda hemat\u00f3gena tras atravesar la barrera hematoencef\u00e1lica (BHE) [ [67](#B67)]. Los estudios observaron una expresi\u00f3n significativa de ACE2 y TMPRSS2 en las c\u00e9lulas del epitelio olfativo y la mielina (oligodendrocitos) y el endotelio neurovascular en humanos [ [80](#B80)]. Adem\u00e1s, diversos estudios de modelos en ratones transg\u00e9nicos, que expresan ACE2 humana, han demostrado la propagaci\u00f3n intracraneal del SARS-CoV-2 a otras partes del cerebro a trav\u00e9s de la v\u00eda olfativa tras la inoculaci\u00f3n intranasal [ [80](#B80)]. El conjunto de evidencias favorece fuertemente el potencial neuroinvasivo del SARS-CoV-2. Adem\u00e1s, la nueva aparici\u00f3n de s\u00edntomas psic\u00f3ticos en algunos pacientes del COVID-19 [ [77](#B77)] indica que se produce una patolog\u00eda sin\u00e1ptica en las regiones cerebrales asociadas con las funciones ejecutivas.\nLos estudios sugieren que los s\u00edntomas neurol\u00f3gicos (incluida la p\u00e9rdida del olfato y el gusto) pueden surgir debido al efecto neurop\u00e1tico directo del virus. Alternativamente, podr\u00eda tratarse de un efecto indirecto de la neuroinflamaci\u00f3n inducida por citocinas o de un efecto mediado por c\u00e9lulas inmunitarias [\n[81](#B81), [82](#B82)] sobre las neuronas (o las c\u00e9lulas gliales) o las c\u00e9lulas endoteliales de la microvasculatura cerebral, que inducen apoptosis celular y aumentan la permeabilidad vascular y el edema en el tejido cerebral relacionado.\nLa mediaci\u00f3n de la infecci\u00f3n por SARS-CoV-2 en el cerebro por el recientemente propuesto receptor alternativo NRP1 es muy plausible. Curiosamente, el NRP1 se expresa de forma significativa en el cerebro humano, incluidas las neuronas olfativas. La prueba del concepto de la entrada del SARS-CoV-2 en el cerebro mediada por el NRP1 procede de un estudio reciente de Cantuti-Castelvetri et al. [\n[29](#B29)] en el que se demuestra la presencia de la prote\u00edna spike del SARS-CoV-2 en las neuronas que expresan NRP1 y en las c\u00e9lulas endoteliales de capilares y vasos de tama\u00f1o medio del bulbo y el tracto olfativo en las muestras de autopsia del cerebro de los fallecidos por COVID-19. Los autores tambi\u00e9n demuestran en ratones, tras la administraci\u00f3n intranasal, la entrega dependiente de NRP1 de nanopart\u00edculas del tama\u00f1o del virus (80 nm de di\u00e1metro) al epitelio olfativo y a las c\u00e9lulas neuronales del bulbo olfativo y del sistema nervioso central (corteza), lo que significa que la v\u00eda olfativa es una ruta de entrada del SARS-CoV-2 en el cerebro [ [29](#B29)].\nLos s\u00edntomas neurol\u00f3gicos tambi\u00e9n pueden surgir por otros motivos, como la encefalopat\u00eda metab\u00f3lica derivada de la disfunci\u00f3n de \u00f3rganos vitales (como el pulm\u00f3n, el h\u00edgado y el ri\u00f1\u00f3n) [\n[7](#B7)] o un mayor riesgo de trombosis neurovascular en pacientes con COVID-19 grave [ [83](#B83)], comorbilidades asociadas o patolog\u00edas neurovasculares relacionadas con la edad.\nOtros sistemas y tipos de tejido\nEl COVID-19 no s\u00f3lo afecta los sistemas fisiol\u00f3gicos clave (mencionados anteriormente), sino tambi\u00e9n casi todos los dem\u00e1s sistemas [\n[5](#B5)], incluidos los \u00f3rganos sensoriales, es decir, los ojos [ [11](#B11)] y los o\u00eddos [ [10](#B10)], adem\u00e1s de los tegumentos, es decir, la piel, el pelo y las u\u00f1as [ [15](#B15), [16](#B16)]. La afectaci\u00f3n patol\u00f3gica de la mayor\u00eda de estos sistemas/tipos de tejido puede predecirse con base en la expresi\u00f3n de los factores de entrada a las c\u00e9lulas hu\u00e9sped del virus [ [31](#B31)] (Figura [(Figura2).2](/pmc/articles/PMC9059041/figure/F2/)). Los mecanismos responsables de la lesi\u00f3n del tejido infectado por el SARS-CoV-2 pueden ser m\u00faltiples, a saber, una lesi\u00f3n directa causada por la citotoxicidad v\u00edrica [ [1](#B1)], disfunci\u00f3n endotelial mediada por el receptor de entrada de la c\u00e9lula hu\u00e9sped v\u00edrica ACE2 y la consiguiente trombosis vascular [ [45](#B45)], o da\u00f1o inflamatorio debido a una respuesta inmunitaria excesiva contra la infecci\u00f3n [ [20](#B20)], o puede deberse a un mecanismo independiente del virus, como ciertas inmunopatolog\u00edas espec\u00edficas de los tejidos que actualmente no est\u00e1n bien explicadas [ [84](#B84)].\nRespuesta inmunitaria del hu\u00e9sped a la infecci\u00f3n por el SARS-CoV-2\nLa infecci\u00f3n por el SARS-CoV-2 provoca respuestas inmunitarias diferentes en los distintos individuos, las cuales determinan la gravedad de los s\u00edntomas [\n[85](#B85)]. Algunos individuos se recuperan con los s\u00edntomas m\u00e1s leves o permanecen completamente asintom\u00e1ticos; en cambio, en otros, la infecci\u00f3n v\u00edrica provoca manifestaciones graves de la enfermedad que dan lugar al SDRA y a la falla multiorg\u00e1nica [ [20](#B20)]. Al igual que en otras infecciones v\u00edricas, la defensa innata mediada por citocinas es la primera respuesta inmunitaria en los individuos infectados. Una forma peculiar de estado hiperinflamatorio sist\u00e9mico, caracterizado por niveles muy elevados de citocinas proinflamatorias, conocido como \u00abtormenta de citocinas\u00bb (TC) se observa com\u00fanmente en pacientes con COVID-19 grave [ [20](#B20)]. Cabe destacar que la TC no es exclusiva del COVID-19, y ha sido un hallazgo caracter\u00edstico en la fase grave de muchas otras enfermedades v\u00edricas respiratorias, como el SARS, el MERS y la influenza [ [86](#B86)]. Sin embargo, la TC inducida por el SARS-CoV-2 es diferente que la de otros virus respiratorios, porque el SARS-CoV-2 no induce necesariamente una firma com\u00fan de citocinas, como la interleucina (IL)-2, la IL-10, la IL-4 o la IL-5 [ [87](#B87)]. En el COVID-19, la TC se caracteriza por un conjunto particular de citocinas muy aumentadas en el suero de los pacientes, como la IL-2, la IL-7, el factor estimulante de colonias de granulocitos y macr\u00f3fagos (GM-CSF), el factor estimulante de colonias de granulocitos (G-CSF), la prote\u00edna 10 inducida por interfer\u00f3n gamma (IP10), la prote\u00edna inflamatoria de macr\u00f3fagos 1-\u03b1 (MIP1-\u03b1), la prote\u00edna quimioatrayente de monocitos 1 (MCP-1), el factor de necrosis tumoral \u03b1 (TNF\u03b1) y el interfer\u00f3n \u03b3 (IFN-\u03b3). Las concentraciones circulantes del ligando 10 de la quimiocina (motivo C-X-C) (CXCL10), del ligando 2 de la quimiocina (motivo C-C) (CCL2), de la IL-2R, de la IL-6, del TNF\u03b1, de la prote\u00edna C-reactiva (PCR) y de la ferritina son significativamente m\u00e1s elevadas en las personas que deben ingresar en la unidad de cuidados intensivos (UCI) [ [87](#B87)]. Adem\u00e1s, la TC se dirige especialmente a la desregulaci\u00f3n de la respuesta del IFN tipo I y sus citocinas descendentes [ [87](#B87)].\nLos investigadores de todo el mundo se esfuerzan por comprender las razones exactas de la mayor respuesta inmunitaria innata observada en los pacientes con COVID-19. Una revisi\u00f3n de la literatura existente sugiere que puede explicarse en parte por los hechos conocidos sobre las interacciones \u00fanicas entre el hu\u00e9sped y los virus respiratorios (revisado en [\n[20](#B20)]). La primera defensa del hu\u00e9sped contra una infecci\u00f3n v\u00edrica est\u00e1 marcada por un aumento de la mol\u00e9cula clave de la respuesta inmunitaria innata: el IFN\u03b1 [ [20](#B20)]. Al igual que en el SARS y el MERS [ [88](#B88)], se ha observado una respuesta retardada del IFN\u03b1 en el COVID-19, lo que indica que se trata de un mecanismo mediado por el virus para facilitar su entrada en la c\u00e9lula. Una respuesta inmune retardada facilitar\u00eda la entrada del virus en el epitelio pulmonar y eso, a su vez, llevar\u00eda a una intensa respuesta inflamatoria causada por el creciente reclutamiento del amplio repertorio de c\u00e9lulas inmunes innatas [ [89](#B89)]. Curiosamente, a diferencia de otros virus respiratorios, como el SARS-CoV, el MERS-CoV y el virus de la influenza tipo A (IVA), el SARS-CoV-2 parece utilizar una estrategia distintiva [ [90](#B90)]. El SARS-CoV-1, el MERS-CoV y el IVA provocan una atenuaci\u00f3n completa de la respuesta inmunitaria innata mediada por el IFN o las quimiocinas (citocinas proinflamatorias con propiedades quimioatrayentes) en el momento de la infecci\u00f3n. Por el contrario, el SARS-CoV-2 mostr\u00f3 una respuesta atenuada de IFN (tipo I, y tambi\u00e9n tipo III), pero parad\u00f3jicamente elev\u00f3 mucho las quimiocinas [ [89](#B89)] (Figura [(Figura5).5](/pmc/articles/PMC9059041/figure/F5/)). La atenuaci\u00f3n de la respuesta temprana del IFN contra la infecci\u00f3n por el SARS-CoV-2 est\u00e1 mediada por la prote\u00edna viral ORF3b [ [90](#B90)]. Esta dicotom\u00eda \u00fanica en la respuesta inmunitaria innata del hu\u00e9sped en el COVID-19 puede promover la invasi\u00f3n viral del epitelio respiratorio (y de las c\u00e9lulas epiteliales en otros sitios) y facilitar la replicaci\u00f3n viral. A su vez, una carga viral elevada en las c\u00e9lulas epiteliales infectadas del hu\u00e9sped puede inducir una lesi\u00f3n tisular y, como consecuencia, un aumento de la secreci\u00f3n de quimiocinas y del reclutamiento de c\u00e9lulas inmunitarias circulantes (Figura [(Figura5).5](/pmc/articles/PMC9059041/figure/F5/)). Una respuesta inmunitaria innata hiperactiva dificultar\u00eda, parad\u00f3jicamente, la eliminaci\u00f3n del virus y promover\u00eda una mayor replicaci\u00f3n viral [ [1](#B1)].\nUna respuesta inmunitaria adaptativa mediada por c\u00e9lulas T y humoral \u00f3ptima es habitual en los casos asintom\u00e1ticos y sintom\u00e1ticos leves. Por el contrario, en pacientes con COVID-19 grave, en el periodo inicial se observa una respuesta inmunitaria adaptativa mediada por c\u00e9lulas T protectora subumbral y retardada en los pacientes sintom\u00e1ticos. Sin embargo, los supervivientes mostraron una respuesta inmune adaptativa robusta y duradera [\n[91](#B91)] (revisado en [ [92](#B92)]).\nCuriosamente, se ha observado que las c\u00e9lulas Th1, un tipo de c\u00e9lulas T CD4 activadas, y las c\u00e9lulas Th17 similares a las c\u00e9lulas de memoria del tejido pulmonar (Trm 17), caracterizadas por una expresi\u00f3n potencialmente pat\u00f3gena de las citocinas IL-17A y GM-CSF, son m\u00e1s elevadas en los pacientes con enfermedad grave que en quienes padecen una enfermedad moderada [\n[93](#B93)]. Es interesante observar que el GM-CSF se elev\u00f3 de forma distintiva s\u00f3lo en los casos graves de COVID-19 y no en los de influenza cuando se compararon ambas condiciones [ [94](#B94)].\nLa linfocitopenia, en particular de c\u00e9lulas T y m\u00e1s intensamente de c\u00e9lulas T CD8, es una observaci\u00f3n com\u00fan independientemente del estadio y la gravedad de los casos de COVID-19 [\n[22](#B22)]. Sin embargo, la linfocitopenia se correlaciona con la gravedad de los s\u00edntomas, y un n\u00famero muy bajo de c\u00e9lulas T predice una mala evoluci\u00f3n de los pacientes [ [95](#B95), [96](#B96)]. Por el contrario, en la mayor\u00eda de los pacientes con s\u00edntomas leves o moderados y con un recuento estable de linfocitos, los anticuerpos neutralizantes [inmunoglobulina G (IgG)] para el spike viral u otras prote\u00ednas aparecen casi siempre entre los d\u00edas, 18 y 21, y el pron\u00f3stico es bastante bueno. Las razones moleculares de la muerte de las c\u00e9lulas T en el COVID-19 son poco conocidas [ [97](#B97)]. Cabe destacar que las c\u00e9lulas T muestran una menor expresi\u00f3n de los receptores de entrada del SARS-CoV-2, por lo que la muerte de las c\u00e9lulas T mediada por el virus en los individuos infectados puede producirse por alg\u00fan otro mecanismo y no por la se\u00f1alizaci\u00f3n del receptor viral [ [85](#B85)]. La atrofia y la lesi\u00f3n de los tejidos linfoides humanos, como el bazo y los ganglios linf\u00e1ticos, mediadas por el SARS-CoV-2 tambi\u00e9n se han evidenciado en estudios recientes [ [58](#B58), [98](#B98), [99](#B99)]. El an\u00e1lisis de los par\u00e1metros de laboratorio en pacientes con COVID-19 sugiere que los altos niveles de marcadores proinflamatorios, o la tormenta de citocinas podr\u00edan explicar la eliminaci\u00f3n de las c\u00e9lulas T [ [100](#B100)]. Los niveles de TNF-\u03b1, IL-6, IL-8 e IL-10 se encuentran significativamente aumentados y se correlacionan negativamente con los recuentos de c\u00e9lulas T en el COVID-19 grave [ [100](#B100)]. Es bien sabido que los niveles s\u00e9ricos elevados de TNF-\u03b1 y otras citocinas inducen apoptosis de las c\u00e9lulas T en las enfermedades inflamatorias, incluidos el SARS y el MERS [ [101](#B101)].\nDe acuerdo con la revisi\u00f3n de la evidencia disponible (discutida anteriormente), una mejor replicaci\u00f3n en las c\u00e9lulas del hu\u00e9sped que resulta en una mayor carga viral y la desregulaci\u00f3n mediada por el virus de la respuesta inmune innata y adaptativa del hu\u00e9sped parece ser el mecanismo m\u00e1s importante detr\u00e1s de la mayor virulencia y riesgo de mortalidad del SARS-CoV-2 con respecto a la influenza y otros BCoVs (SARS-CoV-1 y MERS-CoV). Por lo tanto, junto con una reducci\u00f3n de la replicaci\u00f3n viral mediante f\u00e1rmacos antivirales, el manejo de la respuesta inmunitaria desregulada del hu\u00e9sped, espec\u00edficamente la innata, mediante el uso de inmunomoduladores, citocinas antiinflamatorias y anticuerpos dirigidos a citocinas o las v\u00edas proinflamatorias, constituye una importante estrategia terap\u00e9utica en el COVID-19 (revisado en [\n[20](#B20)]). Cabe destacar que, adem\u00e1s de ser resultado de la desregulaci\u00f3n inducida por el SARS-CoV-2, la respuesta inmunitaria innata hiperactiva puede deberse a factores intr\u00ednsecos del sujeto [ [102](#B102), [103](#B103)]. Concretamente, en algunos adultos j\u00f3venes y sanos sin comorbilidad evidente, el desarrollo de COVID-19 grave y la posterior mortalidad indican claramente la presencia de una vulnerabilidad espec\u00edfica del sujeto [ [103](#B103)]. Es probable que estos individuos tengan una predisposici\u00f3n gen\u00e9tica o inmunofenot\u00edpica para desarrollar la enfermedad grave [ [102](#B102), [103](#B103)]. Discutimos esta cuesti\u00f3n con m\u00e1s detalle en la secci\u00f3n Factores del hu\u00e9sped que afectan la transmisibilidad, la gravedad y la evoluci\u00f3n de los pacientes (subsecci\u00f3n Factores gen\u00e9ticos e inmunofenot\u00edpicos).\nFisiopatolog\u00eda de la trombosis vascular y la falla multiorg\u00e1nica\nLa trombosis de los macrovasos y microvasos en los \u00f3rganos, especialmente en la vasculatura pulmonar, ha sido una manifestaci\u00f3n destacada del COVID-19 grave. La trombosis vascular se ha relacionado con la g\u00e9nesis de fallas multiorg\u00e1nicas y se ha asociado con desenlaces muy desfavorables de la enfermedad, incluyendo una mayor mortalidad. Se han sugerido m\u00faltiples razones para la etiolog\u00eda de la trombosis vascular en el COVID-19, como la toxicidad de las prote\u00ednas v\u00edricas, niveles elevados de marcadores proinflamatorios y la tormenta de citocinas, el impacto protromb\u00f3tico de la enfermedad grave y causas iatrog\u00e9nicas [\n[47](#B47), [104](#B104), [105](#B105)]. Sin embargo, un mecanismo mediado por la uni\u00f3n del SARS-CoV-2 al receptor ACE2 parece encontrarse en la ra\u00edz de todos estos mecanismos [ [45](#B45), [105](#B105), [106](#B106)]. Los factores de entrada del SARS-CoV-2 en la c\u00e9lula hu\u00e9sped, ACE2 y TMPRSS2, se coexpresan en las c\u00e9lulas endoteliales de los vasos sangu\u00edneos humanos y la microvasculatura [ [45](#B45)], as\u00ed como en los componentes de las c\u00e9lulas sangu\u00edneas, en particular las plaquetas [ [106](#B106)]. La regulaci\u00f3n a la baja de ACE2 inducida por la uni\u00f3n del SARS-CoV-2 puede inducir la activaci\u00f3n y liberaci\u00f3n de marcadores proinflamatorios y, por tanto, puede causar lesiones en el endotelio vascular [ [45](#B45), [107](#B107), [108](#B108)]. Adem\u00e1s, una inversi\u00f3n del cociente ACE/ACE2 en la disfunci\u00f3n del endotelio vascular tambi\u00e9n puede inducir trombosis [ [45](#B45)]. Se sabe que un valor m\u00e1s bajo del cociente ACE/ACE2 en el endotelio vascular evita la activaci\u00f3n de la cascada protromb\u00f3tica, al catalizar la degradaci\u00f3n de la angiotensina I (Ang I) a angiotensina 1\u20139 inactiva y de la angiotensina II (Ang II) a angiotensina 1\u20137, con funciones antiproliferativas, antifibr\u00f3ticas y vasodilatadoras por medio de los receptores Mas acoplados a prote\u00ednas G [ [45](#B45), [105](#B105)]. Por el contrario, un cociente ACE/ACE2 m\u00e1s elevado permite una mayor conversi\u00f3n de Ang I en Ang II y la uni\u00f3n de esta \u00faltima a sus receptores de tipo 1 (AT1), por lo que puede inducir vasoconstricci\u00f3n, inflamaci\u00f3n y fibrosis, y finalmente trombosis vascular [ [45](#B45), [105](#B105)]. Adem\u00e1s, la regulaci\u00f3n a la baja de la ACE2 mediada por el SARS-CoV-2 en el endotelio vascular puede activar la v\u00eda de la calicre\u00edna-bradiquinina, induciendo la agregaci\u00f3n plaquetaria y la filtraci\u00f3n de los vasos, que puede agravar a\u00fan m\u00e1s los episodios tromb\u00f3ticos [ [45](#B45)]. Alternativamente, la uni\u00f3n directa del SARS-CoV-2 a la ACE2 expresada en las plaquetas tambi\u00e9n puede inducir agregaci\u00f3n plaquetaria y la consiguiente trombosis [ [106](#B106)].\nEs plausible que la activaci\u00f3n del \u00absistema del complemento\u00bb del hu\u00e9sped por la toxicidad de las prote\u00ednas v\u00edricas y la respuesta inflamatoria sist\u00e9mica inducida por las citocinas pueda contribuir significativamente a la patog\u00e9nesis de la trombosis vascular [\n[20](#B20)]. Gao et al. [ [109](#B109)] demostraron recientemente en ratones que las prote\u00ednas N de los BCoV (SARS-CoV, MERS-CoV y SARS-CoV-2) se unen a la lectina serina proteasa 2 de uni\u00f3n a mananos (MASP-2) (una serina proteasa clave en la activaci\u00f3n del complemento), lo que provoca una activaci\u00f3n aberrante del sistema del complemento del hu\u00e9sped y, en consecuencia, trombosis microvascular y una lesi\u00f3n pulmonar inflamatoria agravada. De manera interesante, la activaci\u00f3n viral del sistema del complemento se revirti\u00f3 con la aplicaci\u00f3n de anticuerpos contra MASP-2 [ [109](#B109)].\nEn los vasos pulmonares, principalmente en los microvasos, se observa con frecuencia la neutrofilia y la formaci\u00f3n de trampas extracelulares de neutr\u00f3filos (NETs) en casos graves. La activaci\u00f3n de la NETosis conduce a un aumento de la concentraci\u00f3n de especies reactivas de ox\u00edgeno (ROS) intracelulares en los neutr\u00f3filos, lo que induce disfunci\u00f3n endotelial y activa las v\u00edas de coagulaci\u00f3n (tanto extr\u00ednsecas como intr\u00ednsecas), por lo que puede sumarse al evento de trombosis vascular en curso. La hiperviscosidad inducida por la hipoxia y la regulaci\u00f3n al alza de la v\u00eda de se\u00f1alizaci\u00f3n HIF-1\u03b1 (factor inducible por hipoxia 1 alfa) pueden ser factores adicionales que contribuyan a la trombosis [\n[5](#B5)].\nLa trombosis vascular, sumada a la toxicidad directa de las prote\u00ednas v\u00edricas en el tejido infectado y al desequilibrio hemodin\u00e1mico mediado por la desregulaci\u00f3n del SRAA, la hiperinflamaci\u00f3n sist\u00e9mica y el s\u00edndrome de choque t\u00f3xico derivado de la tormenta de citocinas, puede culminar en la falla multiorg\u00e1nica [\n[105](#B105), [110](#B110), [111](#B111)]. La presencia de comorbilidades y la vulnerabilidad espec\u00edfica del hu\u00e9sped ante los s\u00edntomas graves de la enfermedad pueden contribuir a\u00fan m\u00e1s a la patog\u00e9nesis de la falla multiorg\u00e1nica [ [21](#B21), [112](#B112)].\nEn la Figura\n[Figura66](/pmc/articles/PMC9059041/figure/F6/) se resume una descripci\u00f3n esquem\u00e1tica de la disfunci\u00f3n del endotelio vascular mediada por la ACE2, en la que interviene el SRAA, y las consiguientes incidencias tromb\u00f3ticas y el desarrollo de fallas multiorg\u00e1nicas en los pacientes con COVID-19.\nFactores del hu\u00e9sped que afectan la transmisibilidad, la gravedad y la evoluci\u00f3n de los pacientes\nAlgunos grupos de poblaci\u00f3n espec\u00edficos, principalmente varones, ancianos y personas con comorbilidades, se han visto afectados de forma m\u00e1s agresiva por el COVID-19 [\n[21](#B21)]. Las razones por las que la enfermedad afecta m\u00e1s a estos grupos de poblaci\u00f3n se est\u00e1n descubriendo gradualmente. La evidencia cient\u00edfica disponible se\u00f1ala los m\u00faltiples factores intr\u00ednsecos al hu\u00e9sped que son responsables de la mala evoluci\u00f3n en algunos individuos [ [21](#B21)]. En esta secci\u00f3n discutiremos brevemente la evidencia emp\u00edrica existente sobre la base patol\u00f3gica de la implicaci\u00f3n de los principales factores intr\u00ednsecos del hu\u00e9sped, que se ha descubierto influyen significativamente en la transmisibilidad, la gravedad y el desenlace de los pacientes de COVID-19.\nEdad\nEn el COVID-19 es com\u00fan observar una enfermedad m\u00e1s grave y una mayor mortalidad en individuos con m\u00e1s de 50 a\u00f1os, sobre todo en ancianos [\n[113](#B113), [114](#B114)]. Se han sugerido varios mecanismos biol\u00f3gicos para ello [ [115](#B115)]. La inmunosenescencia en los individuos de edad avanzada podr\u00eda ser la raz\u00f3n principal (116). La disponibilidad de c\u00e9lulas T naive, el cociente de c\u00e9lulas T CD4/CD8 y el n\u00famero de c\u00e9lulas T reguladoras (Treg) disminuye con el envejecimiento [ [117](#B117)]. Es plausible que la inmunosenescencia comprometa la respuesta contra un nuevo pat\u00f3geno, como el SARS-CoV-2 [ [118](#B118)]. Asimismo, la respuesta inflamatoria protectora empeora con el envejecimiento [ [116](#B116)]. Por otra parte, las personas de edad avanzada tienen m\u00e1s probabilidades de padecer comorbilidades graves [ [115](#B115)].\nEn cambio, en el grupo de edad pedi\u00e1trica se ha reportado un menor n\u00famero de casos y una mortalidad reducida. Sorprendentemente, se ha reportado un raro s\u00edndrome inflamatorio multisist\u00e9mico en ni\u00f1os (MIS-C) en todo el mundo en este grupo de edad [\n[119](#B119)]. El MIS-C se presenta entre 4 y 6 semanas despu\u00e9s de la infecci\u00f3n por el SARS-CoV-2 en forma de fiebre alta y disfunci\u00f3n org\u00e1nica, y los pacientes muestran marcadores de inflamaci\u00f3n muy elevados. La patog\u00e9nesis de la MIS-C a\u00fan no se conoce con claridad. Tiene caracter\u00edsticas cl\u00ednicas que se superponen con la enfermedad de Kawasaki, lo que sugiere que se trata de una vasculitis de etiolog\u00eda autoinmune [ [120](#B120)].\nSexo\nSe ha observado que la gravedad de la enfermedad y la mortalidad son significativamente mayores en los hombres que en las mujeres [\n[121](#B121)]. Un desglose de los datos globales actuales por sexo muestra que por cada 10 mujeres, respectivamente, 10 hombres est\u00e1n infectados, 12 son hospitalizados, 17 ingresan en la UCI y 13 mueren ( [https://globalhealth5050.org](https://globalhealth5050.org), con fecha 08/10/2021) [ [121](#B121)].\nLa base causal por la que los hombres se ven m\u00e1s afectados en el COVID-19 a\u00fan no se comprende bien. Se han sugerido varias razones para ello (revisado en [\n[122](#B122)]). Se han propuesto como razones biol\u00f3gicas de la mala evoluci\u00f3n de los hombres una mayor expresi\u00f3n de los factores de entrada del SARS-CoV-2 en las c\u00e9lulas hu\u00e9sped, ACE2 y TMPRSS2, en los \u00f3rganos reproductores de los hombres [ [123](#B123), [124](#B124), [125](#B125)] y la regulaci\u00f3n androg\u00e9nica de la TMPRSS2 [ [126](#B126)]. Por el contrario, la vinculaci\u00f3n con el cromosoma X y la regulaci\u00f3n mediada por estr\u00f3genos de m\u00faltiples genes de respuesta inmunitaria, incluidos el IFN tipo 1 y el sensor viral TLR-7, podr\u00edan ser las razones principales por las que el pron\u00f3stico es comparativamente mejor en mujeres [ [127](#B127), [128](#B128)].\nComorbilidades\nLas comorbilidades son los factores del hu\u00e9sped que m\u00e1s contribuyen a la gravedad del COVID-19. Los factores que m\u00e1s han contribuido al COVID-19 han sido, respectivamente, las enfermedades cardiovasculares, la diabetes, las enfermedades respiratorias cr\u00f3nicas, la hipertensi\u00f3n y la tejido tejido (revisado en [\n[129](#B129)]).\nLa hipertensi\u00f3n y la obesidad pueden predecir de forma independiente la evoluci\u00f3n de los pacientes con COVID-19 [\n[130](#B130), [131](#B131)], y la diabetes preexistente puede incrementar el riesgo de padecer una enfermedad grave/cr\u00edtica y la mortalidad intrahospitalaria en aproximadamente 2 y 3 veces, respectivamente [ [129](#B129), [132](#B132)]. Las razones de la mayor vulnerabilidad al COVID-19 en presencia de comorbilidades a\u00fan no se comprenden bien. Es plausible que el da\u00f1o residual y la desregulaci\u00f3n de la fisiolog\u00eda pulmonar, y tambi\u00e9n de los dem\u00e1s \u00f3rganos vitales, en los pacientes con comorbilidades se sumen a la patolog\u00eda inducida por el COVID-19 [ [129](#B129)]. La desregulaci\u00f3n del SRAA mediada por el receptor de entrada de la c\u00e9lula hu\u00e9sped del SARS-CoV-2, ACE2, tambi\u00e9n puede intervenir en ello [ [45](#B45)].\nLa obesidad establece un estado de inflamaci\u00f3n sist\u00e9mica cr\u00f3nica y tambi\u00e9n cambia el fenotipo de las c\u00e9lulas inmunitarias de antiinflamatorias a proinflamatorias (c\u00e9lulas T CD4 de Th2 a Th1, y macr\u00f3fagos de M2 a M1) e induce un aumento de la secreci\u00f3n de adipocitocinas proinflamatorias, como la leptina, y una disminuci\u00f3n de la secreci\u00f3n de adipoquinas antiinflamatorias, como la adiponectina, lo que favorece una respuesta inflamatoria grave contra cualquier nueva infecci\u00f3n [\n[133](#B133)]. Por lo tanto, la obesidad puede agravar la patolog\u00eda del COVID-19 al inducir una respuesta inflamatoria temprana y excesiva contra la infecci\u00f3n viral, como las tormentas de citocinas [ [134](#B134)].\nEn estudios recientes se han observado cambios en la glucemia, incluida la aparici\u00f3n de diabetes y mayores complicaciones en algunos pacientes con COVID-19 [\n[72](#B72), [135](#B135)]. El aumento de la mortalidad relacionado con complicaciones diab\u00e9ticas ha sido frecuente en pacientes con COVID-19 [ [132](#B132)]. El SARS-CoV-2 puede invadir las c\u00e9lulas de los islotes pancre\u00e1ticos productoras de insulina [ [35](#B35)]. Adem\u00e1s, la regulaci\u00f3n a la baja mediada por ACE2 del cotransportador 1 de sodio-glucosa (SGLT1) en el epitelio intestinal previene la hiperglucemia en modelos de diabetes mellitus en ratas [ [13](#B13)]. La regulaci\u00f3n a la baja de la expresi\u00f3n de ACE2 mediada por el SARS-CoV-2 puede conducir a la regulaci\u00f3n al alza de SGLT1, precipitando as\u00ed la hiperglucemia [ [13](#B13)]. Adem\u00e1s del intestino, el SGLT1 se expresa en otros tejidos humanos, como el t\u00fabulo proximal del ri\u00f1\u00f3n, el coraz\u00f3n y el h\u00edgado (proteinatlas.org/ENSG00000100170-SLC5A1/tissue). Por lo tanto, una invasi\u00f3n de las c\u00e9lulas de los islotes pancre\u00e1ticos mediada por ACE2 y la desregulaci\u00f3n de SGLT1 en el epitelio intestinal pueden ser mecanismos plausibles para la aparici\u00f3n de diabetes en los pacientes de COVID-19.\nFactores gen\u00e9ticos e inmunofenot\u00edpicos\nSe conocen variantes polim\u00f3rficas para el receptor de entrada a la c\u00e9lula hu\u00e9sped del SARS-CoV-2, ACE2, y las proteasas del hu\u00e9sped asociadas, como TMPRSS2 [\n[136](#B136), [137](#B137)] y furina [ [138](#B138)]. Es posible que algunas de estas variantes polim\u00f3rficas de los receptores del SARS-CoV-2 sean m\u00e1s comunes en las personas con una vulnerabilidad baja o alta para infectarse, o bien que afecten la gravedad de los s\u00edntomas y la mortalidad del COVID-19 [ [137](#B137)].\nAlgunos estudios sugieren que la existencia de mutaciones en los sensores v\u00edricos del hu\u00e9sped y en los genes de la respuesta inmune podr\u00eda aumentar la vulnerabilidad para el desarrollo de COVID-19 grave. Se ha descubierto que una mutaci\u00f3n del receptor tipo Toll-7 (TLR-7) \u2212 un sensor viral (tambi\u00e9n para los coronavirus) en las c\u00e9lulas del hu\u00e9sped \u2212 est\u00e1 asociada con el COVID-19 grave [\n[102](#B102)]. Otro estudio ha reportado que al menos 3.5% de los pacientes con neumon\u00eda por COVID-19 potencialmente mortal ten\u00edan mutaciones conocidas en los genes de la respuesta inmunitaria, como el factor regulador de interfer\u00f3n 7 (IRF7) y el receptor de interfer\u00f3n (IFN)-alfa 1 y 2 (IFNAR1 y -2), TLR3, la mol\u00e9cula adaptadora 1 que contiene el dominio TIR (TICAM1), la quinasa de uni\u00f3n a TANK 1 (TBK1) y el factor regulador de IFN 3 (IRF3) [ [139](#B139)].\nSe han encontrado dos regiones gen\u00f3micas especialmente asociadas con el COVID-19 grave: una regi\u00f3n en el cromosoma 3 (locus 3p31.21) que contiene seis genes y otra en el cromosoma 9 (locus 9q34.2) que representa los grupos sangu\u00edneos ABO [\n[21](#B21), [140](#B140)]. Curiosamente, las variantes gen\u00e9ticas del cromosoma 3 (45.859.651\u201345.909.024 (hg19)) se introdujeron en la poblaci\u00f3n humana mediante un flujo gen\u00e9tico procedente de hom\u00ednidos arcaicos no-Homo sapiens: los neandertales [ [141](#B141)]. Se han reportado asociaciones en todo el genoma en m\u00faltiples loci cromos\u00f3micos adem\u00e1s de los 3 y 9, como en la cr12q24.13 (rs10735079) en un grupo de genes que codifican activadores de enzimas de restricci\u00f3n antivirales (OAS1, OAS2, OAS3), en la cr19p13 2 (rs2109069) cerca del gen que codifica la tirosina quinasa 2 (TYK2), en el chr19p13.3 (rs2109069) en el gen que codifica la dipeptidil peptidasa 9 (DPP9), y en el chr21q22.1 (rs2236757) en el gen IFNAR2 [ [103](#B103), [140](#B140)]. Por el contrario, un estudio reciente descubri\u00f3 que un haplotipo de 75 kb en el cromosoma 12 (pares de bases 113.350.796 a 113.425.679, rs1156361) se asociaba con una reducci\u00f3n de \u223c22% en el riesgo relativo de desarrollar COVID-19 grave [ [142](#B142)]. Se sugiri\u00f3 que los individuos con variantes del ant\u00edgeno leucocitario humano (HLA), B*46:01 y B*15:03, respectivamente, eran m\u00e1s y menos propensos al SARS-CoV-2 y al COVID-19 grave [ [143](#B143)].\nEl papel de los mecanismos epigen\u00e9ticos en la respuesta inmunitaria del hu\u00e9sped en el COVID-19 se demostr\u00f3 en un reciente estudio in vitro en el que se utilizaron tamices CRISPR de edici\u00f3n del genoma (repeticiones palindr\u00f3micas cortas agrupadas y regularmente interespaciadas) en c\u00e9lulas Vero-E6. Los autores identificaron las mol\u00e9culas reguladoras epigen\u00e9ticas High Mobility Group Box 1 (HMGB1) y el complejo de remodelaci\u00f3n de la cromatina SWItch/Sucrose Non-Fermentable (SWI/SNF), cr\u00edticas para la muerte de las c\u00e9lulas hu\u00e9sped inducida por coronavirus, incluido el SARS-CoV-2 [\n[144](#B144)].\nSe descubri\u00f3 que las personas del grupo sangu\u00edneo O ten\u00edan una probabilidad ligeramente menor de contraer COVID-19, as\u00ed como una protecci\u00f3n relativa contra el desarrollo de s\u00edntomas graves y la muerte en comparaci\u00f3n con las personas de los grupos sangu\u00edneos A, B y AB [\n[145](#B145), [146](#B146), [147](#B147)]. Cabe destacar que en un estudio de casos y controles muy reciente, en el que se incluy\u00f3 un n\u00famero elevado de pacientes con COVID-19 (m\u00e1s de 11.000 casos positivos), no se encontraron riesgos aumentados en las personas con grupos sangu\u00edneos A, B y AB, ni protecci\u00f3n alguna para el grupo sangu\u00edneo O contra la infecci\u00f3n, la hospitalizaci\u00f3n, la gravedad de la enfermedad ni su evoluci\u00f3n [ [148](#B148)].\nLa autoinmunidad tambi\u00e9n ha sido un factor en la patog\u00e9nesis de los s\u00edntomas graves en el COVID-19. En un estudio se observ\u00f3 que al menos 10.2% de los pacientes con 25 a 87 a\u00f1os ten\u00edan autoanticuerpos contra el IFN tipo I, y de ellos 95 (94%) eran hombres. Se ha observado otro caso de generaci\u00f3n de autoanticuerpos en pacientes con COVID-19 contra los fosfol\u00edpidos de la c\u00e9lula hu\u00e9sped [\n[149](#B149)]. La presencia de anticuerpos antifosfol\u00edpidos (aPL) protromb\u00f3ticos en el suero de los pacientes con COVID-19 tambi\u00e9n podr\u00eda ser una raz\u00f3n de la mayor incidencia de trombos en algunos pacientes [ [150](#B150), [151](#B151)]. Por el contrario, un estudio de Borghi et al. [ [152](#B152)] encontr\u00f3 una baja prevalencia de aPL en los pacientes con COVID-19 y ninguna asociaci\u00f3n entre la trombosis y los aPL.\nMicrobioma intestinal\nSe afirma que el microbioma intestinal desempe\u00f1a un papel importante en la gravedad de la enfermedad y en la evoluci\u00f3n de los pacientes con COVID-19, porque refuerza la inmunidad local de la mucosa contra las invasiones virales [\n[153](#B153)]. Estudios recientes han demostrado que los pacientes con COVID-19 tienen un microbioma diferente al de los controles, enriquecido con los pat\u00f3genos oportunistas, y el agotamiento de los comensales beneficiosos mostr\u00f3 correlaci\u00f3n con la gravedad de los s\u00edntomas [ [65](#B65), [154](#B154)]. Estos estudios han indicado adem\u00e1s que la composici\u00f3n del microbioma intestinal puede influir en la producci\u00f3n de citocinas inflamatorias inducida por el SARS-CoV-2 y, por consiguiente, en la aparici\u00f3n de la tormenta de citocinas [ [65](#B65), [153](#B153), [155](#B155)].\nInmunidad cruzada y protecci\u00f3n contra la enfermedad grave\nSe encontraron c\u00e9lulas T y anticuerpos reactivos al SARS-CoV-2 en muchos individuos sin exposici\u00f3n previa [\n[156](#B156), [157](#B157)], lo que indica que las infecciones previas con otros CoVs podr\u00edan haber causado esto. Las infecciones respiratorias en humanos por CoVs, especialmente los que causan el resfriado com\u00fan, son comunes. La evidencia acumulada sugiere que las exposiciones existentes a las cepas del resfriado com\u00fan pueden proteger del desarrollo de s\u00edntomas graves en los infectados con SARS-CoV-2 [ [158](#B158)]. Adem\u00e1s de los CoV, las infecciones con otros virus respiratorios, las vacunas recientes contra la influenza y las vacunas infantiles con bacterias/virus vivos atenuados, como el bacilo de Calmette-Gu\u00e9rin (BCG) y la vacuna contra sarampi\u00f3n-paperas-rubeola (MMR) pueden ser parcialmente protectoras [ [159](#B159), [160](#B160), [161](#B161), [162](#B162)]. Se desconocen los mecanismos biol\u00f3gicos exactos de la protecci\u00f3n; sin embargo, un mecanismo epigen\u00e9tico que conduzca a la \u00abinmunidad entrenada\u00bb de las c\u00e9lulas mieloides por las exposiciones previas a pat\u00f3genos relacionados puede ser una causa plausible, de acuerdo con la informaci\u00f3n disponible en la literatura [ [163](#B163)].\nPosible fisiopatolog\u00eda del \u00abCOVID persistente\u00bb\nLa persistencia o reaparici\u00f3n de los s\u00edntomas cl\u00ednicos en forma de \u00abCOVID persistente\u00bb constituye un problema de salud importante en los pacientes dados de alta de COVID-19 [\n[17](#B17), [18](#B18), [19](#B19)]. Adem\u00e1s de la persistencia o recurrencia de ciertos s\u00edntomas cl\u00ednicos, se ha reportado un posible riesgo de infertilidad en varones, fatiga cr\u00f3nica y la aparici\u00f3n de diabetes en los supervivientes de COVID-19 [ [17](#B17), [19](#B19), [72](#B72), [164](#B164)]. Adem\u00e1s, se ha observado la formaci\u00f3n de autoanticuerpos en muchos pacientes con COVID-19, lo que indica que los supervivientes pueden tener mayor riesgo de sufrir trastornos autoinmunes [ [149](#B149), [165](#B165)]. La aparici\u00f3n de discapacidades [ [165](#B165), [166](#B166)] y la probable reducci\u00f3n de la esperanza de vida, tal y como indican estudios recientes [ [167](#B167), [168](#B168)], son preocupaciones importantes en los supervivientes. Tambi\u00e9n se observan problemas de salud a largo plazo en la infecci\u00f3n por otros BCoV, como el SARS-CoV-1 y el MERS-CoV [ [169](#B169)]; sin embargo, a\u00fan no se conocen bien las razones. Aunque en la actualidad no se comprende claramente su fisiopatolog\u00eda, se han planteado diversas especulaciones con base en los hechos conocidos sobre las interacciones entre el virus y el hu\u00e9sped en el COVID-19. En general, la enfermedad cr\u00f3nica y la posterior escarificaci\u00f3n y disfunci\u00f3n de los \u00f3rganos afectados pueden ocasionar problemas de salud a largo plazo [ [167](#B167)]. Adem\u00e1s, la infecci\u00f3n cr\u00f3nica por el SARS-CoV-2 puede inducir cambios epigen\u00e9ticos en \u00f3rganos vitales, reprogramando as\u00ed sus funciones, como se demostr\u00f3 recientemente en un modelo murino de COVID-19, lo que puede preparar el terreno para los problemas de salud a largo plazo [ [38](#B38)]. La inhibici\u00f3n radical del crecimiento celular en las c\u00e9lulas infectadas por el virus en los \u00f3rganos puede ser otro mecanismo molecular importante que conduzca a problemas de salud a largo plazo [ [37](#B37)]. La inhibici\u00f3n del crecimiento celular puede afectar especialmente a los tejidos con alta tasa mit\u00f3tica, como los \u00f3rganos reproductores y endocrinos, el epitelio vascular y de las mucosas, y las regiones cerebrales neurog\u00e9nicas; por tanto, los problemas de salud, incluidos los relacionados con el aprendizaje y la memoria, pueden surgir a largo plazo en los supervivientes del COVID-19.\nEl rostro cambiante de la pandemia: Cambio en las interacciones hu\u00e9sped-virus con las nuevas variantes del SARS-CoV-2\nLa amplia propagaci\u00f3n de la primera oleada de COVID-19 m\u00e1s all\u00e1 de sus l\u00edmites geogr\u00e1ficos habr\u00eda creado una barrera inmunol\u00f3gica en la poblaci\u00f3n infectada contra la cepa de tipo salvaje (WT) del SARS-CoV-2 (nCoV-2019), lo cual, se esperaba, limitar\u00eda las oleadas recurrentes. Parad\u00f3jicamente, se produjeron nuevas oleadas masivas de COVID-19 impulsadas por variantes emergentes de SARS-CoV-2 en los a\u00f1os 2020\u20132021 en todo el mundo [\n[170](#B170), [171](#B171), [172](#B172), [173](#B173)]. Las variantes emergentes del SARS-CoV-2, que parecen tener mayor transmisibilidad y virulencia y son capaces de escapar a la inmunidad natural y adquirida (por vacunas y anticuerpos monoclonales utilizados terap\u00e9uticamente) contra las cepas WT [ [172](#B172), [173](#B173), [174](#B174), [175](#B175)] (Tabla [(Tabla2),2](/pmc/articles/PMC9059041/table/T2/)), han frustrado la esperanza de un final m\u00e1s r\u00e1pido para la pandemia. Los recientes modelos in situ y en animales, as\u00ed como los estudios cl\u00ednicos, han confirmado que las variantes tienen un periodo de incubaci\u00f3n m\u00e1s corto, una mayor carga viral y una excreci\u00f3n viral prolongada [ [176](#B176), [177](#B177), [178](#B178), [179](#B179), [180](#B180), [181](#B181)]. Las variantes pueden causar mayores da\u00f1os en el tejido del hu\u00e9sped infectado; sin embargo, a\u00fan se desconoce si ha habido cambios en el tipo de tejido que afectan o en la patog\u00e9nesis espec\u00edfica en los \u00f3rganos [ [172](#B172)]. La OMS ha identificado cuatro variantes preocupantes (VOC) y cuatro variantes de inter\u00e9s (VOI) en el mundo [ [173](#B173)]. Las variantes del SARS-CoV-2 se caracterizan por mutaciones clave espec\u00edficas de cada linaje en las regiones de la prote\u00edna spike, y se considera que contribuyen a aumentar la transmisibilidad o la virulencia y el escape inmunitario a los anticuerpos naturales y adquiridos por la vacuna [ [3](#B3), [172](#B172), [176](#B176), [177](#B177)] (Figura [(Figura7).7](/pmc/articles/PMC9059041/figure/F7/)). Muchas de las mutaciones de la prote\u00edna spike son comunes a todas las variantes, lo que indica su evoluci\u00f3n convergente y su ventaja selectiva para la aptitud epidemiol\u00f3gica [ [2](#B2)] (Figura [(Figura7).7](/pmc/articles/PMC9059041/figure/F7/)). Las mutaciones espec\u00edficas del linaje tambi\u00e9n est\u00e1n presentes en las regiones no-spike de las variantes [ [182](#B182)]; sin embargo, todav\u00eda se sabe poco sobre su importancia epidemiol\u00f3gica.\nTable 2\n|Etiqueta OMS||Pango Linajes||Estado de la variante (OMS/CDC)||Clado GISAID||Clado Nextstrain||Mutaciones clave en Spike (frecuencia >75%)*||Primer reporte||Fecha de designaci\u00f3n||Transmisi\u00f3n*||Letalidad*||Inmunoescape*|\n|Alfa||B.1.17||Variante preocupante (VOC)#||GRY||20I (V1)||GRY 69del, 70del, 144del, E484K.S494P, N501 Y, A570D, D614G, P681H, T716I, S982A, D1118H K1191N||Reino Unido, Sep-2020||s18-Dic-2020||\u02dc50% mayor transmisi\u00f3n comparada con B.1||Posible aumento de la gravedad con base en las tasas de hospitalizaci\u00f3n y de mortalidad||\u2022 Sin impacto en la susceptibilidad a tratamientos con anticuerpos monoclonales|\n\u2022 Impacto m\u00ednimo en la neutralizaci\u00f3n por suero de convalecientes y vacunados\n|\n|\n|Beta||B.1.351|\nB.1.351.2\nB.1.351.3\n|VOC#||GH/501Y.V2||20 H (V2)||69del, 70del, 144del, E484K, S494P, N501Y, A570D, D614G, P681H, T716I, S982A, D1118H, K1191N||Sudafrica, May-2020||18-Dic-2020||\u02dc50% mayor transmisi\u00f3n||M\u00e1s letal||\u2022 Reducci\u00f3n significativa en susceptibilidad a la combinaci\u00f3n de anticuerpos monoclonales bamlanivimab y etesevimab|\n\u2022 Reducci\u00f3n en la neutralizaci\u00f3n por suero de convalecientes y vacunados\n|\n|\n|Gamma||P.1|\nP.1.1\nP.1.2\nP.1.4\nP.1.6\nP.1.7\n|VOC#||GR/501Y.V3||20J (V3)||L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y, T1027I||Brasil, Nov-2020||11-Ene-2021||A\u00fan no determinada||M\u00e1s letal||\u2022 Reducci\u00f3n significativa en susceptibilidad a la combinaci\u00f3n de anticuerpos monoclonales bamlanivimab y etesevimab|\n\u2022 Reducci\u00f3n en la neutralizaci\u00f3n por suero de convalecientes y vacunados\n|\n|\n|Delta||B.1.617.2|\nAY.1\nAY.2\nAY.3\nAY.3.1\n|VOC#||G/478K.V1||21A||T19R,(G142D), 156del, 157del, R158G, L452R, T478K.D614G, P681R, D950N||India, Oct-2020||VOI:4-Abr-2021 VOC: 11-May-2021||\u02dc50\u201360% mayor transmisi\u00f3n comparada con B.1.1.7||Resultados preliminares sugieren que el riesgo de hospitalizaci\u00f3n en 14 d\u00edas es 2.61 veces mayor que el de B.1.1.7||\u2022 Reducci\u00f3n potencial de neutralizaci\u00f3n por algunos tratamientos con anticuerpos monoclonales|\n\u2022 Reducci\u00f3n potencial de la neutralizaci\u00f3n por suero de pacientes vacunados\n|\n|\n|Lambda||C.37||Variante de inter\u00e9s (VOI)#||GR/452Q.V1||21G||D614G, L452Q, F490S, T859N, T76I, G75V, del247/253||Per\u00fa, Dic-2020||14-Jun-2021||A\u00fan no determinada||A\u00fan no determinada||\u2022 A\u00fan no determinado|\n|\n|\n|Mu||B.1.621, B.1.621.1||VOI#||GH||21H||Spike: T95I, Y144S, Y145N, R346K, E484K, N501 Y, D614G, P681H, D950N||Colombia, Ene-2021||Sep-2021||31-Aug-2021||A\u00fan no determinada||\u2022 A\u00fan no determinado|\n|\n|\n|Eta||B.1.525||Variante bajo monitoreo (VOB)*||G/484K.V3||21D||A67V,69del, 70del, 144del, E484K.D614G, Q677H, F888L||M\u00faltiples pa\u00edses, Dic-2020||17-Mar-2021||A\u00fan no determinada||A\u00fan no determinada||\u2022 Reducci\u00f3n potencial de neutralizaci\u00f3n por algunos tratamientos con anticuerpos monoclonales|\n\u2022 Reducci\u00f3n potencial en la neutralizaci\u00f3n por suero de convalecientes y vacunados\n|\n|\n|Iota||B.1.526||Variante bajo monitoreo (VOB)*||GH/253G.V1||21F||L5F, T95I, D253G, S477N, E484K.D614G, A701V||Estados Unidos de Am\u00e9rica, Nov-2020||24-Mar-2021||A\u00fan no determinada||A\u00fan no determinada||\u2022 Reducci\u00f3n en susceptibilidad a la combinaci\u00f3n de anticuerpos monoclonales bamlanivimab y etesevimab|\n\u2022 Reducci\u00f3n en la neutralizaci\u00f3n por suero de convalecientes y vacunados\n|\n|\n|Kappa||B.1.617.1||Variante bajo monitoreo (VOB)*||G/452R.V3||21B||T95I.G142D, E154K, L452R, E484Q, D614G, P681R, Q1071H||India, Oct-2020||4-Abr-2021||M\u00e1s transmisible||Mayor letalidad en un modelo animal. En humanos, a\u00fan no determinada||\u2022 Reducci\u00f3n potencial de neutralizaci\u00f3n por algunos tratamientos con anticuerpos monoclonales|\n\u2022 Reducci\u00f3n potencial en la neutralizaci\u00f3n por suero de convalecientes y vacunados\nMecanismos plausibles para una mayor transmisibilidad/virulencia y capacidad de escape inmunol\u00f3gico en las variantes del virus\nSe ha reportado un aumento en la transmisibilidad o la virulencia en casi todas las VOC y m\u00faltiples VOI [\n[174](#B174)] (Tabla [(Tabla2).2](/pmc/articles/PMC9059041/table/T2/)). Ciertas regiones de la prote\u00edna spike contienen el sitio de uni\u00f3n con el receptor de entrada a la c\u00e9lula hu\u00e9sped y con los anticuerpos naturales y adquiridos del hu\u00e9sped. Se cree que algunas mutaciones clave en la prote\u00edna spike (Tabla [(Tabla2),2](/pmc/articles/PMC9059041/table/T2/)), principalmente en el dominio de uni\u00f3n al receptor (RBD), inducen cambios conformacionales que dan lugar a una mayor uni\u00f3n al receptor de entrada a la c\u00e9lula hu\u00e9sped, ACE2 [ [2](#B2), [3](#B3)]. Adem\u00e1s, ciertas mutaciones han creado nuevos sitios de contacto, enlaces electrost\u00e1ticos m\u00e1s fuertes o nuevos enlaces de hidr\u00f3geno entre el RBD y el ACE2 del hu\u00e9sped [ [2](#B2)] (revisado en [ [176](#B176), [177](#B177)]].\nEs interesante que las mutaciones en la secuencia de la prote\u00edna spike de ciertas variantes (linaje B.1.1.7 y B.1.617) que se producen en la posici\u00f3n del amino\u00e1cido 681 (P-H/R), que cae en el FCS, mejoran la escisi\u00f3n proteol\u00edtica de la prote\u00edna spike, reforzando la fusi\u00f3n de la membrana viral con la membrana de la c\u00e9lula hu\u00e9sped (revisado en [\n[1](#B1)]). Se especula que una mejor fusi\u00f3n entre el virus y la c\u00e9lula hu\u00e9sped da lugar a una mayor formaci\u00f3n de sincitios [ [1](#B1)]. Se cree que la formaci\u00f3n de sincicios, la fusi\u00f3n de la c\u00e9lula hu\u00e9sped infectada con otras c\u00e9lulas, facilita la propagaci\u00f3n viral, lo que confiere mayor transmisibilidad a las variantes [ [183](#B183), [184](#B184), [185](#B185)]. En particular, la formaci\u00f3n de sincitios ha sido una caracter\u00edstica distintiva del SARS-CoV-2 con respecto al SARS-CoV-1 (revisado en [ [1](#B1)]).\nAdem\u00e1s del aumento en la transmisibilidad y la virulencia, estudios recientes han demostrado que la mayor\u00eda de las variantes, principalmente las VOC, han adquirido cierto nivel de resistencia contra la inmunidad natural y adquirida (por vacunas y anticuerpos monoclonales utilizados terap\u00e9uticamente) [\n[174](#B174)] (Tabla [(Tabla2).2](/pmc/articles/PMC9059041/table/T2/)). Se han reportado frecuentes reinfecciones y escape de la inmunidad vacunal con las variantes [ [172](#B172), [186](#B186), [187](#B187)]. Los mecanismos exactos de la adquisici\u00f3n de la capacidad de escape inmunitario en las variantes no se conocen bien. Sin embargo, seg\u00fan la literatura emergente, los mecanismos de escape inmunol\u00f3gico m\u00e1s probables son (i) la inclusi\u00f3n o eliminaci\u00f3n de residuos de amino\u00e1cidos en los ep\u00edtopos inmunog\u00e9nicos (para los anticuerpos naturales y adquiridos), lo que conlleva cambios conformacionales en la interfaz de uni\u00f3n [ [2](#B2), [3](#B3), [4](#B4), [176](#B176), [177](#B177)]; (ii) la remodelaci\u00f3n del potencial de superficie electrost\u00e1tico en la interfaz de uni\u00f3n ant\u00edgeno-anticuerpo [ [2](#B2), [3](#B3), [4](#B4), [176](#B176), [177](#B177)]; y (iii) la adquisici\u00f3n de sitios de glicosilaci\u00f3n adicionales, que protegen el sitio de uni\u00f3n con los anticuerpos neutralizantes [ [188](#B188)]. Se necesitan m\u00e1s estudios para desentra\u00f1ar los mecanismos que utilizan las variantes para escapar del sistema inmunitario.\nObservaciones finales\nSe han llevado a cabo extensas investigaciones en todo el mundo para desentra\u00f1ar los diversos mecanismos implicados en la patog\u00e9nesis y las respuestas inmunitarias del hu\u00e9sped para el COVID-19. Estos estudios se han centrado principalmente en la prote\u00f3mica y la gen\u00f3mica virales y en los factores dependientes del hu\u00e9sped. Se han realizado amplios estudios experimentales con modelos de COVID-19 basados en cultivos celulares y en animales. Adem\u00e1s, se ha deducido una adaptaci\u00f3n espec\u00edfica para el ser humano de los mecanismos de interacci\u00f3n entre el virus y el hu\u00e9sped a partir de los datos de laboratorio de pacientes con COVID-19 y de estudios experimentales con organoides de tejidos humanos. A la luz de los amplios descubrimientos realizados hasta ahora, tenemos un conocimiento amplio de las interacciones entre el virus y el hu\u00e9sped, el tropismo tisular y la patog\u00e9nesis espec\u00edfica en los \u00f3rganos, la participaci\u00f3n de los sistemas fisiol\u00f3gicos y la respuesta inmunitaria humana contra la infecci\u00f3n por el SARS-CoV-2. La expresi\u00f3n generalizada de los factores de entrada del SARS-CoV-2 en los tejidos humanos, la desregulaci\u00f3n del SRAA y una respuesta inmunitaria innata hiperactiva acompa\u00f1ada de una inmunidad adaptativa retardada o suprimida parecen ser los factores clave de las manifestaciones sist\u00e9micas y la mala evoluci\u00f3n cl\u00ednica de los pacientes. La inclusi\u00f3n de FCS en la secuencia de la prote\u00edna spike puede ser una raz\u00f3n para el aumento de la virulencia del SARS-CoV-2. Adem\u00e1s, la atenuaci\u00f3n de la respuesta temprana al IFN y la subsiguiente tormenta de citocinas, as\u00ed como una respuesta inmunitaria adaptativa suprimida/retrasada, marcada por una intensa linfocitopenia y una s\u00edntesis sub\u00f3ptima de inmunoglobulinas, son las caracter\u00edsticas inmunol\u00f3gicas m\u00e1s destacadas, que parecen impulsar la gravedad de la enfermedad. Los factores gen\u00e9ticos preexistentes pueden estar detr\u00e1s de la mayor vulnerabilidad de ciertos individuos a contraer la infecci\u00f3n y de la agudizaci\u00f3n de la enfermedad; sin embargo, a\u00fan se sabe poco sobre esta cuesti\u00f3n. El microbioma intestinal tambi\u00e9n puede desempe\u00f1ar un papel importante en la evoluci\u00f3n de la enfermedad, tal y como indica la literatura emergente. Quedan m\u00faltiples lagunas en el conocimiento sobre varios aspectos de la enfermedad, que deben abordarse en futuros estudios. Adem\u00e1s, la persistencia o recurrencia de los s\u00edntomas en forma de \u00abCOVID persistente\u00bb es una preocupaci\u00f3n sanitaria seria, que debe investigarse a fondo. Y lo que es m\u00e1s importante, las variantes emergentes del SARS-CoV-2 que impulsan las oleadas recurrentes de COVID-19, causadas por el aumento de la transmisibilidad/virulencia y la capacidad de escape inmunitario, requieren una investigaci\u00f3n m\u00e1s profunda para abordar con precisi\u00f3n su(s) mecanismo(s).\nConflictos de inter\u00e9s\nLos autores declaran que la investigaci\u00f3n se llev\u00f3 a cabo en ausencia de cualquier relaci\u00f3n comercial o financiera que pudiera interpretarse como posible conflicto de inter\u00e9s.\nInformaci\u00f3n sobre licencias\nAshutosh Kumar, Ravi K. Narayan, Pranav Prasoon, Chiman Kumari, Gurjot Kaur, Santosh Kumar, Maheswari Kulandhasamy, Kishore Sesham, Vikas Pareek, Muneeb A. Faiq, Sada N. Pandey, Himanshu N. Singh, Kamla Kant, Prakash S. Shekhawat, Khursheed Raza, Sujeet Kumar: COVID-19 Mechanisms in the Human Body \u2212 What We Know So Far. Front Immunol. 2021 Nov 1;12:693938. \u00a9 2021 Los Autores (traducci\u00f3n; contribuci\u00f3n de los autores, nota del editorial, agradecimientos abreviada), protegido por CC BY 4.0 (\n[https://creativecommons.org/licenses/by/4.0/deed.es](https://creativecommons.org/licenses/by/4.0/deed.es)).\nReferences\n[PubMed](https://pubmed.ncbi.nlm.nih.gov/33085084)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=J+Med+Virol&title=SARS-CoV-2-Specific+Virulence+Factors+in+COVID-19&author=A+Kumar&author=P+Prasoon&author=C+Kumari&author=V+Pareek&author=MA+Faiq&volume=93&publication_year=2020&pages=1343-50&pmid=33085084&)] [PMC free article](/pmc/articles/PMC8611377/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/34168071)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Science+(80-&title=Effect+of+Natural+Mutations+of+SARS-CoV-2+on+Spike+Structure,+Conformation,+and+Antigenicity&author=SM-C+Gobeil&author=K+Janowska&author=S+McDowell&author=K+Mansouri&author=R+Parks&volume=373&issue=(6555)&publication_year=2021&pages=eabi6226&)] [PMC free article](/pmc/articles/PMC9245151/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/34168070)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Science+(80\u2212)&title=Structural+Basis+for+Enhanced+Infectivity+and+Immune+Evasion+of+SARS-CoV-2+Variants&author=Y+Cai&author=J+Zhang&author=T+Xiao&author=CL+Lavine&author=S+Rawson&volume=373&publication_year=2021&pages=642-8&)] [PMC free article](/pmc/articles/PMC9835956/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/34210893)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Science+(80\u2212)&title=SARS-CoV-2+Immune+Evasion+by+the+B.1.427/B.1.429+Variant+of+Concern&author=M+McCallum&author=J+Bassi&author=A+De+Marco&author=A+Chen&author=AC+Walls&volume=373&publication_year=2021&pages=648-54&)] [PubMed](https://pubmed.ncbi.nlm.nih.gov/32651579)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Nat+Med&title=Extrapulmonary+Manifestations+of+COVID-19&author=A+Gupta&author=MV+Madhavan&author=K+Sehgal&author=N+Nair&author=S+Mahajan&volume=26&publication_year=2020&pages=1017-32&pmid=32651579&)] [PMC free article](/pmc/articles/PMC7195311/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32305884)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=J+Clin+Virol&title=Epidemiology+and+Clinical+Features+of+COVID-19:+A+Review+of+Current+Literature&author=JA+Siordia&volume=127&publication_year=2020&pages=104357&pmid=32305884&)] [PMC free article](/pmc/articles/PMC7092819/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32109013)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&title=Clinical+Characteristics+of+Coronavirus+Disease+2019+in+China&author=W+Guan&author=Z+Ni&author=Y+Hu&author=W+Liang&author=C+Ou&volume=382&publication_year=2020&pages=1708-20&pmid=32109013&)] [PMC free article](/pmc/articles/PMC7149362/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32275288)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=JAMA+Neurol&title=Neurologic+Manifestations+of+Hospitalized+Patients+With+Coronavirus+Disease+2019+in+Wuhan,+China&author=L+Mao&author=H+Jin&author=M+Wang&author=Y+Hu&author=S+Chen&volume=77&publication_year=2020&pages=683-90&pmid=32275288&)] [PMC free article](/pmc/articles/PMC7200363/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32389615)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Schizophr+Res&title=The+Potential+Impact+of+COVID-19+on+Psychosis:+A+Rapid+Review+of+Contemporary+Epidemic+and+Pandemic+Research&author=E+Brown&author=R+Gray&author=S+Lo+Monaco&author=B+O'Donoghue&author=B+Nelson&volume=222&publication_year=2020&pages=79-87&pmid=32389615&)] [PMC free article](/pmc/articles/PMC7752038/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33365394)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Laryngoscope+Investig+Otolaryngol&title=Otologic+Dysfunction+in+Patients+With+COVID-19:+A+Systematic+Review&author=S+Maharaj&author=M+Bello+Alvarez&author=S+Mungul&author=K+Hari&volume=5&issue=(6)&publication_year=2020&pages=1192-6&)] [PMC free article](/pmc/articles/PMC7110919/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32232433)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=JAMA+Ophthalmol&title=Characteristics+of+Ocular+Findings+of+Patients+With+Coronavirus+Disease+2019+(COVID-19)+in+Hubei+Province,+China&author=P+Wu&author=F+Duan&author=C+Luo&author=Q+Liu&author=X+Qu&volume=138&publication_year=2020&pages=575-8&pmid=32232433&)] [PMC free article](/pmc/articles/PMC7370876/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32690910)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Cardiol&title=COVID-19+and+Cardiovascular+Disease:+From+Basic+Mechanisms+to+Clinical+Perspectives&author=M+Nishiga&author=DW+Wang&author=Y+Han&author=DB+Lewis&author=JC+Wu&volume=17&publication_year=2020&pages=543-58&pmid=32690910&)] [PMC free article](/pmc/articles/PMC7487155/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33254575)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Med+Hypotheses&title=Relevance+of+SARS-CoV-2+Related+Factors+ACE2+and+TMPRSS2+Expressions+in+Gastrointestinal+Tissue+With+Pathogenesis+of+Digestive+Symptoms,+Diabetes-Associated+Mortality,+and+Disease+Recurrence+in+COVID-19+Patients&author=A+Kumar&author=MA+Faiq&author=V+Pareek&author=K+Raza&author=RK+Narayan&volume=144&publication_year=2020&pages=110271&pmid=33254575&)] [PMC free article](/pmc/articles/PMC7202828/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32423587)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Lancet&title=COVID-19-Associated+Nephritis:+Early+Warning+for+Disease+Severity+and+Complications?&author=O+Gross&author=O+Moerer&author=M+Weber&author=TB+Huber&author=S+Scheithauer&volume=395&publication_year=2020&pages=e87-8&pmid=32423587&)] [PMC free article](/pmc/articles/PMC7323324/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32535979)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=J+Eur+Acad+Dermatol+Venereol&title=The+Red+Half-Moon+Nail+Sign:+A+Novel+Manifestation+of+Coronavirus+Infection&author=I+Neri&author=A+Guglielmo&author=A+Virdi&author=V+Gaspari&author=M+Starace&volume=34&publication_year=2020&pages=e663-5&pmid=32535979&)] [PMC free article](/pmc/articles/PMC7422480/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32849867)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Dermatol+Res+Pract&title=A+Review+of+the+Dermatological+Manifestations+of+Coronavirus+Disease+2019+(COVID-19)&author=F+Marraha&author=I+Al+Faker&author=S+Gallouj&volume=2020&publication_year=2020&pages=9360476&pmid=32849867&)] [PMC free article](/pmc/articles/PMC7611399/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33692530)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Nat+Med&title=Attributes+and+Predictors+of+Long+COVID&author=CH+Sudre&author=B+Murray&author=T+Varsavsky&author=MS+Graham&author=RS+Penfold&volume=27&publication_year=2021&pages=1-6&pmid=33442018&)] [PubMed](https://pubmed.ncbi.nlm.nih.gov/32665317)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=BMJ&title=Covid-19:+What+do+We+Know+About+\u201cLong+Covid\u201d?&author=E+Mahase&volume=370&publication_year=2020&pages=m2815&pmid=32665317&)] [PMC free article](/pmc/articles/PMC7392393/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32730238)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=MMWR+Morb+Mortal+Wkly+Rep&title=Symptom+Duration+and+Risk+Factors+for+Delayed+Return+to+Usual+Health+Among+Outpatients+With+COVID-19+in+a+Multistate+Health+Care+Systems+Network+\u2014+United+States,+March\u2013June+2020&author=MW+Tenforde&author=SS+Kim&author=CJ+Lindsell&author=E+Billig+Rose&author=NI+Shapiro&volume=69&publication_year=2020&pages=993-8&pmid=32730238&)] [PubMed](https://pubmed.ncbi.nlm.nih.gov/33111578)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Int+Rev+Immunol&title=Pathogenesis+Guided+Therapeutic+Management+of+COVID-19:+An+Immunological+Perspective&author=A+Kumar&author=P+Prasoon&author=PS+Sekhawat&author=V+Pareek&author=MA+Faiq&volume=40&publication_year=2020&pages=1-18&)] [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Precis+Clin+Med&title=Host/genetic+Factors+Associated+With+COVID-19+Call+for+Precision+Medicine&author=A.+R.+Thierry&volume=3&issue=(3)&publication_year=2020&pages=228-34&)] [PubMed](https://pubmed.ncbi.nlm.nih.gov/32434211)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Nature&title=Viral+and+Host+Factors+Related+to+the+Clinical+Outcome+of+COVID-19&author=X+Zhang&author=Y+Tan&author=Y+Ling&author=G+Lu&author=F+Liu&volume=583&publication_year=2020&pages=1-7&)] [PMC free article](/pmc/articles/PMC8389999/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/34454673)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Lancet&title=1-Year+Outcomes+in+Hospital+Survivors+With+COVID-19:+A+Longitudinal+Cohort+Study&author=L+Huang&author=Q+Yao&author=X+Gu&author=Q+Wang&author=L+Ren&volume=398&publication_year=2021&pages=747-58&pmid=34454673&)] [PMC free article](/pmc/articles/PMC7102627/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32142651)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Cell&title=SARS-CoV-2+Cell+Entry+Depends+on+ACE2+and+TMPRSS2+and+Is+Blocked+by+a+Clinically+Proven+Protease+Inhibitor&author=M+Hoffmann&author=H+Kleine-Weber&author=S+Schroeder&author=N+Kr\u00fcger&author=T+Herrler&volume=181&publication_year=2020&pages=271-80.e8&pmid=32142651&)] [PMC free article](/pmc/articles/PMC7114094/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32057769)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Antiviral+Res&title=The+Spike+Glycoprotein+of+the+New+Coronavirus+2019-Ncov+Contains+a+Furin-Like+Cleavage+Site+Absent+in+CoV+of+the+Same+Clade&author=B+Coutard&author=C+Valle&author=X+de+Lamballerie&author=B+Canard&author=NG+Seidah&volume=176&publication_year=2020&pages=104742&pmid=32057769&)] [PMC free article](/pmc/articles/PMC6682551/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/31406574)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Clin+Transl+Immunol&title=Furin\u2010mediated+protein+processing+in+infectious+diseases+and+cancer&author=E.+Braun&author=D.+Sauter&volume=8&issue=(8)&publication_year=2019&pages=e1073&)] [PMC free article](/pmc/articles/PMC7289711/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32532959)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Signal+Transduct+Target+Ther&title=The+Role+of+Furin+Cleavage+Site+in+SARS-CoV-2+Spike+Protein-Mediated+Membrane+Fusion+in+the+Presence+or+Absence+of+Trypsin&author=S+Xia&author=Q+Lan&author=S+Su&author=X+Wang&author=W+Xu&volume=5&publication_year=2020&pages=1-3&pmid=32296011&)] [PMC free article](/pmc/articles/PMC8175039/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33494095)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=bioRxiv&title=Furin+Cleavage+Site+Is+Key+to+SARS-CoV-2+Pathogenesis&author=BA+Johnson&author=X+Xie&author=B+Kalveram&author=KG+Lokugamage&author=A+Muruato&publication_year=2020&)] [PMC free article](/pmc/articles/PMC7857391/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33082293)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Science+(80\u2212)&title=Neuropilin-1+Facilitates+SARS-CoV-2+Cell+Entry+and+Infectivity&author=L+Cantuti-Castelvetri&author=R+Ojha&author=LD+Pedro&author=M+Djannatian&author=J+Franz&volume=370&publication_year=2020&pages=eabd2985&)] [PMC free article](/pmc/articles/PMC7612957/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33082294)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Science+(80\u2212)&title=Neuropilin-1+is+a+Host+Factor+for+SARS-CoV-2+Infection&author=JL+Daly&author=B+Simonetti&author=K+Klein&author=KE+Chen&author=MK+Williamson&volume=370&publication_year=2020&pages=861-5&)] [PMC free article](/pmc/articles/PMC7252096/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32413319)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Cell&title=SARS-CoV-2+Receptor+ACE2+Is+an+Interferon-Stimulated+Gene+in+Human+Airway+Epithelial+Cells+and+Is+Detected+in+Specific+Cell+Subsets+Across+Tissues&author=CGK+Ziegler&author=SJ+Allon&author=SK+Nyquist&author=IM+Mbano&author=VN+Miao&volume=181&publication_year=2020&pages=1016-35.e19&pmid=32413319&)] [PMC free article](/pmc/articles/PMC8637938/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32327758)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Nat+Med&title=SARS-CoV-2+Entry+Factors+Are+Highly+Expressed+in+Nasal+Epithelial+Cells+Together+With+Innate+Immune+Genes&author=W+Sungnak&author=N+Huang&author=C+B\u00e9cavin&author=M+Berg&author=R+Queen&volume=26&publication_year=2020&pages=1-7&pmid=31932805&)] [Google Scholar](https://scholar.google.com/scholar_lookup?journal=bioRxiv&title=Integrated+Analyses+of+Single-Cell+Atlases+Reveal+Age,+Gender,+and+Smoking+Status+Associations+With+Cell+Type-Specific+Expression+of+Mediators+of+SARS-CoV-2+Viral+Entry+and+Highlights+Inflammatory+Programs+in+Putative+Target+Cells&author=C+Muus&author=MD+Luecken&author=G+Eraslan&author=A+Waghray&author=G+Heimberg&publication_year=2020&)] [PubMed](https://pubmed.ncbi.nlm.nih.gov/32817204)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=J+Clin+Pathol&title=Histopathological+Observations+in+COVID-19:+A+Systematic+Review&author=V+Deshmukh&author=R+Motwani&author=A+Kumar&author=C+Kumari&author=K+Raza&volume=74&publication_year=2020&pages=1-8&pmid=32907914&)] [PMC free article](/pmc/articles/PMC7303620/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32579880)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Cell+Stem+Cell&title=A+Human+Pluripotent+Stem+Cell-Based+Platform+to+Study+SARS-CoV-2+Tropism+and+Model+Virus+Infection+in+Human+Cells+and+Organoids&author=L+Yang&author=Y+Han&author=BE+Nilsson-Payant&author=V+Gupta&author=P+Wang&volume=27&publication_year=2020&pages=125-136.e7&pmid=32579880&)] [PMC free article](/pmc/articles/PMC7321036/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32645325)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Cell&title=Krogan+Correspondence+NJ.+The+Global+Phosphorylation+Landscape+of+SARS-CoV-2+Infection&author=M+Bouhaddou&author=D+Memon&author=DL+Swaney&author=P+Beltrao&volume=182&publication_year=2020&pages=685-712&pmid=32645325&)] [PMC free article](/pmc/articles/PMC7418786/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32877642)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Mol+Cell&title=Growth+Factor+Receptor+Signaling+Inhibition+Prevents+SARS-CoV-2+Replication&author=K+Klann&author=D+Bojkova&author=G+Tascher&author=S+Ciesek&author=C+M\u00fcnch&volume=80&publication_year=2020&pages=164-e4&pmid=32877642&)] [PMC free article](/pmc/articles/PMC7934846/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33284134)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=JCI+Insight&title=Metabolic+Reprogramming+and+Epigenetic+Changes+of+Vital+Organs+in+SARS-CoV-2\u2013Induced+Systemic+Toxicity&author=S+Li&author=F+Ma&author=T+Yokota&author=G+Garcia&author=A+Palermo&volume=6&publication_year=2021&pages=e145027&)] [PMC free article](/pmc/articles/PMC7402621/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32680882)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Science&title=Structural+Basis+for+Translational+Shutdown+and+Immune+Evasion+by+the+Nsp1+Protein+of+SARS-CoV-2&author=M+Thoms&author=R+Buschauer&author=M+Ameismeier&author=L+Koepke&author=T+Denk&volume=369&publication_year=2020&pages=1249-55&pmid=32680882&)] [PMC free article](/pmc/articles/PMC7381649/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32709886)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Nat+Commun&title=Structural+Basis+of+RNA+Cap+Modification+by+SARS-CoV-2&author=T+Viswanathan&author=S+Arya&author=S-H+Chan&author=S+Qi&author=N+Dai&volume=11&publication_year=2020&pages=3718&pmid=32709886&)] [PMC free article](/pmc/articles/PMC7343387/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32452762)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Elife&title=SARS-CoV-2+Strategically+Mimics+Proteolytic+Activation+of+Human+ENaC&author=P+Anand&author=A+Puranik&author=M+Aravamudan&author=AJ+Venkatakrishnan&author=V+Soundararajan&volume=9&publication_year=2020&pages=e58603&pmid=32452762&)] [PMC free article](/pmc/articles/PMC5524836/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/28791006)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Front+Immunol&title=Regulation+of+Lung+Epithelial+Sodium+Channels+by+Cytokines+and+Chemokines&author=BM+Wynne&author=L+Zou&author=V+Linck&author=RS+Hoover&author=HP+Ma&volume=8&publication_year=2017&pages=766&pmid=28791006&)] [PMC free article](/pmc/articles/PMC6349474/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/30585851)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Curr+Opin+Nephrol+Hypertens&title=New+Insights+Regarding+Epithelial+Na++Channel+Regulation+and+Its+Role+in+the+Kidney,+Immune+System+and+Vasculature&author=SM+Mutchler&author=TR+Kleyman&volume=28&issue=(2)&publication_year=2019&pages=113-9&pmid=30585851&)] [PMC free article](/pmc/articles/PMC7415847/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32771682)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=EBioMedicine&title=SARS-CoV-2+and+ACE2:+The+Biology+and+Clinical+Data+Settling+the+ARB+and+ACEI+Controversy&author=MK+Chung&author=S+Karnik&author=J+Saef&author=C+Bergmann&author=J+Barnard&volume=58&publication_year=2020&pages=102907&pmid=32771682&)] [PMC free article](/pmc/articles/PMC7525265/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33032170)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Med+Hypotheses&title=SARS-CoV-2+Cell+Entry+Receptor+ACE2+Mediated+Endothelial+Dysfunction+Leads+to+Vascular+Thrombosis+in+COVID-19+Patients&author=A+Kumar&author=RK+Narayan&author=C+Kumari&author=MA+Faiq&author=M+Kulandhasamy&volume=145&publication_year=2020&pages=110320&pmid=33032170&)] [PMC free article](/pmc/articles/PMC7347958/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32493030)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=American+Journal+of+Physiology-Lung+Cellular+and+Molecular+Physiology&title=Thoughts+on+the+Alveolar+Phase+of+COVID-19&author=R.+J.+Mason&volume=319&issue=(1)&publication_year=2020&pages=L115-20&pmid=32493030&)] [PMC free article](/pmc/articles/PMC7412750/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32437596)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&title=Pulmonary+Vascular+Endothelialitis,+Thrombosis,+and+Angiogenesis+in+Covid-19&author=M+Ackermann&author=SE+Verleden&author=M+Kuehnel&author=A+Haverich&author=T+Welte&volume=383&publication_year=2020&pages=120-8&pmid=32437596&)] [PubMed](https://pubmed.ncbi.nlm.nih.gov/33086866)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Arterioscler+Thromb+Vasc+Biol&title=ACE2+(Angiotensin-Converting+Enzyme+2)+and+TMPRSS2+(Transmembrane+Serine+Protease+2)+Expression+and+Localization+of+SARS-CoV-2+Infection+in+the+Human+Heart&author=A+Sakamoto&author=R+Kawakami&author=K+Kawai&author=A+Gianatti&author=D+Pellegrini&volume=41&publication_year=2020&pages=542-4&pmid=33086866&)] [PMC free article](/pmc/articles/PMC7194533/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32360126)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Life+Sci&title=Myocardial+Injury+and+COVID-19:+Possible+Mechanisms&author=S+Babapoor-Farrokhran&author=D+Gill&author=J+Walker&author=RT+Rasekhi&author=B+Bozorgnia&volume=253&publication_year=2020&pages=117723&pmid=32360126&)] [PMC free article](/pmc/articles/PMC7385672/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32730555)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=JAMA+Cardiol&title=Association+of+Cardiac+Infection+With+SARS-CoV-2+in+Confirmed+COVID-19+Autopsy+Cases&author=D+Lindner&author=A+Fitzek&author=H+Br\u00e4uninger&author=G+Aleshcheva&author=C+Edler&volume=5&publication_year=2020&pages=1281-5&pmid=32730555&)] [PMC free article](/pmc/articles/PMC7191628/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32228252)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Am+J+Physiol+Heart+Circ+Physiol&title=COVID-19,+ACE2,+and+the+Cardiovascular+Consequences&author=AM+South&author=DI+Diz&author=MC+Chappell&volume=318&publication_year=2020&pages=H1084-90&pmid=32228252&)] [PMC free article](/pmc/articles/PMC7236830/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32341103)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Eur+Respir+J&title=Understanding+the+Renin-Angiotensin-Aldosterone-SARS-CoV+Axis:+A+Comprehensive+Review&author=NE+Ingraham&author=AG+Barakat&author=R+Reilkoff&author=T+Bezdicek&author=T+Schacker&volume=56&publication_year=2020&pages=2000912&pmid=32341103&)] [PMC free article](/pmc/articles/PMC10016902/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32943474)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Postgrad+Med+J&title=K+C+MB.+COVID-19+and+the+Heart:+What+We+Have+Learnt+So+Far&author=KB+Shaha&author=DN+Manandhar&author=JR+Cho&author=A+Adhikari&volume=97&publication_year=2020&pages=655-66&pmid=32943474&)] [PMC free article](/pmc/articles/PMC7781399/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33398605)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Clin+Exp+Nephrol&title=Hypokalemia+in+Patients+With+COVID-19&author=G+Alfano&author=A+Ferrari&author=F+Fontana&author=R+Perrone&author=G+Mori&volume=25&publication_year=2021&pages=1-9&pmid=32857255&)] [PMC free article](/pmc/articles/PMC7316659/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32903321)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Kidney+Dis+(Basel)&title=Localization+of+Cell+Receptor-Related+Genes+of+SARS-CoV-2+in+the+Kidney+Through+Single-Cell+Transcriptome+Analysis&author=QL+Chen&author=JQ+Li&author=ZD+Xiang&author=Y+Lang&author=GJ+Guo&volume=6&publication_year=2020&pages=258-70&pmid=32903321&)] [PMC free article](/pmc/articles/PMC7144544/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32273593)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Nephrol&title=Kidney+Involvement+in+COVID-19+and+Rationale+for+Extracorporeal+Therapies&author=C+Ronco&author=T+Reis&volume=16&issue=(6)&publication_year=2020&pages=308-10&pmid=32273593&)] [PMC free article](/pmc/articles/PMC7646060/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33022818)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Rev+Med+Virol&title=Covid-19+and+Kidney+Injury:+Pathophysiology+and+Molecular+Mechanisms&author=E+Ahmadian&author=SM+Hosseiniyan+Khatibi&author=S+Razi+Soofiyani&author=S+Abediazar&author=MM+Shoja&volume=31&publication_year=2020&pages=e2176&pmid=33022818&)] [PMC free article](/pmc/articles/PMC7365650/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32682491)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Lancet&title=Histopathology+and+Ultrastructural+Findings+of+Fatal+COVID-19+Infections+in+Washington+State:+A+Case+Series&author=BT+Bradley&author=H+Maioli&author=R+Johnston&author=I+Chaudhry&author=SL+Fink&volume=396&publication_year=2020&pages=320-32&pmid=32682491&)] [PubMed](https://pubmed.ncbi.nlm.nih.gov/32405028)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Nat+Med&title=Infection+of+Bat+and+Human+Intestinal+Organoids+by+SARS-CoV-2&author=J+Zhou&author=C+Li&author=X+Liu&author=MC+Chiu&author=X+Zhao&volume=26&publication_year=2020&pages=1-7&pmid=31932805&)] [PMC free article](/pmc/articles/PMC7199907/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32358202)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Science+(80\u2212)&title=SARS-CoV-2+Productively+Infects+Human+Gut+Enterocytes&author=MM+Lamers&author=J+Beumer&author=J+van+der+Vaart&author=K+Knoops&author=J+Puschhof&volume=369&publication_year=2020&pages=eabc1669&)] [PMC free article](/pmc/articles/PMC7725054/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33307034)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Gastroenterology&title=The+Gastrointestinal+Tract+Is+an+Alternative+Route+for+SARS-CoV-2+Infection+in+a+Nonhuman+Primate+Model&author=L+Jiao&author=H+Li&author=J+Xu&author=M+Yang&author=C+Ma&volume=160&publication_year=2020&pages=1647-61&pmid=33307034&)] [PMC free article](/pmc/articles/PMC7883337/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33589829)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Gastroenterol+Hepatol&title=Potential+Intestinal+Infection+and+Faecal\u2013Oral+Transmission+of+SARS-CoV-2&author=M+Guo&author=W+Tao&author=RA+Flavell&author=S+Zhu&volume=18&publication_year=2021&pages=1-15&pmid=32963339&)] [PubMed](https://pubmed.ncbi.nlm.nih.gov/28498998)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=J+Infect+Dis&title=Mechanism+of+Human+Influenza+Virus+RNA+Persistence+and+Virion+Survival+in+Feces:+Mucus+Protects+Virions+From+Acid+and+Digestive+Juices&author=R+Hirose&author=T+Nakaya&author=Y+Naito&author=T+Daidoji&author=Y+Watanabe&volume=216&publication_year=2017&pages=105-9&pmid=28498998&)] [PMC free article](/pmc/articles/PMC7694956/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33172188)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Microorganisms&title=Intestinal+Barrier+Function+in+Health+and+Disease-Any+role+of+SARS-CoV-2?&author=L+Sharma&author=A+Riva&volume=8&publication_year=2020&pages=1-27&)] [PMC free article](/pmc/articles/PMC7314193/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32497191)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Clin+Infect+Dis&title=Alterations+of+the+Gut+Microbiota+in+Patients+With+Coronavirus+Disease+2019+or+H1N1+Influenza&author=S+Gu&author=Y+Chen&author=Z+Wu&author=Y+Chen&author=H+Gao&volume=71&publication_year=2020&pages=2669-78&pmid=32497191&)] [PMC free article](/pmc/articles/PMC7605324/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33138836)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=J+Transl+Med&title=Detection+of+Novel+Coronavirus+(SARS-CoV-2)+RNA+in+Peripheral+Blood+Specimens&author=M+Azghandi&author=MA+Kerachian&volume=18&publication_year=2020&pages=412&pmid=33138836&)] [PMC free article](/pmc/articles/PMC7547916/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33053430)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Neurobiol+Dis&title=The+SARS-CoV-2+Spike+Protein+Alters+Barrier+Function+in+2D+Static+and+3D+Microfluidic+in-Vitro+Models+of+the+Human+Blood\u2013Brain+Barrier&author=TP+Buzhdygan&author=BJ+DeOre&author=A+Baldwin-Leclair&author=TA+Bullock&author=HM+McGary&volume=146&publication_year=2020&pages=105131&pmid=33053430&)] [PMC free article](/pmc/articles/PMC7189193/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32388469)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=J+Clin+Virol&title=Gastrointestinal,+Hepatobiliary,+and+Pancreatic+Manifestations+of+COVID-19&author=KP+Patel&author=PA+Patel&author=RR+Vunnam&author=AT+Hewlett&author=R+Jain&volume=128&publication_year=2020&pages=104386&pmid=32388469&)] [PMC free article](/pmc/articles/PMC7444942/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32861070)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=BioMed+Pharmacother&title=ACE2,+TMPRSS2+Distribution+and+Extrapulmonary+Organ+Injury+in+Patients+With+COVID-19&author=M+Dong&author=J+Zhang&author=X+Ma&author=J+Tan&author=L+Chen&volume=131&publication_year=2020&pages=110678&pmid=32861070&)] [PMC free article](/pmc/articles/PMC7304415/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32530585)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&title=New-Onset+Diabetes+in+Covid-19&author=F+Rubino&author=SA+Amiel&author=P+Zimmet&author=G+Alberti&author=S+Bornstein&volume=383&publication_year=2020&pages=789-90&pmid=32530585&)] [PMC free article](/pmc/articles/PMC7220586/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32404898)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Eur+J+Clin+Nutr&title=Diabetes+and+COVID-19:+Evidence,+Current+Status+and+Unanswered+Research+Questions&author=R+Gupta&author=A+Hussain&author=A+Misra&volume=74&publication_year=2020&pages=864-70&pmid=32404898&)] [PMC free article](/pmc/articles/PMC7669477/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33395782)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Diabetes+&+Metabolic+Syndrome:+Clinical+Research+&+Reviews&title=New+Onset+Diabetes,+Type+1+Diabetes+and+COVID-19&author=S.+K.+Boddu&author=G.+Aurangabadkar&author=M.+S.+Kuchay&volume=14&issue=(6)&publication_year=2020&pages=2211-7&)] [PubMed](https://pubmed.ncbi.nlm.nih.gov/32303650)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Neurology&title=Miller+Fisher+Syndrome+and+Polyneuritis+Cranialis+in+COVID-19&author=C+Guti\u00e9rrez-Ortiz&author=A+M\u00e9ndez&author=S+Rodrigo-Rey&author=E+San+Pedro-Murillo&author=L+Bermejo-Guerrero&volume=95&publication_year=2020&pages=e601-5&pmid=32303650&)] [PMC free article](/pmc/articles/PMC7195378/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32251791)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Int+J+Infect+Dis&title=A+First+Case+of+Meningitis/Encephalitis+Associated+With+SARS-Coronavirus-2&author=T+Moriguchi&author=N+Harii&author=J+Goto&author=D+Harada&author=H+Sugawara&volume=94&publication_year=2020&pages=55-8&pmid=32251791&)] [PMC free article](/pmc/articles/PMC7233386/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32228363)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Radiology&title=COVID-19\u2013Associated+Acute+Hemorrhagic+Necrotizing+Encephalopathy:+CT+and+MRI+Features&author=N+Poyiadji&author=G+Shahin&author=D+Noujaim&author=M+Stone&author=S+Patel&volume=201187&publication_year=2020&pages=E119-20&)] [PMC free article](/pmc/articles/PMC7454352/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32637987)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Brain&title=The+Emerging+Spectrum+of+COVID-19+Neurology:+Clinical,+Radiological+and+Laboratory+Findings&author=RW+Paterson&author=RL+Brown&author=L+Benjamin&author=R+Nortley&author=S+Wiethoff&volume=143&publication_year=2020&pages=3104-20&pmid=32637987&)] [PMC free article](/pmc/articles/PMC7316461/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32593341)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Lancet+Psychiatry&title=Neurological+and+Neuropsychiatric+Complications+of+COVID-19+in+153+Patients:+A+UK-Wide+Surveillance+Study&author=A+Varatharaj&author=N+Thomas&author=MA+Ellul&author=NWS+Davies&author=TA+Pollak&volume=7&publication_year=2020&pages=875-82&pmid=32593341&)] [PMC free article](/pmc/articles/PMC7304421/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32530583)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&title=Neuropathological+Features+of+Covid-19&author=IH+Solomon&author=E+Normandin&author=S+Bhattacharyya&author=SS+Mukerji&author=K+Keller&volume=383&publication_year=2020&pages=989-92&pmid=32530583&)] [PMC free article](/pmc/articles/PMC7269702/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32220634)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Travel+Med+Infect+Dis&title=Sars-Cov-2:+Underestimated+Damage+to+Nervous+System&author=L+Zhou&author=M+Zhang&author=J+Wang&author=J+Gao&volume=36&publication_year=2020&pages=101642&pmid=32220634&)] [PubMed](https://pubmed.ncbi.nlm.nih.gov/32869376)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=J+Neurosci+Res&title=Possible+Routes+of+SARS-CoV-2+Invasion+in+Brain:+In+Context+of+Neurological+Symptoms+in+COVID-19+Patients&author=A+Kumar&author=V+Pareek&author=P+Prasoon&author=MA+Faiq&author=P+Kumar&volume=98&publication_year=2020&pages=2376-83&pmid=32869376&)] [PMC free article](/pmc/articles/PMC7096820/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/16415928)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Microbiol&title=Coronavirus+Infection+of+the+Central+Nervous+System:+Host-Virus+Stand-Off&author=CC+Bergmann&author=TE+Lane&author=SA+Stohlman&volume=4&publication_year=2006&pages=121-32&pmid=16415928&)] [PMC free article](/pmc/articles/PMC1829448/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/17392154)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Am+J+Pathol&title=Pathology+and+Pathogenesis+of+Severe+Acute+Respiratory+Syndrome&author=J+Gu&author=C+Korteweg&volume=170&issue=(4)&publication_year=2007&pages=1136-47&pmid=17392154&)] [PMC free article](/pmc/articles/PMC7231545/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32354768)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=J+Neurol+Neurosurg+Psychiatry&title=Characteristics+of+Ischaemic+Stroke+Associated+With+COVID-19&author=R+Beyrouti&author=ME+Adams&author=L+Benjamin&author=H+Cohen&author=SF+Farmer&volume=91&publication_year=2020&pages=889-91&pmid=32354768&)] [PMC free article](/pmc/articles/PMC7874430/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33217246)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&title=Tissue-Specific+Immunopathology+in+Fatal+COVID-19&author=DA+Dorward&author=CD+Russell&author=IH+Um&author=M+Elshani&author=SD+Armstrong&volume=203&publication_year=2021&pages=192-201&pmid=33217246&)] [PubMed](https://pubmed.ncbi.nlm.nih.gov/33481684)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Viral+Immunol&title=Expression+of+SARS-CoV-2+Host+Cell+Entry+Factors+in+Immune+System+Components+of+Healthy+Individuals+and+Its+Relevance+for+COVID-19+Immunopathology&author=A+Kumar&author=S+Kumar&author=RK+Narayan&author=C+Kumari&author=V+Pareek&volume=34&issue=(5)&publication_year=2021&pages=352-7&pmid=33481684&)] [PMC free article](/pmc/articles/PMC7832378/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33333256)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Clin+Immunol&title=Influenza+Infection,+SARS,+MERS+and+COVID-19:+Cytokine+Storm+\u2212+The+Common+Denominator+and+the+Lessons+to+be+Learned&author=VA+Ryabkova&author=LP+Churilov&author=Y+Shoenfeld&volume=223&publication_year=2021&pages=108652&pmid=33333256&)] [PMC free article](/pmc/articles/PMC7956943/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33732251)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Front+Immunol&title=SARS-CoV-2+Causes+a+Different+Cytokine+Response+Compared+to+Other+Cytokine+Storm-Causing+Respiratory+Viruses+in+Severely+Ill+Patients&author=M+Olbei&author=I+Hautefort&author=D+Modos&author=A+Treveil&author=M+Poletti&volume=12&publication_year=2021&pages=629193&pmid=33732251&)] [PMC free article](/pmc/articles/PMC4752723/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/26867177)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Cell+Host+Microbe&title=Dysregulated+Type+I+Interferon+and+Inflammatory+Monocyte-Macrophage+Responses+Cause+Lethal+Pneumonia+in+SARS-CoV-Infected+Mice&author=R+Channappanavar&author=AR+Fehr&author=R+Vijay&author=M+Mack&author=J+Zhao&volume=19&publication_year=2016&pages=181-93&pmid=26867177&)] [PMC free article](/pmc/articles/PMC7227586/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32416070)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Cell&title=Imbalanced+Host+Response+to+SARS-CoV-2+Drives+Development+of+COVID-19&author=D+Blanco-Melo&author=BE+Nilsson-Payant&author=WC+Liu&author=S+Uhl&author=D+Hoagland&volume=181&publication_year=2020&pages=1036-1045.e9&pmid=32416070&)] [PMC free article](/pmc/articles/PMC7473339/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32941788)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Cell+Rep&title=SARS-CoV-2+ORF3b+Is+a+Potent+Interferon+Antagonist+Whose+Activity+Is+Increased+by+a+Naturally+Occurring+Elongation+Variant&author=Y+Konno&author=I+Kimura&author=K+Uriu&author=M+Fukushi&author=T+Irie&volume=32&publication_year=2020&pages=108185&pmid=32941788&)] [PMC free article](/pmc/articles/PMC7273175/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32357808)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Emerg+Microbes+Infect&title=Kinetics+of+SARS-CoV-2+Specific+IgM+and+IgG+Responses+in+COVID-19+Patients&author=B+Sun&author=Y+Feng&author=X+Mo&author=P+Zheng&author=Q+Wang&volume=9&publication_year=2020&pages=940-8&pmid=32357808&)] [PMC free article](/pmc/articles/PMC7803150/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33497610)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Cell&title=Adaptive+Immunity+to+SARS-CoV-2+and+COVID-19&author=A+Sette&author=S+Crotty&volume=184&issue=(4)&publication_year=2021&pages=861&pmid=33497610&)] [PMC free article](/pmc/articles/PMC8128299/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33622974)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Sci+Immunol&title=Clonal+Expansion+and+Activation+of+Tissue-Resident+Memory-Like+Th17+Cells+Expressing+GM-CSF+in+the+Lungs+of+Severe+COVID-19+Patients&author=Y+Zhao&author=C+Kilian&author=J-E+Turner&author=L+Bosurgi&author=K+Roedl&volume=6&publication_year=2021&pages=eabf6692&pmid=33622974&)] [PMC free article](/pmc/articles/PMC8128298/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33692097)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Sci+Immunol&title=Inflammatory+Profiles+Across+the+Spectrum+of+Disease+Reveal+a+Distinct+Role+for+GM-CSF+in+Severe+COVID-19&author=RS+Thwaites&author=A+Sanchez+Sevilla+Uruchurtu&author=MK+Siggins&author=F+Liew&author=CD+Russell&volume=6&publication_year=2021&pages=eabg9873&pmid=33692097&)] [PMC free article](/pmc/articles/PMC7405282/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32779838)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Int+J+Lab+Hematol&title=Absolute+Lymphocyte+Count+is+a+Prognostic+Marker+in+Covid-19:+A+Retrospective+Cohort+Review&author=J+Wagner&author=A+DuPont&author=S+Larson&author=B+Cash&author=A+Farooq&volume=42&publication_year=2020&pages=761-5&pmid=32779838&)] [PMC free article](/pmc/articles/PMC7390589/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32726241)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=West+J+Emerg+Med&title=Predictors+of+Mortality+in+Adults+Admitted+With+COVID-19:+Retrospective+Cohort+Study+From+New+York+City&author=S+Chilimuri&author=H+Sun&author=A+Alemam&author=N+Mantri&author=E+Shehi&volume=21&publication_year=2020&pages=779-84&pmid=32726241&)] [PMC free article](/pmc/articles/PMC7100419/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32296069)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Signal+Transduct+Target+Ther&title=Lymphopenia+Predicts+Disease+Severity+of+COVID-19:+A+Descriptive+and+Predictive+Study&author=L+Tan&author=Q+Wang&author=D+Zhang&author=J+Ding&author=Q+Huang&volume=5&publication_year=2020&pages=1-3&pmid=32296011&)] [PMC free article](/pmc/articles/PMC7543449/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/34676085)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Natl+Sci+Rev&title=Pathological+Changes+in+the+Lungs+and+Lymphatic+Organs+of+12+COVID-19+Autopsy+Cases&author=Q+Liu&author=Y+Shi&author=J+Cai&author=Y+Duan&author=R+Wang&volume=7&publication_year=2020&pages=1868-78&pmid=34676085&)] [PMC free article](/pmc/articles/PMC7573917/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32942274)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Pathobiology&title=Autopsy+Findings+in+32+Patients+With+COVID-19:+A+Single-Institution+Experience&author=SS+Elsoukkary&author=M+Mostyka&author=A+Dillard&author=DR+Berman&author=LX+Ma&volume=88&publication_year=2021&pages=56-68&pmid=32942274&)] [PMC free article](/pmc/articles/PMC7205903/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32425950)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Front+Immunol&title=Reduction+and+Functional+Exhaustion+of+T+Cells+in+Patients+With+Coronavirus+Disease+2019+(COVID-19)&author=B+Diao&author=C+Wang&author=Y+Tan&author=X+Chen&author=Y+Liu&volume=11&publication_year=2020&pages=827&pmid=32425950&)] [PMC free article](/pmc/articles/PMC7079893/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/28466096)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Semin+Immunopathol&title=Pathogenic+Human+Coronavirus+Infections:+Causes+and+Consequences+of+Cytokine+Storm+and+Immunopathology&author=R+Channappanavar&author=S+Perlman&volume=39&issue=(5)&publication_year=2017&pages=529-39&pmid=28466096&)] [PMC free article](/pmc/articles/PMC7382021/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32706371)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=JAMA&title=Presence+of+Genetic+Variants+Among+Young+Men+With+Severe+COVID-19&author=CI+van+der+Made&author=A+Simons&author=J+Schuurs-Hoeijmakers&author=G+van+den+Heuvel&author=T+Mantere&volume=324&publication_year=2020&pages=663-73&pmid=32706371&)] [PubMed](https://pubmed.ncbi.nlm.nih.gov/33307546)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Nature&title=Genetic+Mechanisms+of+Critical+Illness+in+Covid-19&author=E+Pairo-Castineira&author=S+Clohisey&author=L+Klaric&author=AD+Bretherick&author=K+Rawlik&volume=591&publication_year=2020&pages=92-8&pmid=33307546&)] [PMC free article](/pmc/articles/PMC7164881/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32311448)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=J+Am+Coll+Cardiol&title=COVID-19+and+Thrombotic+or+Thromboembolic+Disease:+Implications+for+Prevention,+Antithrombotic+Therapy,+and+Follow-Up&author=B+Bikdeli&author=MV+Madhavan&author=D+Jimenez&author=T+Chuich&author=I+Dreyfus&volume=75&publication_year=2020&pages=2950-73&pmid=32311448&)] [PMC free article](/pmc/articles/PMC7386875/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32586214)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Circ+Res&title=The+Emerging+Threat+of+(Micro)Thrombosis+in+COVID-19+and+Its+Therapeutic+Implications&author=JD+McFadyen&author=H+Stevens&author=K+Peter&volume=127&publication_year=2020&pages=571-87&pmid=32586214&)] [PMC free article](/pmc/articles/PMC7471641/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32887634)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=J+Hematol+Oncol&title=SARS-CoV-2+Binds+Platelet+ACE2+to+Enhance+Thrombosis+in+COVID-19&author=S+Zhang&author=Y+Liu&author=X+Wang&author=L+Yang&author=H+Li&volume=13&publication_year=2020&pages=120&pmid=32887634&)] [PMC free article](/pmc/articles/PMC7454504/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32691039)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Eur+Heart+J&title=ACE2+Down-Regulation+may+Contribute+to+the+Increased+Thrombotic+Risk+in+COVID-19&author=L+Lupi&author=M+Adamo&author=RM+Inciardi&author=M+Metra&volume=41&publication_year=2020&pages=3200-0&pmid=32691039&)] [PMC free article](/pmc/articles/PMC7167588/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32336612)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Eur+J+Intern+Med&title=The+Pivotal+Link+Between+ACE2+Deficiency+and+SARS-CoV-2+Infection&author=P+Verdecchia&author=C+Cavallini&author=A+Spanevello&author=F+Angeli&volume=76&publication_year=2020&pages=14&pmid=32336612&)] [Google Scholar](https://scholar.google.com/scholar_lookup?journal=medRxiv&title=Highly+Pathogenic+Coronavirus+N+Protein+Aggravates+Lung+Injury+by+MASP-2-Mediated+Complement+Over-Activation&author=T+Gao&author=M+Hu&author=X+Zhang&author=H+Li&author=L+Zhu&publication_year=2020&)] [PMC free article](/pmc/articles/PMC7187881/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32439197)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Curr+Probl+Cardiol&title=COVID-19+and+Multiorgan+Response&author=S+Zaim&author=JH+Chong&author=V+Sankaranarayanan&author=A+Harky&volume=45&publication_year=2020&pages=100618&pmid=32439197&)] [PMC free article](/pmc/articles/PMC7273827/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32339221)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Blood&title=COVID-19+and+Its+Implications+for+Thrombosis+and+Anticoagulation&author=JM+Connors&author=JH+Levy&volume=135&issue=(23)&publication_year=2020&pages=2033-40&pmid=32339221&)] [PMC free article](/pmc/articles/PMC7314621/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32838147)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=SN+Compr+Clin+Med&title=Comorbidity+and+Its+Impact+on+Patients+With+COVID-19&author=A+Sanyaolu&author=C+Okorie&author=A+Marinkovic&author=R+Patidar&author=K+Younis&volume=2&publication_year=2020&pages=1069-76&pmid=32838147&)] [https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/older-adults.html](https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/older-adults.html)(Accessed December 4, 2020) [https://www.worldometers.info/coronavirus/coronavirus-age-sex-demographics/](https://www.worldometers.info/coronavirus/coronavirus-age-sex-demographics/)(Accessed November 24, 2020) [PMC free article](/pmc/articles/PMC7499698/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33214754)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Public+Policy+Aging+Rep&title=Age-Related+Vulnerability+to+Coronavirus+Disease+2019+(COVID-19):+Biological,+Contextual,+and+Policy-Related+Factors&author=EM+Crimmins&volume=30&publication_year=2020&pages=142-6&pmid=33214754&)] [PubMed](https://pubmed.ncbi.nlm.nih.gov/29242543)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Nat+Immunol&title=The+Twilight+of+Immunity:+Emerging+Concepts+in+Aging+of+the+Immune+System+Review-Article&author=J+Nikolich-\u017dugich&volume=19&publication_year=2018&pages=10-9&pmid=29242543&)] [PubMed](https://pubmed.ncbi.nlm.nih.gov/28704827)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Gerontology&title=Age-Dependent+Changes+in+Regulatory+T+Lymphocyte+Development+and+Function:+A+Mini-Review&author=J+Darrigues&author=JPM+van+Meerwijk&author=P+Romagnoli&volume=64&publication_year=2018&pages=28-35&pmid=28704827&)] [PMC free article](/pmc/articles/PMC7276714/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32427393)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=FASEB+J&title=Telomeres+and+COVID-19&author=A+Aviv&volume=34&publication_year=2020&pages=7247-52&pmid=32427393&)] [PMC free article](/pmc/articles/PMC7473262/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32923992)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=EClinicalMedicine&title=Multisystem+Inflammatory+Syndrome+in+Children:+A+Systematic+Review&author=M+Ahmed&author=S+Advani&author=A+Moreira&author=S+Zoretic&author=J+Martinez&volume=26&publication_year=2020&pages=100527&pmid=32923992&)] [PMC free article](/pmc/articles/PMC7598032/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32870815)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=J+Clin+Invest&title=Immune+pathogenesis+of+COVID-19-related+multisystem+inflammatory+syndrome+in+children&author=AH+Rowley&author=ST+Shulman&author=M+Arditi&volume=130&publication_year=2020&pages=5619-21&pmid=32870815&)] [https://globalhealth5050.org/the-sex-gender-and-covid-19-project/dataset/](https://globalhealth5050.org/the-sex-gender-and-covid-19-project/dataset/)(Accessed October 13, 2020) [PMC free article](/pmc/articles/PMC8353216/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/34340720)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Expert+Rev+Mol+Med&title=COVID-19+Pandemic:+Insights+Into+Molecular+Mechanisms+Leading+to+Sex-Based+Differences+in+Patient+Outcomes&author=A+Kumar&author=RK+Narayan&author=M+Kulandhasamy&author=P+Prasoon&author=C+Kumari&volume=23&publication_year=2021&pages=e7&pmid=34340720&)] [PMC free article](/pmc/articles/PMC7361928/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32594644)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=J+Cell+Mol+Med&title=The+ACE2+Expression+in+Sertoli+Cells+and+Germ+Cells+may+Cause+Male+Reproductive+Disorder+After+SARS-CoV-2+Infection&author=Q+Shen&author=X+Xiao&author=A+Aierken&author=W+Yue&author=X+Wu&volume=24&publication_year=2020&pages=9472-7&pmid=32594644&)] [PMC free article](/pmc/articles/PMC7226809/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32283711)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Cells&title=scRNA-Seq+Profiling+of+Human+Testes+Reveals+the+Presence+of+the+ACE2+Receptor,+A+Target+for+SARS-CoV-2+Infection+in+Spermatogonia,+Leydig+and+Sertoli+Cells&author=Z+Wang&author=X+Xu&volume=9&publication_year=2020&pages=920&)] [https://www.proteinatlas.org/ENSG00000184012-TMPRSS2/tissue](https://www.proteinatlas.org/ENSG00000184012-TMPRSS2/tissue)(Accessed May 14, 2020) [PMC free article](/pmc/articles/PMC7202813/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32387456)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Ann+Oncol&title=Androgen-Deprivation+Therapies+for+Prostate+Cancer+and+Risk+of+Infection+by+SARS-CoV-2:+A+Population-Based+Study+(N+=+4532)&author=M+Montopoli&author=S+Zumerle&author=R+Vettor&author=M+Rugge&author=M+Zorzi&volume=31&publication_year=2020&pages=1040-5&pmid=32387456&)] [PMC free article](/pmc/articles/PMC7430299/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32853545)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Immunity&title=Implications+of+Sex+Differences+in+Immunity+for+SARS-CoV-2+Pathogenesis+and+Design+of+Therapeutic+Interventions&author=MJ+Bunders&author=M+Altfeld&volume=53&publication_year=2020&pages=487-95&pmid=32853545&)] [PubMed](https://pubmed.ncbi.nlm.nih.gov/27546235)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Immunol&title=Sex+Differences+in+Immune+Responses&author=SL+Klein&author=KL+Flanagan&volume=16&issue=(10)&publication_year=2016&pages=626-38&pmid=27546235&)] [PMC free article](/pmc/articles/PMC7402107/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32788073)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=J+Infect+Public+Health&title=COVID-19+and+Comorbidities:+Deleterious+Impact+on+Infected+Patients&author=H+Ejaz&author=A+Alsrhani&author=A+Zafar&author=H+Javed&author=K+Junaid&volume=13&publication_year=2020&pages=1833-9&pmid=32788073&)] [PubMed](https://pubmed.ncbi.nlm.nih.gov/32654555)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Hypertension&title=Clinical+Features+of+COVID-19+in+Patients+With+Essential+Hypertension+and+the+Impacts+of+Renin-Angiotensin-Aldosterone+System+Inhibitors+on+the+Prognosis+of+COVID-19+Patients&author=W+Pan&author=J+Zhang&author=M+Wang&author=J+Ye&author=Y+Xu&volume=76&publication_year=2020&pages=732-41&pmid=32654555&)] [PMC free article](/pmc/articles/PMC7283736/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32445512)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Obesity+(Silver+Spring)&title=Severe+Obesity+as+an+Independent+Risk+Factor+for+COVID-19+Mortality+in+Hospitalized+Patients+Younger+Than+50&author=E+Klang&author=G+Kassim&author=S+Soffer&author=R+Freeman&author=MA+Levin&volume=28&publication_year=2020&pages=1595-9&pmid=32445512&)] [PMC free article](/pmc/articles/PMC7258796/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32571616)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Nutr+Metab+Cardiovasc+Dis&title=Diabetes+as+a+Risk+Factor+for+Greater+COVID-19+Severity+and+in-Hospital+Death:+A+Meta-Analysis+of+Observational+Studies&author=A+Mantovani&author=CD+Byrne&author=MH+Zheng&author=G+Targher&volume=30&issue=(8)&publication_year=2020&pages=1236-48&pmid=32571616&)] [PMC free article](/pmc/articles/PMC4390759/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/26064849)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=J+Lifestyle+Med&title=Immunological+Profiling+of+Obesity&author=RM+Ignacio&author=CS+Kim&author=SK+Kim&volume=4&publication_year=2014&pages=1-7&pmid=26064849&)] [PMC free article](/pmc/articles/PMC7275979/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32593459)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Br+J+Anaesth&title=Potential+pathophysiology+of+COVID-19+in+patients+with+obesity.+Comment+on+Br+J+Anaesth+2020;+125:+e262-e263&author=B+Lui&author=JD+Samuels&author=RS+White&volume=125&publication_year=2020&pages=e283-4&pmid=32593459&)] [PMC free article](/pmc/articles/PMC7264681/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32314455)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Diabetes+Obes+Metab&title=COVID-19+Infection+may+Cause+Ketosis+and+Ketoacidosis&author=J+Li&author=X+Wang&author=J+Chen&author=X+Zuo&author=H+Zhang&volume=22&publication_year=2020&pages=1935-41&pmid=32314455&)] [PMC free article](/pmc/articles/PMC7360473/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32664879)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=BMC+Med&title=New+Insights+Into+Genetic+Susceptibility+of+COVID-19:+An+ACE2+and+TMPRSS2+Polymorphism+Analysis&author=Y+Hou&author=J+Zhao&author=W+Martin&author=A+Kallianpur&author=MK+Chung&volume=18&publication_year=2020&pages=216&pmid=32664879&)] [PMC free article](/pmc/articles/PMC7709597/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33278516)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Microb+Pathog&title=ACE2+and+TMPRSS2+Polymorphisms+in+Various+Diseases+With+Special+Reference+to+Its+Impact+on+COVID-19+Disease&author=H+Singh&author=R+Choudhari&author=V+Nema&author=AA+Khan&volume=150&publication_year=2020&pages=104621&pmid=33278516&)] [PMC free article](/pmc/articles/PMC4100901/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/25029565)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=PloS+One&title=Type+II+Transmembrane+Serine+Protease+Gene+Variants+Associate+With+Breast+Cancer&author=K+Luostari&author=JM+Hartikainen&author=M+Tengstr\u00f6m&author=JJ+Palvimo&author=V+Kataja&volume=9&publication_year=2014&pages=e102519&pmid=25029565&)] [PMC free article](/pmc/articles/PMC7857407/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32972995)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Science&title=Inborn+Errors+of+Type+I+IFN+Immunity+in+Patients+With+Life-Threatening+COVID-19&author=Q+Zhang&author=P+Bastard&author=Z+Liu&author=J+Le+Pen&author=M+Moncada-Velez&volume=370&publication_year=2020&pages=eabd4570&pmid=32972995&)] [PMC free article](/pmc/articles/PMC8674144/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/34237774)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Nature&title=Mapping+the+Human+Genetic+Architecture+of+COVID-19&volume=2021&publication_year=2021&pages=1-8&)] [PubMed](https://pubmed.ncbi.nlm.nih.gov/32998156)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Nature&title=The+Major+Genetic+Risk+Factor+for+Severe+COVID-19+is+Inherited+From+Neanderthals&author=H+Zeberg&author=S+P\u00e4\u00e4bo&volume=587&issue=(7835)&publication_year=2020&pages=610-2&pmid=32998156&)] [PMC free article](/pmc/articles/PMC7936282/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33593941)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&title=A+Genomic+Region+Associated+With+Protection+Against+Severe+COVID-19+is+Inherited+From+Neandertals&author=H+Zeberg&author=S+P\u00e4\u00e4bo&volume=118&issue=(9)&publication_year=2021&pages=e2026309118&pmid=33593941&)] [PMC free article](/pmc/articles/PMC7214856/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32398162)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Hum+Genomics&title=COVID-19+Vulnerability:+The+Potential+Impact+of+Genetic+Susceptibility+and+Airborne+Transmission&author=KJ+Godri+Pollitt&author=J+Peccia&author=AI+Ko&author=N+Kaminski&author=CS+Dela+Cruz&volume=14&publication_year=2020&pages=17&pmid=32398162&)] [PMC free article](/pmc/articles/PMC7574718/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33147444)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Cell&title=Genome-Wide+CRISPR+Screens+Reveal+Host+Factors+Critical+for+SARS-CoV-2+Infection&author=J+Wei&author=MM+Alfajaro&author=PC+DeWeirdt&author=RE+Hanna&author=WJ+Lu-Culligan&volume=184&publication_year=2020&pages=1-16&)] [PMC free article](/pmc/articles/PMC7594382/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33057631)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Blood+Adv&title=Reduced+Prevalence+of+SARS-CoV-2+Infection+in+ABO+Blood+Group+O.&author=MB+Barnkob&author=A+Potteg\u00e5rd&author=H+St\u00f8vring&author=TM+Haunstrup&author=K+Homburg&volume=4&publication_year=2020&pages=4990-3&pmid=33057631&)] [PMC free article](/pmc/articles/PMC7594392/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33057633)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Blood+Adv&title=The+Association+of+ABO+Blood+Group+With+Indices+of+Disease+Severity+and+Multiorgan+Dysfunction+in+COVID-19&author=RL+Hoiland&author=NA+Fergusson&author=AR+Mitra&author=DEG+Griesdale&author=DV+Devine&volume=4&publication_year=2020&pages=4981-9&pmid=33057633&)] [PMC free article](/pmc/articles/PMC7354354/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32656591)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Ann+Hematol&title=Blood+Type+and+Outcomes+in+Patients+With+COVID-19&author=CA+Latz&author=C+DeCarlo&author=L+Boitano&author=CYM+Png&author=R+Patell&volume=99&publication_year=2020&pages=2113-8&pmid=32656591&)] [PMC free article](/pmc/articles/PMC8022215/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33818622)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=JAMA+Netw+Open&title=Association+of+Sociodemographic+Factors+and+Blood+Group+Type+With+Risk+of+COVID-19+in+a+US+Population&author=JL+Anderson&author=HT+May&author=S+Knight&author=TL+Bair&author=JB+Muhlestein&volume=4&publication_year=2021&pages=e217429&pmid=33818622&)] [PMC free article](/pmc/articles/PMC7724273/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33139519)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Sci+Transl+Med&title=Prothrombotic+Autoantibodies+in+Serum+From+Patients+Hospitalized+With+COVID-19&author=Y+Zuo&author=SK+Estes&author=RA+Ali&author=AA+Gandhi&author=S+Yalavarthi&volume=12&publication_year=2020&pages=eabd3876&pmid=33139519&)] [PMC free article](/pmc/articles/PMC7361253/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32619328)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=J+Thromb+Haemost&title=Antiphospholipid+Antibodies+in+Patients+With+COVID-19:+A+Relevant+Observation?&author=KMJ+Devreese&author=EA+Linskens&author=D+Benoit&author=H+Peperstraete&volume=18&publication_year=2020&pages=2191-201&pmid=32619328&)] [PMC free article](/pmc/articles/PMC7161262/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32268022)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&title=Coagulopathy+and+Antiphospholipid+Antibodies+in+Patients+With+Covid-19&author=Y+Zhang&author=M+Xiao&author=S+Zhang&author=P+Xia&author=W+Cao&volume=382&publication_year=2020&pages=e38&pmid=32268022&)] [PMC free article](/pmc/articles/PMC7593765/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33178218)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Front+Immunol&title=Anti-Phospholipid+Antibodies+in+COVID-19+Are+Different+From+Those+Detectable+in+the+Anti-Phospholipid+Syndrome&author=MO+Borghi&author=A+Beltagy&author=E+Garrafa&author=D+Curreli&author=G+Cecchini&volume=11&publication_year=2020&pages=584241&pmid=33178218&)] [PMC free article](/pmc/articles/PMC7217790/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32430279)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Virus+Res&title=Gut+Microbiota+and+Covid-19-+Possible+Link+and+Implications&author=D+Dhar&author=A+Mohanty&volume=285&publication_year=2020&pages=198018&pmid=32430279&)] [PMC free article](/pmc/articles/PMC7237927/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32442562)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Gastroenterology&title=Alterations+in+Gut+Microbiota+of+Patients+With+COVID-19+During+Time+of+Hospitalization&author=T+Zuo&author=F+Zhang&author=GCY+Lui&author=YK+Yeoh&author=AYL+Li&volume=159&publication_year=2020&pages=944-55.e8&pmid=32442562&)] [PMC free article](/pmc/articles/PMC7832617/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/34173452)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Med+Microecol&title=Analysis+of+the+Intestinal+Microbiota+in+COVID-19+Patients+and+Its+Correlation+With+the+Inflammatory+Factor+IL-18&author=W+Tao&author=G+Zhang&author=X+Wang&author=M+Guo&author=W+Zeng&volume=5&publication_year=2020&pages=100023&pmid=34173452&)] [PMC free article](/pmc/articles/PMC7857411/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33159009)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Science+(80-&title=Preexisting+and+De+Novo+Humoral+Immunity+to+SARS-CoV-2+in+Humans&author=KW+Ng&author=N+Faulkner&author=GH+Cornish&author=A+Rosa&author=R+Harvey&publication_year=2020&pages=1339-43&)] [PMC free article](/pmc/articles/PMC7574914/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32753554)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Science+(80\u2212)&title=Selective+and+Cross-Reactive+SARS-CoV-2+T+Cell+Epitopes+in+Unexposed+Humans&author=J+Mateus&author=A+Grifoni&author=A+Tarke&author=J+Sidney&author=SI+Ramirez&volume=370&publication_year=2020&pages=89-94&)] [PMC free article](/pmc/articles/PMC7773342/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32997649)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=J+Clin+Invest&title=Recent+Endemic+Coronavirus+Infection+Is+Associated+With+Less+Severe+COVID-19&author=M+Sagar&author=K+Reifler&author=M+Rossi&author=NS+Miller&author=P+Sinha&volume=131&publication_year=2020&pages=e143380&)] [PMC free article](/pmc/articles/PMC7304316/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32561657)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=MBio&title=Could+an+Unrelated+Live+Attenuated+Vaccine+Serve+as+a+Preventive+Measure+to+Dampen+Septic+Inflammation+Associated+With+Covid-19+Infection?&author=PL+Fidel&author=MC+Noverr&volume=11&publication_year=2020&pages=1-4&)] [PubMed](https://pubmed.ncbi.nlm.nih.gov/33310766)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=BMJ+Evid+Based+Med&title=Inactivated+Trivalent+Influenza+Vaccination+is+Associated+With+Lower+Mortality+Among+Patients+With+COVID-19+in+Brazil&author=G+Fink&author=N+Orlova-Fink&author=T+Schindler&author=S+Grisi&author=APS+Ferrer&publication_year=2020&)] [PMC free article](/pmc/articles/PMC7686805/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33219096)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=MBio&title=Analysis+of+Measles-Mumps-Rubella+(MMR)+Titers+of+Recovered+COVID-19+Patients&author=JE+Gold&author=WH+Baumgartl&author=RA+Okyay&author=WE+Licht&author=PL+Fidel&volume=11&publication_year=2020&pages=e02628-20&pmid=33219096&)] [PMC free article](/pmc/articles/PMC7655788/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33194993)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Front+Public+Health&title=Childhood+Immunization+and+COVID-19:+An+Early+Narrative+Review&author=B+Beric-Stojsic&author=J+Kalabalik-Hoganson&author=D+Rizzolo&author=S+Roy&volume=8&publication_year=2020&pages=587007&pmid=33194993&)] [PubMed](https://pubmed.ncbi.nlm.nih.gov/32169166)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Cell+Stem+Cell&title=C/Ebp\u03b2-Dependent+Epigenetic+Memory+Induces+Trained+Immunity+in+Hematopoietic+Stem+Cells&author=B+de+Laval&author=J+Maurizio&author=PK+Kandalla&author=G+Brisou&author=L+Simonnet&volume=26&publication_year=2020&pages=657-74.e8&pmid=32169166&)] [PMC free article](/pmc/articles/PMC7584442/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33134901)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=EClinicalMedicine&title=Impaired+Spermatogenesis+in+COVID-19+Patients&author=H+Li&author=X+Xiao&author=J+Zhang&author=MI+Zafar&author=C+Wu&volume=28&publication_year=2020&pages=100604&pmid=33134901&)] [PMC free article](/pmc/articles/PMC7857397/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32972996)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Science&title=Autoantibodies+Against+Type+I+IFNs+in+Patients+With+Life-Threatening+COVID-19&author=P+Bastard&author=LB+Rosen&author=Q+Zhang&author=E+Michailidis&author=HH+Hoffmann&volume=370&publication_year=2020&pages=eabd4585&pmid=32972996&)] [PMC free article](/pmc/articles/PMC7556454/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33052920)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=PloS+One&title=Residual+Clinical+Damage+After+COVID-19:+A+Retrospective+and+Prospective+Observational+Cohort+Study&author=R+De+Lorenzo&author=C+Conte&author=C+Lanzani&author=F+Benedetti&author=L+Roveri&volume=15&publication_year=2020&pages=e0239570&pmid=33052920&)] [PMC free article](/pmc/articles/PMC7892867/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33603008)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Sci+Rep&title=Years+of+Life+Lost+to+COVID-19+in+81+Countries&author=H+Pifarr\u00e9+i+Arolas&author=E+Acosta&author=G+L\u00f3pez-Casasnovas&author=A+Lo&author=C+Nicodemo&volume=11&publication_year=2021&pages=3504&pmid=33603008&)] [PMC free article](/pmc/articles/PMC8500096/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/34564730)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Int+J+Epidemiol&title=Quantifying+Impacts+of+the+COVID-19+Pandemic+Through+Life-Expectancy+Losses:+A+Population-Level+Study+of+29+Countries&author=JM+Aburto&author=J+Sch\u00f6ley&author=I+Kashnitsky&author=L+Zhang&author=C+Rahal&publication_year=2021&pages=dyab207&)] [PMC free article](/pmc/articles/PMC7850177/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33144403)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Clin+Med&title=Long-Term+Sequelae+Following+Previous+Coronavirus+Epidemics&author=O+O'Sullivan&volume=21&publication_year=2021&pages=e68-70&)] [PMC free article](/pmc/articles/PMC8139423/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33853970)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Science+(80-)&title=Genomics+and+Epidemiology+of+the+P.1+SARS-CoV-2+Lineage+in+Manaus,+Brazil&author=NR+Faria&author=TA+Mellan&author=C+Whittaker&author=IM+Claro&author=DS+Candidoda&volume=372&publication_year=2021&pages=815-21&)] [Google Scholar](https://scholar.google.com/scholar_lookup?journal=medRxiv&title=Second+Wave+of+COVID-19+in+India+Could+be+Predicted+With+Genomic+Surveillance+of+SARS-CoV-2+Variants+Coupled+With+Epidemiological+Data:+A+Tool+for+Future&author=A+Kumar&author=P+Dwivedi&author=G+Kumar&author=RK+Narayan&author=RK+Jha&publication_year=2021&)] [PMC free article](/pmc/articles/PMC9011477/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/34811761)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=SSRN+Electron+J&title=Emerging+SARS-CoV-2+Variants+Can+Potentially+Break+Set+Epidemiological+Barriers+in+COVID-19&author=A+Kumar&author=R+Parashar&author=MA+Faiq&author=S+Kumar&author=C+Kumari&publication_year=2021&)] [https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/](https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/)(Accessed June 17, 2021) [https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html](https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html)(Accessed June 25, 2021) [PMC free article](/pmc/articles/PMC8397301/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/34461056)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Lancet+Infect+Dis&title=Hospital+Admission+and+Emergency+Care+Attendance+Risk+for+SARS-CoV-2+Delta+(B.1.617.2)+Compared+With+Alpha+(B.1.1.7)+Variants+of+Concern:+A+Cohort+Study&author=KA+Twohig&author=T+Nyberg&author=A+Zaidi&author=S+Thelwall&author=MA+Sinnathamby&volume=S1473\u20133099&issue=(21)&publication_year=2021&pages=00475-8&)] [PubMed](https://pubmed.ncbi.nlm.nih.gov/33834772)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=J+Med+Chem&title=Insights+Into+SARS-CoV-2's+Mutations+for+Evading+Human+Antibodies:+Sacrifice+and+Survival&author=B+Luan&author=T+Huynh&publication_year=2021&)] [PMC free article](/pmc/articles/PMC8167834/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/34075212)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Microbiol&title=SARS-CoV-2+Variants,+Spike+Mutations+and+Immune+Escape&author=WT+Harvey&author=AM+Carabelli&author=B+Jackson&author=RK+Gupta&author=EC+Thomson&volume=19&publication_year=2021&pages=409-24&pmid=34075212&)] [Google Scholar](https://scholar.google.com/scholar_lookup?journal=bioRxiv+Prepr+Serv+Biol&title=SARS-CoV-2+B.1.1.7+and+B.1.351+Variants+of+Concern+Induce+Lethal+Disease+in+K18-Hace2+Transgenic+Mice+Despite+Convalescent+Plasma+Therapy&author=AM+Horspool&author=C+Ye&author=TY+Wong&author=BP+Russ&author=KS+Lee&publication_year=2021&)] [Google Scholar](https://scholar.google.com/scholar_lookup?journal=bioRxiv&title=SARS+CoV-2+Variant+B.1.617.1+is+Highly+Pathogenic+in+Hamsters+Than+B.1+Variant&author=PD+Yadav&author=S+Mohandas&author=AM+Shete&author=DA+Nyayanit&author=N+Gupta&publication_year=2021&)] [PMC free article](/pmc/articles/PMC8786931/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/35075154)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=medRxiv&title=Viral+Infection+and+Transmission+in+a+Large,+Well-Traced+Outbreak+Caused+by+the+SARS-CoV-2+Delta+Variant&author=B+Li&author=A+Deng&author=K+Li&author=Y+Hu&author=Z+Li&publication_year=2021&)] [Google Scholar](https://scholar.google.com/scholar_lookup?journal=bioRxiv&title=The+B1.351+and+P.1+Variants+Extend+SARS-CoV-2+Host+Range+to+Mice&author=X+Montagutelli&author=M+Prot&author=L+Levillayer&author=EB+Salazar&author=G+Jouvion&publication_year=2021&)] [https://outbreak.info/situation-reports?pango=AY.1&loc=IND&loc=GBR&loc=USA](https://outbreak.info/situation-reports?pango=AY.1&loc=IND&loc=GBR&loc=USA)(Accessed August 28, 2021) [PMC free article](/pmc/articles/PMC7194065/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32362314)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Mol+Cell&title=A+Multibasic+Cleavage+Site+in+the+Spike+Protein+of+SARS-CoV-2+Is+Essential+for+Infection+of+Human+Lung+Cells&author=M+Hoffmann&author=H+Kleine-Weber&author=S+P\u00f6hlmann&volume=78&publication_year=2020&pages=779-e5&pmid=32362314&)] [PMC free article](/pmc/articles/PMC7194977/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32272173)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Antiviral+Res&title=Coronavirus+Membrane+Fusion+Mechanism+Offers+a+Potential+Target+for+Antiviral+Development&author=T+Tang&author=M+Bidon&author=JA+Jaimes&author=GR+Whittaker&author=S+Daniel&volume=178&publication_year=2020&pages=104792&pmid=32272173&)] [PubMed](https://pubmed.ncbi.nlm.nih.gov/34237773)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Nature&title=Reduced+Sensitivity+of+SARS-CoV-2+Variant+Delta+to+Antibody+Neutralization&author=D+Planas&author=D+Veyer&author=A+Baidaliuk&author=I+Staropoli&author=F+Guivel-Benhassine&volume=2021&publication_year=2021&pages=1-7&)] [PMC free article](/pmc/articles/PMC8117968/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33882219)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&title=Vaccine+Breakthrough+Infections+With+SARS-CoV-2+Variants&author=E+Hacisuleyman&author=C+Hale&author=Y+Saito&author=NE+Blachere&author=M+Bergh&volume=384&publication_year=2021&pages=2212-8&pmid=33882219&)] [PMC free article](/pmc/articles/PMC8363499/)] [ [PubMed](https://pubmed.ncbi.nlm.nih.gov/34127854)] [ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Nat+Med&title=Evidence+for+Increased+Breakthrough+Rates+of+SARS-CoV-2+Variants+of+Concern+in+BNT162b2-mRNA-Vaccinated+Individuals&author=T+Kustin&author=N+Harel&author=U+Finkel&author=S+Perchik&author=S+Harari&volume=27&publication_year=2021&pages=1-6&pmid=33442018&)] [Google Scholar](https://scholar.google.com/scholar_lookup?journal=bioRxiv&title=Computational+Assessment+of+the+Spike+Protein+Antigenicity+Reveals+Diversity+in+B+Cell+Epitopes+But+Stability+in+T+Cell+Epitopes+Across+SARS-CoV-2+Variants&author=A+Ge&author=M+Rioux&author=AA+Kelvin&author=AK+Ca&author=A+Kelvin&publication_year=2021&)]", "language": null, "image": "https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0", "pagetype": "article", "links": ["#main-content", "https://www.ncbi.nlm.nih.gov/", "https://account.ncbi.nlm.nih.gov", "/myncbi/", "/myncbi/collections/bibliography/", "/account/settings/", "/account/signout/", "https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys", "https://www.ncbi.nlm.nih.gov", "/myncbi/", "#maincontent", "#", "/pmc/", "https://www.ncbi.nlm.nih.gov/pmc/advanced", "/pmc/about/userguide/", "/pmc/journals/", "/pmc/?term=Karger%20Publishers%20PMC%20COVID-19%20Collection[filter]", "/pmc/articles/PMC9059041/?report=reader", "/pmc/articles/PMC9059041/pdf/kxn-0001.pdf", "#", "https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9059041%2F&text=Mecanismos%20del%20COVID-19%20en%20el%20cuerpo%20humano%3A%20Lo%20que%20sabemos%20hasta%20ahora", "https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9059041%2F", "/pmc/journals/", "/pmc/?term=Karger%20Publishers%20PMC%20COVID-19%20Collection[filter]", "/pmc/about/disclaimer/", "/pmc/about/copyright/", "//doi.org/10.1159%2F000521507", "#", "#", "https://pubmed.ncbi.nlm.nih.gov/?term=Kumar%20A%5BAuthor%5D", "https://pubmed.ncbi.nlm.nih.gov/?term=Narayan%20RK%5BAuthor%5D", "https://pubmed.ncbi.nlm.nih.gov/?term=Prasoon%20P%5BAuthor%5D", "https://pubmed.ncbi.nlm.nih.gov/?term=Kumari%20C%5BAuthor%5D", "https://pubmed.ncbi.nlm.nih.gov/?term=Kaur%20G%5BAuthor%5D", "https://pubmed.ncbi.nlm.nih.gov/?term=Kumar%20S%5BAuthor%5D", "https://pubmed.ncbi.nlm.nih.gov/?term=Kulandhasamy%20M%5BAuthor%5D", "https://pubmed.ncbi.nlm.nih.gov/?term=Sesham%20K%5BAuthor%5D", "https://pubmed.ncbi.nlm.nih.gov/?term=Pareek%20V%5BAuthor%5D", "https://pubmed.ncbi.nlm.nih.gov/?term=Faiq%20MA%5BAuthor%5D", "https://pubmed.ncbi.nlm.nih.gov/?term=Pandey%20SN%5BAuthor%5D", "https://pubmed.ncbi.nlm.nih.gov/?term=Singh%20HN%5BAuthor%5D", "https://pubmed.ncbi.nlm.nih.gov/?term=Kant%20K%5BAuthor%5D", "https://pubmed.ncbi.nlm.nih.gov/?term=Shekhawat%20PS%5BAuthor%5D", "https://pubmed.ncbi.nlm.nih.gov/?term=Raza%20K%5BAuthor%5D", "https://pubmed.ncbi.nlm.nih.gov/?term=Kumar%20S%5BAuthor%5D", "https://pubmed.ncbi.nlm.nih.gov/?term=Kumar%20A%5BAuthor%5D", "https://pubmed.ncbi.nlm.nih.gov/?term=Narayan%20RK%5BAuthor%5D", "https://pubmed.ncbi.nlm.nih.gov/?term=Prasoon%20P%5BAuthor%5D", "https://pubmed.ncbi.nlm.nih.gov/?term=Kumari%20C%5BAuthor%5D", "https://pubmed.ncbi.nlm.nih.gov/?term=Kaur%20G%5BAuthor%5D", "https://pubmed.ncbi.nlm.nih.gov/?term=Kumar%20S%5BAuthor%5D", "https://pubmed.ncbi.nlm.nih.gov/?term=Kulandhasamy%20M%5BAuthor%5D", "https://pubmed.ncbi.nlm.nih.gov/?term=Sesham%20K%5BAuthor%5D", "https://pubmed.ncbi.nlm.nih.gov/?term=Pareek%20V%5BAuthor%5D", "https://pubmed.ncbi.nlm.nih.gov/?term=Faiq%20MA%5BAuthor%5D", "https://pubmed.ncbi.nlm.nih.gov/?term=Pandey%20SN%5BAuthor%5D", "https://pubmed.ncbi.nlm.nih.gov/?term=Singh%20HN%5BAuthor%5D", "https://pubmed.ncbi.nlm.nih.gov/?term=Kant%20K%5BAuthor%5D", "https://pubmed.ncbi.nlm.nih.gov/?term=Shekhawat%20PS%5BAuthor%5D", "https://pubmed.ncbi.nlm.nih.gov/?term=Raza%20K%5BAuthor%5D", "https://pubmed.ncbi.nlm.nih.gov/?term=Kumar%20S%5BAuthor%5D", "#", "#", "/pmc/about/disclaimer/", "mailto:dev@null", "/pmc/about/copyright/", "#B1", "#B1", "#B2", "#B3", "#B4", "#B5", "/pmc/articles/PMC9059041/table/T1/", "/pmc/articles/PMC9059041/figure/F1/", "#B17", "#B17", "#B18", "#B19", "/pmc/articles/PMC9059041/figure/F1/", "#B20", "#B21", "#B22", "/pmc/articles/PMC9059041/figure/F1/", "/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&p=PMC3&id=9059041_kxn-0001-g01.jpg", "/pmc/articles/PMC9059041/figure/F1/?report=objectonly", "/pmc/articles/PMC9059041/figure/F1/", "#B6", "#B7", "#B6", "#B7", "#B1", "#B9", "#B10", "#B11", "#B12", "#B6", "#B7", "#B13", "#B14", "#B6", "#B6", "#B15", "#B16", "/pmc/articles/PMC9059041/table/T1/?report=objectonly", "#B17", "#B23", "#B24", "/pmc/articles/PMC9059041/figure/F2/", "#B1", "/pmc/articles/PMC9059041/figure/F2/", "#B1", "/pmc/articles/PMC9059041/figure/F2/", "/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&p=PMC3&id=9059041_kxn-0001-g02.jpg", "/pmc/articles/PMC9059041/figure/F2/?report=objectonly", "/pmc/articles/PMC9059041/figure/F2/", "#B1", "#B1", "#B25", "#B26", "#B25", "#B27", "#B1", "#B28", "#B25", "#B26", "#B29", "#B30", "#B31", "#B32", "#B33", "#B32", "#B33", "#B5", "#B34", "#B35", "/pmc/articles/PMC9059041/figure/F3/", "/pmc/articles/PMC9059041/figure/F3/", "/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&p=PMC3&id=9059041_kxn-0001-g03.jpg", "/pmc/articles/PMC9059041/figure/F3/?report=objectonly", "/pmc/articles/PMC9059041/figure/F3/", "https://www.proteinatlas.org/", "#B36", "#B37", "#B38", "#B38", "#B37", "#B37", "#B38", "#B36", "#B39", "#B40", "#B41", "#B42", "#B43", "#B44", "#B22", "#B9", "#B17", "#B42", "/pmc/articles/PMC9059041/figure/F4/", "/pmc/articles/PMC9059041/figure/F4/", "/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&p=PMC3&id=9059041_kxn-0001-g04.jpg", "/pmc/articles/PMC9059041/figure/F4/?report=objectonly", "/pmc/articles/PMC9059041/figure/F4/", "#B5", "/pmc/articles/PMC9059041/table/T1/", "#B5", "#B32", "#B32", "#B33", "#B44", "#B45", "#B20", "#B45", "#B46", "#B20", "#B20", "#B45", "#B47", "#B48", "#B49", "#B50", "#B51", "#B52", "#B12", "#B53", "#B53", "#B53", "#B54", "#B33", "#B55", "#B34", "#B56", "#B57", "#B6", "#B13", "#B34", "#B58", "#B13", "#B59", "#B60", "#B61", "#B62", "#B62", "#B62", "#B13", "#B63", "#B13", "#B13", "#B64", "#B13", "#B13", "#B65", "#B13", "#B45", "#B66", "#B67", "#B34", "#B68", "#B68", "#B34", "#B35", "#B69", "#B70", "#B71", "#B72", "#B13", "#B35", "#B8", "#B73", "#B74", "#B75", "#B76", "#B77", "#B78", "#B74", "#B79", "#B80", "#B67", "#B80", "#B80", "#B77", "#B81", "#B82", "#B29", "#B29", "#B7", "#B83", "#B5", "#B11", "#B10", "#B15", "#B16", "#B31", "/pmc/articles/PMC9059041/figure/F2/", "#B1", "#B45", "#B20", "#B84", "#B85", "#B20", "#B20", "#B86", "#B87", "#B87", "#B87", "#B20", "#B20", "#B88", "#B89", "#B90", "#B89", "/pmc/articles/PMC9059041/figure/F5/", "#B90", "/pmc/articles/PMC9059041/figure/F5/", "#B1", "/pmc/articles/PMC9059041/figure/F5/", "/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&p=PMC3&id=9059041_kxn-0001-g05.jpg", "/pmc/articles/PMC9059041/figure/F5/?report=objectonly", "/pmc/articles/PMC9059041/figure/F5/", "#B91", "#B92", "#B93", "#B94", "#B22", "#B95", "#B96", "#B97", "#B85", "#B58", "#B98", "#B99", "#B100", "#B100", "#B101", "#B20", "#B102", "#B103", "#B103", "#B102", "#B103", "#B47", "#B104", "#B105", "#B45", "#B105", "#B106", "#B45", "#B106", "#B45", "#B107", "#B108", "#B45", "#B45", "#B105", "#B45", "#B105", "#B45", "#B106", "#B20", "#B109", "#B109", "#B5", "#B105", "#B110", "#B111", "#B21", "#B112", "/pmc/articles/PMC9059041/figure/F6/", "/pmc/articles/PMC9059041/figure/F6/", "/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&p=PMC3&id=9059041_kxn-0001-g06.jpg", "/pmc/articles/PMC9059041/figure/F6/?report=objectonly", "/pmc/articles/PMC9059041/figure/F6/", "#B21", "#B21", "#B113", "#B114", "#B115", "#B117", "#B118", "#B116", "#B115", "#B119", "#B120", "#B121", "https://globalhealth5050.org", "#B121", "#B122", "#B123", "#B124", "#B125", "#B126", "#B127", "#B128", "#B129", "#B130", "#B131", "#B129", "#B132", "#B129", "#B45", "#B133", "#B134", "#B72", "#B135", "#B132", "#B35", "#B13", "#B13", "#B136", "#B137", "#B138", "#B137", "#B102", "#B139", "#B21", "#B140", "#B141", "#B103", "#B140", "#B142", "#B143", "#B144", "#B145", "#B146", "#B147", "#B148", "#B149", "#B150", "#B151", "#B152", "#B153", "#B65", "#B154", "#B65", "#B153", "#B155", "#B156", "#B157", "#B158", "#B159", "#B160", "#B161", "#B162", "#B163", "#B17", "#B18", "#B19", "#B17", "#B19", "#B72", "#B164", "#B149", "#B165", "#B165", "#B166", "#B167", "#B168", "#B169", "#B167", "#B38", "#B37", "#B170", "#B171", "#B172", "#B173", "#B172", "#B173", "#B174", "#B175", "/pmc/articles/PMC9059041/table/T2/", "#B176", "#B177", "#B178", "#B179", "#B180", "#B181", "#B172", "#B173", "#B3", "#B172", "#B176", "#B177", "/pmc/articles/PMC9059041/figure/F7/", "#B2", "/pmc/articles/PMC9059041/figure/F7/", "#B182", "/pmc/articles/PMC9059041/figure/F7/", "/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&p=PMC3&id=9059041_kxn-0001-g07.jpg", "/pmc/articles/PMC9059041/figure/F7/?report=objectonly", "/pmc/articles/PMC9059041/figure/F7/", "http://www.outbreak.info", "/pmc/articles/PMC9059041/table/T2/?report=objectonly", "#B173", "#B174", "#B174", "/pmc/articles/PMC9059041/table/T2/", "/pmc/articles/PMC9059041/table/T2/", "#B2", "#B3", "#B2", "#B176", "#B177", "#B1", "#B1", "#B183", "#B184", "#B185", "#B1", "#B174", "/pmc/articles/PMC9059041/table/T2/", "#B172", "#B186", "#B187", "#B2", "#B3", "#B4", "#B176", "#B177", "#B2", "#B3", "#B4", "#B176", "#B177", "#B188", "https://creativecommons.org/licenses/by/4.0/deed.es", "https://pubmed.ncbi.nlm.nih.gov/33085084", "https://scholar.google.com/scholar_lookup?journal=J+Med+Virol&title=SARS-CoV-2-Specific+Virulence+Factors+in+COVID-19&author=A+Kumar&author=P+Prasoon&author=C+Kumari&author=V+Pareek&author=MA+Faiq&volume=93&publication_year=2020&pages=1343-50&pmid=33085084&", "/pmc/articles/PMC8611377/", "https://pubmed.ncbi.nlm.nih.gov/34168071", "https://scholar.google.com/scholar_lookup?journal=Science+(80-&title=Effect+of+Natural+Mutations+of+SARS-CoV-2+on+Spike+Structure,+Conformation,+and+Antigenicity&author=SM-C+Gobeil&author=K+Janowska&author=S+McDowell&author=K+Mansouri&author=R+Parks&volume=373&issue=(6555)&publication_year=2021&pages=eabi6226&", "/pmc/articles/PMC9245151/", "https://pubmed.ncbi.nlm.nih.gov/34168070", "https://scholar.google.com/scholar_lookup?journal=Science+(80\u2212)&title=Structural+Basis+for+Enhanced+Infectivity+and+Immune+Evasion+of+SARS-CoV-2+Variants&author=Y+Cai&author=J+Zhang&author=T+Xiao&author=CL+Lavine&author=S+Rawson&volume=373&publication_year=2021&pages=642-8&", "/pmc/articles/PMC9835956/", "https://pubmed.ncbi.nlm.nih.gov/34210893", "https://scholar.google.com/scholar_lookup?journal=Science+(80\u2212)&title=SARS-CoV-2+Immune+Evasion+by+the+B.1.427/B.1.429+Variant+of+Concern&author=M+McCallum&author=J+Bassi&author=A+De+Marco&author=A+Chen&author=AC+Walls&volume=373&publication_year=2021&pages=648-54&", "https://pubmed.ncbi.nlm.nih.gov/32651579", "https://scholar.google.com/scholar_lookup?journal=Nat+Med&title=Extrapulmonary+Manifestations+of+COVID-19&author=A+Gupta&author=MV+Madhavan&author=K+Sehgal&author=N+Nair&author=S+Mahajan&volume=26&publication_year=2020&pages=1017-32&pmid=32651579&", "/pmc/articles/PMC7195311/", "https://pubmed.ncbi.nlm.nih.gov/32305884", "https://scholar.google.com/scholar_lookup?journal=J+Clin+Virol&title=Epidemiology+and+Clinical+Features+of+COVID-19:+A+Review+of+Current+Literature&author=JA+Siordia&volume=127&publication_year=2020&pages=104357&pmid=32305884&", "/pmc/articles/PMC7092819/", "https://pubmed.ncbi.nlm.nih.gov/32109013", "https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&title=Clinical+Characteristics+of+Coronavirus+Disease+2019+in+China&author=W+Guan&author=Z+Ni&author=Y+Hu&author=W+Liang&author=C+Ou&volume=382&publication_year=2020&pages=1708-20&pmid=32109013&", "/pmc/articles/PMC7149362/", "https://pubmed.ncbi.nlm.nih.gov/32275288", "https://scholar.google.com/scholar_lookup?journal=JAMA+Neurol&title=Neurologic+Manifestations+of+Hospitalized+Patients+With+Coronavirus+Disease+2019+in+Wuhan,+China&author=L+Mao&author=H+Jin&author=M+Wang&author=Y+Hu&author=S+Chen&volume=77&publication_year=2020&pages=683-90&pmid=32275288&", "/pmc/articles/PMC7200363/", "https://pubmed.ncbi.nlm.nih.gov/32389615", "https://scholar.google.com/scholar_lookup?journal=Schizophr+Res&title=The+Potential+Impact+of+COVID-19+on+Psychosis:+A+Rapid+Review+of+Contemporary+Epidemic+and+Pandemic+Research&author=E+Brown&author=R+Gray&author=S+Lo+Monaco&author=B+O'Donoghue&author=B+Nelson&volume=222&publication_year=2020&pages=79-87&pmid=32389615&", "/pmc/articles/PMC7752038/", "https://pubmed.ncbi.nlm.nih.gov/33365394", "https://scholar.google.com/scholar_lookup?journal=Laryngoscope+Investig+Otolaryngol&title=Otologic+Dysfunction+in+Patients+With+COVID-19:+A+Systematic+Review&author=S+Maharaj&author=M+Bello+Alvarez&author=S+Mungul&author=K+Hari&volume=5&issue=(6)&publication_year=2020&pages=1192-6&", "/pmc/articles/PMC7110919/", "https://pubmed.ncbi.nlm.nih.gov/32232433", "https://scholar.google.com/scholar_lookup?journal=JAMA+Ophthalmol&title=Characteristics+of+Ocular+Findings+of+Patients+With+Coronavirus+Disease+2019+(COVID-19)+in+Hubei+Province,+China&author=P+Wu&author=F+Duan&author=C+Luo&author=Q+Liu&author=X+Qu&volume=138&publication_year=2020&pages=575-8&pmid=32232433&", "/pmc/articles/PMC7370876/", "https://pubmed.ncbi.nlm.nih.gov/32690910", "https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Cardiol&title=COVID-19+and+Cardiovascular+Disease:+From+Basic+Mechanisms+to+Clinical+Perspectives&author=M+Nishiga&author=DW+Wang&author=Y+Han&author=DB+Lewis&author=JC+Wu&volume=17&publication_year=2020&pages=543-58&pmid=32690910&", "/pmc/articles/PMC7487155/", "https://pubmed.ncbi.nlm.nih.gov/33254575", "https://scholar.google.com/scholar_lookup?journal=Med+Hypotheses&title=Relevance+of+SARS-CoV-2+Related+Factors+ACE2+and+TMPRSS2+Expressions+in+Gastrointestinal+Tissue+With+Pathogenesis+of+Digestive+Symptoms,+Diabetes-Associated+Mortality,+and+Disease+Recurrence+in+COVID-19+Patients&author=A+Kumar&author=MA+Faiq&author=V+Pareek&author=K+Raza&author=RK+Narayan&volume=144&publication_year=2020&pages=110271&pmid=33254575&", "/pmc/articles/PMC7202828/", "https://pubmed.ncbi.nlm.nih.gov/32423587", "https://scholar.google.com/scholar_lookup?journal=Lancet&title=COVID-19-Associated+Nephritis:+Early+Warning+for+Disease+Severity+and+Complications?&author=O+Gross&author=O+Moerer&author=M+Weber&author=TB+Huber&author=S+Scheithauer&volume=395&publication_year=2020&pages=e87-8&pmid=32423587&", "/pmc/articles/PMC7323324/", "https://pubmed.ncbi.nlm.nih.gov/32535979", "https://scholar.google.com/scholar_lookup?journal=J+Eur+Acad+Dermatol+Venereol&title=The+Red+Half-Moon+Nail+Sign:+A+Novel+Manifestation+of+Coronavirus+Infection&author=I+Neri&author=A+Guglielmo&author=A+Virdi&author=V+Gaspari&author=M+Starace&volume=34&publication_year=2020&pages=e663-5&pmid=32535979&", "/pmc/articles/PMC7422480/", "https://pubmed.ncbi.nlm.nih.gov/32849867", "https://scholar.google.com/scholar_lookup?journal=Dermatol+Res+Pract&title=A+Review+of+the+Dermatological+Manifestations+of+Coronavirus+Disease+2019+(COVID-19)&author=F+Marraha&author=I+Al+Faker&author=S+Gallouj&volume=2020&publication_year=2020&pages=9360476&pmid=32849867&", "/pmc/articles/PMC7611399/", "https://pubmed.ncbi.nlm.nih.gov/33692530", "https://scholar.google.com/scholar_lookup?journal=Nat+Med&title=Attributes+and+Predictors+of+Long+COVID&author=CH+Sudre&author=B+Murray&author=T+Varsavsky&author=MS+Graham&author=RS+Penfold&volume=27&publication_year=2021&pages=1-6&pmid=33442018&", "https://pubmed.ncbi.nlm.nih.gov/32665317", "https://scholar.google.com/scholar_lookup?journal=BMJ&title=Covid-19:+What+do+We+Know+About+\u201cLong+Covid\u201d?&author=E+Mahase&volume=370&publication_year=2020&pages=m2815&pmid=32665317&", "/pmc/articles/PMC7392393/", "https://pubmed.ncbi.nlm.nih.gov/32730238", "https://scholar.google.com/scholar_lookup?journal=MMWR+Morb+Mortal+Wkly+Rep&title=Symptom+Duration+and+Risk+Factors+for+Delayed+Return+to+Usual+Health+Among+Outpatients+With+COVID-19+in+a+Multistate+Health+Care+Systems+Network+\u2014+United+States,+March\u2013June+2020&author=MW+Tenforde&author=SS+Kim&author=CJ+Lindsell&author=E+Billig+Rose&author=NI+Shapiro&volume=69&publication_year=2020&pages=993-8&pmid=32730238&", "https://pubmed.ncbi.nlm.nih.gov/33111578", "https://scholar.google.com/scholar_lookup?journal=Int+Rev+Immunol&title=Pathogenesis+Guided+Therapeutic+Management+of+COVID-19:+An+Immunological+Perspective&author=A+Kumar&author=P+Prasoon&author=PS+Sekhawat&author=V+Pareek&author=MA+Faiq&volume=40&publication_year=2020&pages=1-18&", "https://scholar.google.com/scholar_lookup?journal=Precis+Clin+Med&title=Host/genetic+Factors+Associated+With+COVID-19+Call+for+Precision+Medicine&author=A.+R.+Thierry&volume=3&issue=(3)&publication_year=2020&pages=228-34&", "https://pubmed.ncbi.nlm.nih.gov/32434211", "https://scholar.google.com/scholar_lookup?journal=Nature&title=Viral+and+Host+Factors+Related+to+the+Clinical+Outcome+of+COVID-19&author=X+Zhang&author=Y+Tan&author=Y+Ling&author=G+Lu&author=F+Liu&volume=583&publication_year=2020&pages=1-7&", "/pmc/articles/PMC8389999/", "https://pubmed.ncbi.nlm.nih.gov/34454673", "https://scholar.google.com/scholar_lookup?journal=Lancet&title=1-Year+Outcomes+in+Hospital+Survivors+With+COVID-19:+A+Longitudinal+Cohort+Study&author=L+Huang&author=Q+Yao&author=X+Gu&author=Q+Wang&author=L+Ren&volume=398&publication_year=2021&pages=747-58&pmid=34454673&", "/pmc/articles/PMC7102627/", "https://pubmed.ncbi.nlm.nih.gov/32142651", "https://scholar.google.com/scholar_lookup?journal=Cell&title=SARS-CoV-2+Cell+Entry+Depends+on+ACE2+and+TMPRSS2+and+Is+Blocked+by+a+Clinically+Proven+Protease+Inhibitor&author=M+Hoffmann&author=H+Kleine-Weber&author=S+Schroeder&author=N+Kr\u00fcger&author=T+Herrler&volume=181&publication_year=2020&pages=271-80.e8&pmid=32142651&", "/pmc/articles/PMC7114094/", "https://pubmed.ncbi.nlm.nih.gov/32057769", "https://scholar.google.com/scholar_lookup?journal=Antiviral+Res&title=The+Spike+Glycoprotein+of+the+New+Coronavirus+2019-Ncov+Contains+a+Furin-Like+Cleavage+Site+Absent+in+CoV+of+the+Same+Clade&author=B+Coutard&author=C+Valle&author=X+de+Lamballerie&author=B+Canard&author=NG+Seidah&volume=176&publication_year=2020&pages=104742&pmid=32057769&", "/pmc/articles/PMC6682551/", "https://pubmed.ncbi.nlm.nih.gov/31406574", "https://scholar.google.com/scholar_lookup?journal=Clin+Transl+Immunol&title=Furin\u2010mediated+protein+processing+in+infectious+diseases+and+cancer&author=E.+Braun&author=D.+Sauter&volume=8&issue=(8)&publication_year=2019&pages=e1073&", "/pmc/articles/PMC7289711/", "https://pubmed.ncbi.nlm.nih.gov/32532959", "https://scholar.google.com/scholar_lookup?journal=Signal+Transduct+Target+Ther&title=The+Role+of+Furin+Cleavage+Site+in+SARS-CoV-2+Spike+Protein-Mediated+Membrane+Fusion+in+the+Presence+or+Absence+of+Trypsin&author=S+Xia&author=Q+Lan&author=S+Su&author=X+Wang&author=W+Xu&volume=5&publication_year=2020&pages=1-3&pmid=32296011&", "/pmc/articles/PMC8175039/", "https://pubmed.ncbi.nlm.nih.gov/33494095", "https://scholar.google.com/scholar_lookup?journal=bioRxiv&title=Furin+Cleavage+Site+Is+Key+to+SARS-CoV-2+Pathogenesis&author=BA+Johnson&author=X+Xie&author=B+Kalveram&author=KG+Lokugamage&author=A+Muruato&publication_year=2020&", "/pmc/articles/PMC7857391/", "https://pubmed.ncbi.nlm.nih.gov/33082293", "https://scholar.google.com/scholar_lookup?journal=Science+(80\u2212)&title=Neuropilin-1+Facilitates+SARS-CoV-2+Cell+Entry+and+Infectivity&author=L+Cantuti-Castelvetri&author=R+Ojha&author=LD+Pedro&author=M+Djannatian&author=J+Franz&volume=370&publication_year=2020&pages=eabd2985&", "/pmc/articles/PMC7612957/", "https://pubmed.ncbi.nlm.nih.gov/33082294", "https://scholar.google.com/scholar_lookup?journal=Science+(80\u2212)&title=Neuropilin-1+is+a+Host+Factor+for+SARS-CoV-2+Infection&author=JL+Daly&author=B+Simonetti&author=K+Klein&author=KE+Chen&author=MK+Williamson&volume=370&publication_year=2020&pages=861-5&", "/pmc/articles/PMC7252096/", "https://pubmed.ncbi.nlm.nih.gov/32413319", "https://scholar.google.com/scholar_lookup?journal=Cell&title=SARS-CoV-2+Receptor+ACE2+Is+an+Interferon-Stimulated+Gene+in+Human+Airway+Epithelial+Cells+and+Is+Detected+in+Specific+Cell+Subsets+Across+Tissues&author=CGK+Ziegler&author=SJ+Allon&author=SK+Nyquist&author=IM+Mbano&author=VN+Miao&volume=181&publication_year=2020&pages=1016-35.e19&pmid=32413319&", "/pmc/articles/PMC8637938/", "https://pubmed.ncbi.nlm.nih.gov/32327758", "https://scholar.google.com/scholar_lookup?journal=Nat+Med&title=SARS-CoV-2+Entry+Factors+Are+Highly+Expressed+in+Nasal+Epithelial+Cells+Together+With+Innate+Immune+Genes&author=W+Sungnak&author=N+Huang&author=C+B\u00e9cavin&author=M+Berg&author=R+Queen&volume=26&publication_year=2020&pages=1-7&pmid=31932805&", "https://scholar.google.com/scholar_lookup?journal=bioRxiv&title=Integrated+Analyses+of+Single-Cell+Atlases+Reveal+Age,+Gender,+and+Smoking+Status+Associations+With+Cell+Type-Specific+Expression+of+Mediators+of+SARS-CoV-2+Viral+Entry+and+Highlights+Inflammatory+Programs+in+Putative+Target+Cells&author=C+Muus&author=MD+Luecken&author=G+Eraslan&author=A+Waghray&author=G+Heimberg&publication_year=2020&", "https://pubmed.ncbi.nlm.nih.gov/32817204", "https://scholar.google.com/scholar_lookup?journal=J+Clin+Pathol&title=Histopathological+Observations+in+COVID-19:+A+Systematic+Review&author=V+Deshmukh&author=R+Motwani&author=A+Kumar&author=C+Kumari&author=K+Raza&volume=74&publication_year=2020&pages=1-8&pmid=32907914&", "/pmc/articles/PMC7303620/", "https://pubmed.ncbi.nlm.nih.gov/32579880", "https://scholar.google.com/scholar_lookup?journal=Cell+Stem+Cell&title=A+Human+Pluripotent+Stem+Cell-Based+Platform+to+Study+SARS-CoV-2+Tropism+and+Model+Virus+Infection+in+Human+Cells+and+Organoids&author=L+Yang&author=Y+Han&author=BE+Nilsson-Payant&author=V+Gupta&author=P+Wang&volume=27&publication_year=2020&pages=125-136.e7&pmid=32579880&", "/pmc/articles/PMC7321036/", "https://pubmed.ncbi.nlm.nih.gov/32645325", "https://scholar.google.com/scholar_lookup?journal=Cell&title=Krogan+Correspondence+NJ.+The+Global+Phosphorylation+Landscape+of+SARS-CoV-2+Infection&author=M+Bouhaddou&author=D+Memon&author=DL+Swaney&author=P+Beltrao&volume=182&publication_year=2020&pages=685-712&pmid=32645325&", "/pmc/articles/PMC7418786/", "https://pubmed.ncbi.nlm.nih.gov/32877642", "https://scholar.google.com/scholar_lookup?journal=Mol+Cell&title=Growth+Factor+Receptor+Signaling+Inhibition+Prevents+SARS-CoV-2+Replication&author=K+Klann&author=D+Bojkova&author=G+Tascher&author=S+Ciesek&author=C+M\u00fcnch&volume=80&publication_year=2020&pages=164-e4&pmid=32877642&", "/pmc/articles/PMC7934846/", "https://pubmed.ncbi.nlm.nih.gov/33284134", "https://scholar.google.com/scholar_lookup?journal=JCI+Insight&title=Metabolic+Reprogramming+and+Epigenetic+Changes+of+Vital+Organs+in+SARS-CoV-2\u2013Induced+Systemic+Toxicity&author=S+Li&author=F+Ma&author=T+Yokota&author=G+Garcia&author=A+Palermo&volume=6&publication_year=2021&pages=e145027&", "/pmc/articles/PMC7402621/", "https://pubmed.ncbi.nlm.nih.gov/32680882", "https://scholar.google.com/scholar_lookup?journal=Science&title=Structural+Basis+for+Translational+Shutdown+and+Immune+Evasion+by+the+Nsp1+Protein+of+SARS-CoV-2&author=M+Thoms&author=R+Buschauer&author=M+Ameismeier&author=L+Koepke&author=T+Denk&volume=369&publication_year=2020&pages=1249-55&pmid=32680882&", "/pmc/articles/PMC7381649/", "https://pubmed.ncbi.nlm.nih.gov/32709886", "https://scholar.google.com/scholar_lookup?journal=Nat+Commun&title=Structural+Basis+of+RNA+Cap+Modification+by+SARS-CoV-2&author=T+Viswanathan&author=S+Arya&author=S-H+Chan&author=S+Qi&author=N+Dai&volume=11&publication_year=2020&pages=3718&pmid=32709886&", "/pmc/articles/PMC7343387/", "https://pubmed.ncbi.nlm.nih.gov/32452762", "https://scholar.google.com/scholar_lookup?journal=Elife&title=SARS-CoV-2+Strategically+Mimics+Proteolytic+Activation+of+Human+ENaC&author=P+Anand&author=A+Puranik&author=M+Aravamudan&author=AJ+Venkatakrishnan&author=V+Soundararajan&volume=9&publication_year=2020&pages=e58603&pmid=32452762&", "/pmc/articles/PMC5524836/", "https://pubmed.ncbi.nlm.nih.gov/28791006", "https://scholar.google.com/scholar_lookup?journal=Front+Immunol&title=Regulation+of+Lung+Epithelial+Sodium+Channels+by+Cytokines+and+Chemokines&author=BM+Wynne&author=L+Zou&author=V+Linck&author=RS+Hoover&author=HP+Ma&volume=8&publication_year=2017&pages=766&pmid=28791006&", "/pmc/articles/PMC6349474/", "https://pubmed.ncbi.nlm.nih.gov/30585851", "https://scholar.google.com/scholar_lookup?journal=Curr+Opin+Nephrol+Hypertens&title=New+Insights+Regarding+Epithelial+Na++Channel+Regulation+and+Its+Role+in+the+Kidney,+Immune+System+and+Vasculature&author=SM+Mutchler&author=TR+Kleyman&volume=28&issue=(2)&publication_year=2019&pages=113-9&pmid=30585851&", "/pmc/articles/PMC7415847/", "https://pubmed.ncbi.nlm.nih.gov/32771682", "https://scholar.google.com/scholar_lookup?journal=EBioMedicine&title=SARS-CoV-2+and+ACE2:+The+Biology+and+Clinical+Data+Settling+the+ARB+and+ACEI+Controversy&author=MK+Chung&author=S+Karnik&author=J+Saef&author=C+Bergmann&author=J+Barnard&volume=58&publication_year=2020&pages=102907&pmid=32771682&", "/pmc/articles/PMC7525265/", "https://pubmed.ncbi.nlm.nih.gov/33032170", "https://scholar.google.com/scholar_lookup?journal=Med+Hypotheses&title=SARS-CoV-2+Cell+Entry+Receptor+ACE2+Mediated+Endothelial+Dysfunction+Leads+to+Vascular+Thrombosis+in+COVID-19+Patients&author=A+Kumar&author=RK+Narayan&author=C+Kumari&author=MA+Faiq&author=M+Kulandhasamy&volume=145&publication_year=2020&pages=110320&pmid=33032170&", "/pmc/articles/PMC7347958/", "https://pubmed.ncbi.nlm.nih.gov/32493030", "https://scholar.google.com/scholar_lookup?journal=American+Journal+of+Physiology-Lung+Cellular+and+Molecular+Physiology&title=Thoughts+on+the+Alveolar+Phase+of+COVID-19&author=R.+J.+Mason&volume=319&issue=(1)&publication_year=2020&pages=L115-20&pmid=32493030&", "/pmc/articles/PMC7412750/", "https://pubmed.ncbi.nlm.nih.gov/32437596", "https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&title=Pulmonary+Vascular+Endothelialitis,+Thrombosis,+and+Angiogenesis+in+Covid-19&author=M+Ackermann&author=SE+Verleden&author=M+Kuehnel&author=A+Haverich&author=T+Welte&volume=383&publication_year=2020&pages=120-8&pmid=32437596&", "https://pubmed.ncbi.nlm.nih.gov/33086866", "https://scholar.google.com/scholar_lookup?journal=Arterioscler+Thromb+Vasc+Biol&title=ACE2+(Angiotensin-Converting+Enzyme+2)+and+TMPRSS2+(Transmembrane+Serine+Protease+2)+Expression+and+Localization+of+SARS-CoV-2+Infection+in+the+Human+Heart&author=A+Sakamoto&author=R+Kawakami&author=K+Kawai&author=A+Gianatti&author=D+Pellegrini&volume=41&publication_year=2020&pages=542-4&pmid=33086866&", "/pmc/articles/PMC7194533/", "https://pubmed.ncbi.nlm.nih.gov/32360126", "https://scholar.google.com/scholar_lookup?journal=Life+Sci&title=Myocardial+Injury+and+COVID-19:+Possible+Mechanisms&author=S+Babapoor-Farrokhran&author=D+Gill&author=J+Walker&author=RT+Rasekhi&author=B+Bozorgnia&volume=253&publication_year=2020&pages=117723&pmid=32360126&", "/pmc/articles/PMC7385672/", "https://pubmed.ncbi.nlm.nih.gov/32730555", "https://scholar.google.com/scholar_lookup?journal=JAMA+Cardiol&title=Association+of+Cardiac+Infection+With+SARS-CoV-2+in+Confirmed+COVID-19+Autopsy+Cases&author=D+Lindner&author=A+Fitzek&author=H+Br\u00e4uninger&author=G+Aleshcheva&author=C+Edler&volume=5&publication_year=2020&pages=1281-5&pmid=32730555&", "/pmc/articles/PMC7191628/", "https://pubmed.ncbi.nlm.nih.gov/32228252", "https://scholar.google.com/scholar_lookup?journal=Am+J+Physiol+Heart+Circ+Physiol&title=COVID-19,+ACE2,+and+the+Cardiovascular+Consequences&author=AM+South&author=DI+Diz&author=MC+Chappell&volume=318&publication_year=2020&pages=H1084-90&pmid=32228252&", "/pmc/articles/PMC7236830/", "https://pubmed.ncbi.nlm.nih.gov/32341103", "https://scholar.google.com/scholar_lookup?journal=Eur+Respir+J&title=Understanding+the+Renin-Angiotensin-Aldosterone-SARS-CoV+Axis:+A+Comprehensive+Review&author=NE+Ingraham&author=AG+Barakat&author=R+Reilkoff&author=T+Bezdicek&author=T+Schacker&volume=56&publication_year=2020&pages=2000912&pmid=32341103&", "/pmc/articles/PMC10016902/", "https://pubmed.ncbi.nlm.nih.gov/32943474", "https://scholar.google.com/scholar_lookup?journal=Postgrad+Med+J&title=K+C+MB.+COVID-19+and+the+Heart:+What+We+Have+Learnt+So+Far&author=KB+Shaha&author=DN+Manandhar&author=JR+Cho&author=A+Adhikari&volume=97&publication_year=2020&pages=655-66&pmid=32943474&", "/pmc/articles/PMC7781399/", "https://pubmed.ncbi.nlm.nih.gov/33398605", "https://scholar.google.com/scholar_lookup?journal=Clin+Exp+Nephrol&title=Hypokalemia+in+Patients+With+COVID-19&author=G+Alfano&author=A+Ferrari&author=F+Fontana&author=R+Perrone&author=G+Mori&volume=25&publication_year=2021&pages=1-9&pmid=32857255&", "/pmc/articles/PMC7316659/", "https://pubmed.ncbi.nlm.nih.gov/32903321", "https://scholar.google.com/scholar_lookup?journal=Kidney+Dis+(Basel)&title=Localization+of+Cell+Receptor-Related+Genes+of+SARS-CoV-2+in+the+Kidney+Through+Single-Cell+Transcriptome+Analysis&author=QL+Chen&author=JQ+Li&author=ZD+Xiang&author=Y+Lang&author=GJ+Guo&volume=6&publication_year=2020&pages=258-70&pmid=32903321&", "/pmc/articles/PMC7144544/", "https://pubmed.ncbi.nlm.nih.gov/32273593", "https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Nephrol&title=Kidney+Involvement+in+COVID-19+and+Rationale+for+Extracorporeal+Therapies&author=C+Ronco&author=T+Reis&volume=16&issue=(6)&publication_year=2020&pages=308-10&pmid=32273593&", "/pmc/articles/PMC7646060/", "https://pubmed.ncbi.nlm.nih.gov/33022818", "https://scholar.google.com/scholar_lookup?journal=Rev+Med+Virol&title=Covid-19+and+Kidney+Injury:+Pathophysiology+and+Molecular+Mechanisms&author=E+Ahmadian&author=SM+Hosseiniyan+Khatibi&author=S+Razi+Soofiyani&author=S+Abediazar&author=MM+Shoja&volume=31&publication_year=2020&pages=e2176&pmid=33022818&", "/pmc/articles/PMC7365650/", "https://pubmed.ncbi.nlm.nih.gov/32682491", "https://scholar.google.com/scholar_lookup?journal=Lancet&title=Histopathology+and+Ultrastructural+Findings+of+Fatal+COVID-19+Infections+in+Washington+State:+A+Case+Series&author=BT+Bradley&author=H+Maioli&author=R+Johnston&author=I+Chaudhry&author=SL+Fink&volume=396&publication_year=2020&pages=320-32&pmid=32682491&", "https://pubmed.ncbi.nlm.nih.gov/32405028", "https://scholar.google.com/scholar_lookup?journal=Nat+Med&title=Infection+of+Bat+and+Human+Intestinal+Organoids+by+SARS-CoV-2&author=J+Zhou&author=C+Li&author=X+Liu&author=MC+Chiu&author=X+Zhao&volume=26&publication_year=2020&pages=1-7&pmid=31932805&", "/pmc/articles/PMC7199907/", "https://pubmed.ncbi.nlm.nih.gov/32358202", "https://scholar.google.com/scholar_lookup?journal=Science+(80\u2212)&title=SARS-CoV-2+Productively+Infects+Human+Gut+Enterocytes&author=MM+Lamers&author=J+Beumer&author=J+van+der+Vaart&author=K+Knoops&author=J+Puschhof&volume=369&publication_year=2020&pages=eabc1669&", "/pmc/articles/PMC7725054/", "https://pubmed.ncbi.nlm.nih.gov/33307034", "https://scholar.google.com/scholar_lookup?journal=Gastroenterology&title=The+Gastrointestinal+Tract+Is+an+Alternative+Route+for+SARS-CoV-2+Infection+in+a+Nonhuman+Primate+Model&author=L+Jiao&author=H+Li&author=J+Xu&author=M+Yang&author=C+Ma&volume=160&publication_year=2020&pages=1647-61&pmid=33307034&", "/pmc/articles/PMC7883337/", "https://pubmed.ncbi.nlm.nih.gov/33589829", "https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Gastroenterol+Hepatol&title=Potential+Intestinal+Infection+and+Faecal\u2013Oral+Transmission+of+SARS-CoV-2&author=M+Guo&author=W+Tao&author=RA+Flavell&author=S+Zhu&volume=18&publication_year=2021&pages=1-15&pmid=32963339&", "https://pubmed.ncbi.nlm.nih.gov/28498998", "https://scholar.google.com/scholar_lookup?journal=J+Infect+Dis&title=Mechanism+of+Human+Influenza+Virus+RNA+Persistence+and+Virion+Survival+in+Feces:+Mucus+Protects+Virions+From+Acid+and+Digestive+Juices&author=R+Hirose&author=T+Nakaya&author=Y+Naito&author=T+Daidoji&author=Y+Watanabe&volume=216&publication_year=2017&pages=105-9&pmid=28498998&", "/pmc/articles/PMC7694956/", "https://pubmed.ncbi.nlm.nih.gov/33172188", "https://scholar.google.com/scholar_lookup?journal=Microorganisms&title=Intestinal+Barrier+Function+in+Health+and+Disease-Any+role+of+SARS-CoV-2?&author=L+Sharma&author=A+Riva&volume=8&publication_year=2020&pages=1-27&", "/pmc/articles/PMC7314193/", "https://pubmed.ncbi.nlm.nih.gov/32497191", "https://scholar.google.com/scholar_lookup?journal=Clin+Infect+Dis&title=Alterations+of+the+Gut+Microbiota+in+Patients+With+Coronavirus+Disease+2019+or+H1N1+Influenza&author=S+Gu&author=Y+Chen&author=Z+Wu&author=Y+Chen&author=H+Gao&volume=71&publication_year=2020&pages=2669-78&pmid=32497191&", "/pmc/articles/PMC7605324/", "https://pubmed.ncbi.nlm.nih.gov/33138836", "https://scholar.google.com/scholar_lookup?journal=J+Transl+Med&title=Detection+of+Novel+Coronavirus+(SARS-CoV-2)+RNA+in+Peripheral+Blood+Specimens&author=M+Azghandi&author=MA+Kerachian&volume=18&publication_year=2020&pages=412&pmid=33138836&", "/pmc/articles/PMC7547916/", "https://pubmed.ncbi.nlm.nih.gov/33053430", "https://scholar.google.com/scholar_lookup?journal=Neurobiol+Dis&title=The+SARS-CoV-2+Spike+Protein+Alters+Barrier+Function+in+2D+Static+and+3D+Microfluidic+in-Vitro+Models+of+the+Human+Blood\u2013Brain+Barrier&author=TP+Buzhdygan&author=BJ+DeOre&author=A+Baldwin-Leclair&author=TA+Bullock&author=HM+McGary&volume=146&publication_year=2020&pages=105131&pmid=33053430&", "/pmc/articles/PMC7189193/", "https://pubmed.ncbi.nlm.nih.gov/32388469", "https://scholar.google.com/scholar_lookup?journal=J+Clin+Virol&title=Gastrointestinal,+Hepatobiliary,+and+Pancreatic+Manifestations+of+COVID-19&author=KP+Patel&author=PA+Patel&author=RR+Vunnam&author=AT+Hewlett&author=R+Jain&volume=128&publication_year=2020&pages=104386&pmid=32388469&", "/pmc/articles/PMC7444942/", "https://pubmed.ncbi.nlm.nih.gov/32861070", "https://scholar.google.com/scholar_lookup?journal=BioMed+Pharmacother&title=ACE2,+TMPRSS2+Distribution+and+Extrapulmonary+Organ+Injury+in+Patients+With+COVID-19&author=M+Dong&author=J+Zhang&author=X+Ma&author=J+Tan&author=L+Chen&volume=131&publication_year=2020&pages=110678&pmid=32861070&", "/pmc/articles/PMC7304415/", "https://pubmed.ncbi.nlm.nih.gov/32530585", "https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&title=New-Onset+Diabetes+in+Covid-19&author=F+Rubino&author=SA+Amiel&author=P+Zimmet&author=G+Alberti&author=S+Bornstein&volume=383&publication_year=2020&pages=789-90&pmid=32530585&", "/pmc/articles/PMC7220586/", "https://pubmed.ncbi.nlm.nih.gov/32404898", "https://scholar.google.com/scholar_lookup?journal=Eur+J+Clin+Nutr&title=Diabetes+and+COVID-19:+Evidence,+Current+Status+and+Unanswered+Research+Questions&author=R+Gupta&author=A+Hussain&author=A+Misra&volume=74&publication_year=2020&pages=864-70&pmid=32404898&", "/pmc/articles/PMC7669477/", "https://pubmed.ncbi.nlm.nih.gov/33395782", "https://scholar.google.com/scholar_lookup?journal=Diabetes+&+Metabolic+Syndrome:+Clinical+Research+&+Reviews&title=New+Onset+Diabetes,+Type+1+Diabetes+and+COVID-19&author=S.+K.+Boddu&author=G.+Aurangabadkar&author=M.+S.+Kuchay&volume=14&issue=(6)&publication_year=2020&pages=2211-7&", "https://pubmed.ncbi.nlm.nih.gov/32303650", "https://scholar.google.com/scholar_lookup?journal=Neurology&title=Miller+Fisher+Syndrome+and+Polyneuritis+Cranialis+in+COVID-19&author=C+Guti\u00e9rrez-Ortiz&author=A+M\u00e9ndez&author=S+Rodrigo-Rey&author=E+San+Pedro-Murillo&author=L+Bermejo-Guerrero&volume=95&publication_year=2020&pages=e601-5&pmid=32303650&", "/pmc/articles/PMC7195378/", "https://pubmed.ncbi.nlm.nih.gov/32251791", "https://scholar.google.com/scholar_lookup?journal=Int+J+Infect+Dis&title=A+First+Case+of+Meningitis/Encephalitis+Associated+With+SARS-Coronavirus-2&author=T+Moriguchi&author=N+Harii&author=J+Goto&author=D+Harada&author=H+Sugawara&volume=94&publication_year=2020&pages=55-8&pmid=32251791&", "/pmc/articles/PMC7233386/", "https://pubmed.ncbi.nlm.nih.gov/32228363", "https://scholar.google.com/scholar_lookup?journal=Radiology&title=COVID-19\u2013Associated+Acute+Hemorrhagic+Necrotizing+Encephalopathy:+CT+and+MRI+Features&author=N+Poyiadji&author=G+Shahin&author=D+Noujaim&author=M+Stone&author=S+Patel&volume=201187&publication_year=2020&pages=E119-20&", "/pmc/articles/PMC7454352/", "https://pubmed.ncbi.nlm.nih.gov/32637987", "https://scholar.google.com/scholar_lookup?journal=Brain&title=The+Emerging+Spectrum+of+COVID-19+Neurology:+Clinical,+Radiological+and+Laboratory+Findings&author=RW+Paterson&author=RL+Brown&author=L+Benjamin&author=R+Nortley&author=S+Wiethoff&volume=143&publication_year=2020&pages=3104-20&pmid=32637987&", "/pmc/articles/PMC7316461/", "https://pubmed.ncbi.nlm.nih.gov/32593341", "https://scholar.google.com/scholar_lookup?journal=Lancet+Psychiatry&title=Neurological+and+Neuropsychiatric+Complications+of+COVID-19+in+153+Patients:+A+UK-Wide+Surveillance+Study&author=A+Varatharaj&author=N+Thomas&author=MA+Ellul&author=NWS+Davies&author=TA+Pollak&volume=7&publication_year=2020&pages=875-82&pmid=32593341&", "/pmc/articles/PMC7304421/", "https://pubmed.ncbi.nlm.nih.gov/32530583", "https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&title=Neuropathological+Features+of+Covid-19&author=IH+Solomon&author=E+Normandin&author=S+Bhattacharyya&author=SS+Mukerji&author=K+Keller&volume=383&publication_year=2020&pages=989-92&pmid=32530583&", "/pmc/articles/PMC7269702/", "https://pubmed.ncbi.nlm.nih.gov/32220634", "https://scholar.google.com/scholar_lookup?journal=Travel+Med+Infect+Dis&title=Sars-Cov-2:+Underestimated+Damage+to+Nervous+System&author=L+Zhou&author=M+Zhang&author=J+Wang&author=J+Gao&volume=36&publication_year=2020&pages=101642&pmid=32220634&", "https://pubmed.ncbi.nlm.nih.gov/32869376", "https://scholar.google.com/scholar_lookup?journal=J+Neurosci+Res&title=Possible+Routes+of+SARS-CoV-2+Invasion+in+Brain:+In+Context+of+Neurological+Symptoms+in+COVID-19+Patients&author=A+Kumar&author=V+Pareek&author=P+Prasoon&author=MA+Faiq&author=P+Kumar&volume=98&publication_year=2020&pages=2376-83&pmid=32869376&", "/pmc/articles/PMC7096820/", "https://pubmed.ncbi.nlm.nih.gov/16415928", "https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Microbiol&title=Coronavirus+Infection+of+the+Central+Nervous+System:+Host-Virus+Stand-Off&author=CC+Bergmann&author=TE+Lane&author=SA+Stohlman&volume=4&publication_year=2006&pages=121-32&pmid=16415928&", "/pmc/articles/PMC1829448/", "https://pubmed.ncbi.nlm.nih.gov/17392154", "https://scholar.google.com/scholar_lookup?journal=Am+J+Pathol&title=Pathology+and+Pathogenesis+of+Severe+Acute+Respiratory+Syndrome&author=J+Gu&author=C+Korteweg&volume=170&issue=(4)&publication_year=2007&pages=1136-47&pmid=17392154&", "/pmc/articles/PMC7231545/", "https://pubmed.ncbi.nlm.nih.gov/32354768", "https://scholar.google.com/scholar_lookup?journal=J+Neurol+Neurosurg+Psychiatry&title=Characteristics+of+Ischaemic+Stroke+Associated+With+COVID-19&author=R+Beyrouti&author=ME+Adams&author=L+Benjamin&author=H+Cohen&author=SF+Farmer&volume=91&publication_year=2020&pages=889-91&pmid=32354768&", "/pmc/articles/PMC7874430/", "https://pubmed.ncbi.nlm.nih.gov/33217246", "https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&title=Tissue-Specific+Immunopathology+in+Fatal+COVID-19&author=DA+Dorward&author=CD+Russell&author=IH+Um&author=M+Elshani&author=SD+Armstrong&volume=203&publication_year=2021&pages=192-201&pmid=33217246&", "https://pubmed.ncbi.nlm.nih.gov/33481684", "https://scholar.google.com/scholar_lookup?journal=Viral+Immunol&title=Expression+of+SARS-CoV-2+Host+Cell+Entry+Factors+in+Immune+System+Components+of+Healthy+Individuals+and+Its+Relevance+for+COVID-19+Immunopathology&author=A+Kumar&author=S+Kumar&author=RK+Narayan&author=C+Kumari&author=V+Pareek&volume=34&issue=(5)&publication_year=2021&pages=352-7&pmid=33481684&", "/pmc/articles/PMC7832378/", "https://pubmed.ncbi.nlm.nih.gov/33333256", "https://scholar.google.com/scholar_lookup?journal=Clin+Immunol&title=Influenza+Infection,+SARS,+MERS+and+COVID-19:+Cytokine+Storm+\u2212+The+Common+Denominator+and+the+Lessons+to+be+Learned&author=VA+Ryabkova&author=LP+Churilov&author=Y+Shoenfeld&volume=223&publication_year=2021&pages=108652&pmid=33333256&", "/pmc/articles/PMC7956943/", "https://pubmed.ncbi.nlm.nih.gov/33732251", "https://scholar.google.com/scholar_lookup?journal=Front+Immunol&title=SARS-CoV-2+Causes+a+Different+Cytokine+Response+Compared+to+Other+Cytokine+Storm-Causing+Respiratory+Viruses+in+Severely+Ill+Patients&author=M+Olbei&author=I+Hautefort&author=D+Modos&author=A+Treveil&author=M+Poletti&volume=12&publication_year=2021&pages=629193&pmid=33732251&", "/pmc/articles/PMC4752723/", "https://pubmed.ncbi.nlm.nih.gov/26867177", "https://scholar.google.com/scholar_lookup?journal=Cell+Host+Microbe&title=Dysregulated+Type+I+Interferon+and+Inflammatory+Monocyte-Macrophage+Responses+Cause+Lethal+Pneumonia+in+SARS-CoV-Infected+Mice&author=R+Channappanavar&author=AR+Fehr&author=R+Vijay&author=M+Mack&author=J+Zhao&volume=19&publication_year=2016&pages=181-93&pmid=26867177&", "/pmc/articles/PMC7227586/", "https://pubmed.ncbi.nlm.nih.gov/32416070", "https://scholar.google.com/scholar_lookup?journal=Cell&title=Imbalanced+Host+Response+to+SARS-CoV-2+Drives+Development+of+COVID-19&author=D+Blanco-Melo&author=BE+Nilsson-Payant&author=WC+Liu&author=S+Uhl&author=D+Hoagland&volume=181&publication_year=2020&pages=1036-1045.e9&pmid=32416070&", "/pmc/articles/PMC7473339/", "https://pubmed.ncbi.nlm.nih.gov/32941788", "https://scholar.google.com/scholar_lookup?journal=Cell+Rep&title=SARS-CoV-2+ORF3b+Is+a+Potent+Interferon+Antagonist+Whose+Activity+Is+Increased+by+a+Naturally+Occurring+Elongation+Variant&author=Y+Konno&author=I+Kimura&author=K+Uriu&author=M+Fukushi&author=T+Irie&volume=32&publication_year=2020&pages=108185&pmid=32941788&", "/pmc/articles/PMC7273175/", "https://pubmed.ncbi.nlm.nih.gov/32357808", "https://scholar.google.com/scholar_lookup?journal=Emerg+Microbes+Infect&title=Kinetics+of+SARS-CoV-2+Specific+IgM+and+IgG+Responses+in+COVID-19+Patients&author=B+Sun&author=Y+Feng&author=X+Mo&author=P+Zheng&author=Q+Wang&volume=9&publication_year=2020&pages=940-8&pmid=32357808&", "/pmc/articles/PMC7803150/", "https://pubmed.ncbi.nlm.nih.gov/33497610", "https://scholar.google.com/scholar_lookup?journal=Cell&title=Adaptive+Immunity+to+SARS-CoV-2+and+COVID-19&author=A+Sette&author=S+Crotty&volume=184&issue=(4)&publication_year=2021&pages=861&pmid=33497610&", "/pmc/articles/PMC8128299/", "https://pubmed.ncbi.nlm.nih.gov/33622974", "https://scholar.google.com/scholar_lookup?journal=Sci+Immunol&title=Clonal+Expansion+and+Activation+of+Tissue-Resident+Memory-Like+Th17+Cells+Expressing+GM-CSF+in+the+Lungs+of+Severe+COVID-19+Patients&author=Y+Zhao&author=C+Kilian&author=J-E+Turner&author=L+Bosurgi&author=K+Roedl&volume=6&publication_year=2021&pages=eabf6692&pmid=33622974&", "/pmc/articles/PMC8128298/", "https://pubmed.ncbi.nlm.nih.gov/33692097", "https://scholar.google.com/scholar_lookup?journal=Sci+Immunol&title=Inflammatory+Profiles+Across+the+Spectrum+of+Disease+Reveal+a+Distinct+Role+for+GM-CSF+in+Severe+COVID-19&author=RS+Thwaites&author=A+Sanchez+Sevilla+Uruchurtu&author=MK+Siggins&author=F+Liew&author=CD+Russell&volume=6&publication_year=2021&pages=eabg9873&pmid=33692097&", "/pmc/articles/PMC7405282/", "https://pubmed.ncbi.nlm.nih.gov/32779838", "https://scholar.google.com/scholar_lookup?journal=Int+J+Lab+Hematol&title=Absolute+Lymphocyte+Count+is+a+Prognostic+Marker+in+Covid-19:+A+Retrospective+Cohort+Review&author=J+Wagner&author=A+DuPont&author=S+Larson&author=B+Cash&author=A+Farooq&volume=42&publication_year=2020&pages=761-5&pmid=32779838&", "/pmc/articles/PMC7390589/", "https://pubmed.ncbi.nlm.nih.gov/32726241", "https://scholar.google.com/scholar_lookup?journal=West+J+Emerg+Med&title=Predictors+of+Mortality+in+Adults+Admitted+With+COVID-19:+Retrospective+Cohort+Study+From+New+York+City&author=S+Chilimuri&author=H+Sun&author=A+Alemam&author=N+Mantri&author=E+Shehi&volume=21&publication_year=2020&pages=779-84&pmid=32726241&", "/pmc/articles/PMC7100419/", "https://pubmed.ncbi.nlm.nih.gov/32296069", "https://scholar.google.com/scholar_lookup?journal=Signal+Transduct+Target+Ther&title=Lymphopenia+Predicts+Disease+Severity+of+COVID-19:+A+Descriptive+and+Predictive+Study&author=L+Tan&author=Q+Wang&author=D+Zhang&author=J+Ding&author=Q+Huang&volume=5&publication_year=2020&pages=1-3&pmid=32296011&", "/pmc/articles/PMC7543449/", "https://pubmed.ncbi.nlm.nih.gov/34676085", "https://scholar.google.com/scholar_lookup?journal=Natl+Sci+Rev&title=Pathological+Changes+in+the+Lungs+and+Lymphatic+Organs+of+12+COVID-19+Autopsy+Cases&author=Q+Liu&author=Y+Shi&author=J+Cai&author=Y+Duan&author=R+Wang&volume=7&publication_year=2020&pages=1868-78&pmid=34676085&", "/pmc/articles/PMC7573917/", "https://pubmed.ncbi.nlm.nih.gov/32942274", "https://scholar.google.com/scholar_lookup?journal=Pathobiology&title=Autopsy+Findings+in+32+Patients+With+COVID-19:+A+Single-Institution+Experience&author=SS+Elsoukkary&author=M+Mostyka&author=A+Dillard&author=DR+Berman&author=LX+Ma&volume=88&publication_year=2021&pages=56-68&pmid=32942274&", "/pmc/articles/PMC7205903/", "https://pubmed.ncbi.nlm.nih.gov/32425950", "https://scholar.google.com/scholar_lookup?journal=Front+Immunol&title=Reduction+and+Functional+Exhaustion+of+T+Cells+in+Patients+With+Coronavirus+Disease+2019+(COVID-19)&author=B+Diao&author=C+Wang&author=Y+Tan&author=X+Chen&author=Y+Liu&volume=11&publication_year=2020&pages=827&pmid=32425950&", "/pmc/articles/PMC7079893/", "https://pubmed.ncbi.nlm.nih.gov/28466096", "https://scholar.google.com/scholar_lookup?journal=Semin+Immunopathol&title=Pathogenic+Human+Coronavirus+Infections:+Causes+and+Consequences+of+Cytokine+Storm+and+Immunopathology&author=R+Channappanavar&author=S+Perlman&volume=39&issue=(5)&publication_year=2017&pages=529-39&pmid=28466096&", "/pmc/articles/PMC7382021/", "https://pubmed.ncbi.nlm.nih.gov/32706371", "https://scholar.google.com/scholar_lookup?journal=JAMA&title=Presence+of+Genetic+Variants+Among+Young+Men+With+Severe+COVID-19&author=CI+van+der+Made&author=A+Simons&author=J+Schuurs-Hoeijmakers&author=G+van+den+Heuvel&author=T+Mantere&volume=324&publication_year=2020&pages=663-73&pmid=32706371&", "https://pubmed.ncbi.nlm.nih.gov/33307546", "https://scholar.google.com/scholar_lookup?journal=Nature&title=Genetic+Mechanisms+of+Critical+Illness+in+Covid-19&author=E+Pairo-Castineira&author=S+Clohisey&author=L+Klaric&author=AD+Bretherick&author=K+Rawlik&volume=591&publication_year=2020&pages=92-8&pmid=33307546&", "/pmc/articles/PMC7164881/", "https://pubmed.ncbi.nlm.nih.gov/32311448", "https://scholar.google.com/scholar_lookup?journal=J+Am+Coll+Cardiol&title=COVID-19+and+Thrombotic+or+Thromboembolic+Disease:+Implications+for+Prevention,+Antithrombotic+Therapy,+and+Follow-Up&author=B+Bikdeli&author=MV+Madhavan&author=D+Jimenez&author=T+Chuich&author=I+Dreyfus&volume=75&publication_year=2020&pages=2950-73&pmid=32311448&", "/pmc/articles/PMC7386875/", "https://pubmed.ncbi.nlm.nih.gov/32586214", "https://scholar.google.com/scholar_lookup?journal=Circ+Res&title=The+Emerging+Threat+of+(Micro)Thrombosis+in+COVID-19+and+Its+Therapeutic+Implications&author=JD+McFadyen&author=H+Stevens&author=K+Peter&volume=127&publication_year=2020&pages=571-87&pmid=32586214&", "/pmc/articles/PMC7471641/", "https://pubmed.ncbi.nlm.nih.gov/32887634", "https://scholar.google.com/scholar_lookup?journal=J+Hematol+Oncol&title=SARS-CoV-2+Binds+Platelet+ACE2+to+Enhance+Thrombosis+in+COVID-19&author=S+Zhang&author=Y+Liu&author=X+Wang&author=L+Yang&author=H+Li&volume=13&publication_year=2020&pages=120&pmid=32887634&", "/pmc/articles/PMC7454504/", "https://pubmed.ncbi.nlm.nih.gov/32691039", "https://scholar.google.com/scholar_lookup?journal=Eur+Heart+J&title=ACE2+Down-Regulation+may+Contribute+to+the+Increased+Thrombotic+Risk+in+COVID-19&author=L+Lupi&author=M+Adamo&author=RM+Inciardi&author=M+Metra&volume=41&publication_year=2020&pages=3200-0&pmid=32691039&", "/pmc/articles/PMC7167588/", "https://pubmed.ncbi.nlm.nih.gov/32336612", "https://scholar.google.com/scholar_lookup?journal=Eur+J+Intern+Med&title=The+Pivotal+Link+Between+ACE2+Deficiency+and+SARS-CoV-2+Infection&author=P+Verdecchia&author=C+Cavallini&author=A+Spanevello&author=F+Angeli&volume=76&publication_year=2020&pages=14&pmid=32336612&", "https://scholar.google.com/scholar_lookup?journal=medRxiv&title=Highly+Pathogenic+Coronavirus+N+Protein+Aggravates+Lung+Injury+by+MASP-2-Mediated+Complement+Over-Activation&author=T+Gao&author=M+Hu&author=X+Zhang&author=H+Li&author=L+Zhu&publication_year=2020&", "/pmc/articles/PMC7187881/", "https://pubmed.ncbi.nlm.nih.gov/32439197", "https://scholar.google.com/scholar_lookup?journal=Curr+Probl+Cardiol&title=COVID-19+and+Multiorgan+Response&author=S+Zaim&author=JH+Chong&author=V+Sankaranarayanan&author=A+Harky&volume=45&publication_year=2020&pages=100618&pmid=32439197&", "/pmc/articles/PMC7273827/", "https://pubmed.ncbi.nlm.nih.gov/32339221", "https://scholar.google.com/scholar_lookup?journal=Blood&title=COVID-19+and+Its+Implications+for+Thrombosis+and+Anticoagulation&author=JM+Connors&author=JH+Levy&volume=135&issue=(23)&publication_year=2020&pages=2033-40&pmid=32339221&", "/pmc/articles/PMC7314621/", "https://pubmed.ncbi.nlm.nih.gov/32838147", "https://scholar.google.com/scholar_lookup?journal=SN+Compr+Clin+Med&title=Comorbidity+and+Its+Impact+on+Patients+With+COVID-19&author=A+Sanyaolu&author=C+Okorie&author=A+Marinkovic&author=R+Patidar&author=K+Younis&volume=2&publication_year=2020&pages=1069-76&pmid=32838147&", "https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/older-adults.html", "https://www.worldometers.info/coronavirus/coronavirus-age-sex-demographics/", "/pmc/articles/PMC7499698/", "https://pubmed.ncbi.nlm.nih.gov/33214754", "https://scholar.google.com/scholar_lookup?journal=Public+Policy+Aging+Rep&title=Age-Related+Vulnerability+to+Coronavirus+Disease+2019+(COVID-19):+Biological,+Contextual,+and+Policy-Related+Factors&author=EM+Crimmins&volume=30&publication_year=2020&pages=142-6&pmid=33214754&", "https://pubmed.ncbi.nlm.nih.gov/29242543", "https://scholar.google.com/scholar_lookup?journal=Nat+Immunol&title=The+Twilight+of+Immunity:+Emerging+Concepts+in+Aging+of+the+Immune+System+Review-Article&author=J+Nikolich-\u017dugich&volume=19&publication_year=2018&pages=10-9&pmid=29242543&", "https://pubmed.ncbi.nlm.nih.gov/28704827", "https://scholar.google.com/scholar_lookup?journal=Gerontology&title=Age-Dependent+Changes+in+Regulatory+T+Lymphocyte+Development+and+Function:+A+Mini-Review&author=J+Darrigues&author=JPM+van+Meerwijk&author=P+Romagnoli&volume=64&publication_year=2018&pages=28-35&pmid=28704827&", "/pmc/articles/PMC7276714/", "https://pubmed.ncbi.nlm.nih.gov/32427393", "https://scholar.google.com/scholar_lookup?journal=FASEB+J&title=Telomeres+and+COVID-19&author=A+Aviv&volume=34&publication_year=2020&pages=7247-52&pmid=32427393&", "/pmc/articles/PMC7473262/", "https://pubmed.ncbi.nlm.nih.gov/32923992", "https://scholar.google.com/scholar_lookup?journal=EClinicalMedicine&title=Multisystem+Inflammatory+Syndrome+in+Children:+A+Systematic+Review&author=M+Ahmed&author=S+Advani&author=A+Moreira&author=S+Zoretic&author=J+Martinez&volume=26&publication_year=2020&pages=100527&pmid=32923992&", "/pmc/articles/PMC7598032/", "https://pubmed.ncbi.nlm.nih.gov/32870815", "https://scholar.google.com/scholar_lookup?journal=J+Clin+Invest&title=Immune+pathogenesis+of+COVID-19-related+multisystem+inflammatory+syndrome+in+children&author=AH+Rowley&author=ST+Shulman&author=M+Arditi&volume=130&publication_year=2020&pages=5619-21&pmid=32870815&", "https://globalhealth5050.org/the-sex-gender-and-covid-19-project/dataset/", "/pmc/articles/PMC8353216/", "https://pubmed.ncbi.nlm.nih.gov/34340720", "https://scholar.google.com/scholar_lookup?journal=Expert+Rev+Mol+Med&title=COVID-19+Pandemic:+Insights+Into+Molecular+Mechanisms+Leading+to+Sex-Based+Differences+in+Patient+Outcomes&author=A+Kumar&author=RK+Narayan&author=M+Kulandhasamy&author=P+Prasoon&author=C+Kumari&volume=23&publication_year=2021&pages=e7&pmid=34340720&", "/pmc/articles/PMC7361928/", "https://pubmed.ncbi.nlm.nih.gov/32594644", "https://scholar.google.com/scholar_lookup?journal=J+Cell+Mol+Med&title=The+ACE2+Expression+in+Sertoli+Cells+and+Germ+Cells+may+Cause+Male+Reproductive+Disorder+After+SARS-CoV-2+Infection&author=Q+Shen&author=X+Xiao&author=A+Aierken&author=W+Yue&author=X+Wu&volume=24&publication_year=2020&pages=9472-7&pmid=32594644&", "/pmc/articles/PMC7226809/", "https://pubmed.ncbi.nlm.nih.gov/32283711", "https://scholar.google.com/scholar_lookup?journal=Cells&title=scRNA-Seq+Profiling+of+Human+Testes+Reveals+the+Presence+of+the+ACE2+Receptor,+A+Target+for+SARS-CoV-2+Infection+in+Spermatogonia,+Leydig+and+Sertoli+Cells&author=Z+Wang&author=X+Xu&volume=9&publication_year=2020&pages=920&", "https://www.proteinatlas.org/ENSG00000184012-TMPRSS2/tissue", "/pmc/articles/PMC7202813/", "https://pubmed.ncbi.nlm.nih.gov/32387456", "https://scholar.google.com/scholar_lookup?journal=Ann+Oncol&title=Androgen-Deprivation+Therapies+for+Prostate+Cancer+and+Risk+of+Infection+by+SARS-CoV-2:+A+Population-Based+Study+(N+=+4532)&author=M+Montopoli&author=S+Zumerle&author=R+Vettor&author=M+Rugge&author=M+Zorzi&volume=31&publication_year=2020&pages=1040-5&pmid=32387456&", "/pmc/articles/PMC7430299/", "https://pubmed.ncbi.nlm.nih.gov/32853545", "https://scholar.google.com/scholar_lookup?journal=Immunity&title=Implications+of+Sex+Differences+in+Immunity+for+SARS-CoV-2+Pathogenesis+and+Design+of+Therapeutic+Interventions&author=MJ+Bunders&author=M+Altfeld&volume=53&publication_year=2020&pages=487-95&pmid=32853545&", "https://pubmed.ncbi.nlm.nih.gov/27546235", "https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Immunol&title=Sex+Differences+in+Immune+Responses&author=SL+Klein&author=KL+Flanagan&volume=16&issue=(10)&publication_year=2016&pages=626-38&pmid=27546235&", "/pmc/articles/PMC7402107/", "https://pubmed.ncbi.nlm.nih.gov/32788073", "https://scholar.google.com/scholar_lookup?journal=J+Infect+Public+Health&title=COVID-19+and+Comorbidities:+Deleterious+Impact+on+Infected+Patients&author=H+Ejaz&author=A+Alsrhani&author=A+Zafar&author=H+Javed&author=K+Junaid&volume=13&publication_year=2020&pages=1833-9&pmid=32788073&", "https://pubmed.ncbi.nlm.nih.gov/32654555", "https://scholar.google.com/scholar_lookup?journal=Hypertension&title=Clinical+Features+of+COVID-19+in+Patients+With+Essential+Hypertension+and+the+Impacts+of+Renin-Angiotensin-Aldosterone+System+Inhibitors+on+the+Prognosis+of+COVID-19+Patients&author=W+Pan&author=J+Zhang&author=M+Wang&author=J+Ye&author=Y+Xu&volume=76&publication_year=2020&pages=732-41&pmid=32654555&", "/pmc/articles/PMC7283736/", "https://pubmed.ncbi.nlm.nih.gov/32445512", "https://scholar.google.com/scholar_lookup?journal=Obesity+(Silver+Spring)&title=Severe+Obesity+as+an+Independent+Risk+Factor+for+COVID-19+Mortality+in+Hospitalized+Patients+Younger+Than+50&author=E+Klang&author=G+Kassim&author=S+Soffer&author=R+Freeman&author=MA+Levin&volume=28&publication_year=2020&pages=1595-9&pmid=32445512&", "/pmc/articles/PMC7258796/", "https://pubmed.ncbi.nlm.nih.gov/32571616", "https://scholar.google.com/scholar_lookup?journal=Nutr+Metab+Cardiovasc+Dis&title=Diabetes+as+a+Risk+Factor+for+Greater+COVID-19+Severity+and+in-Hospital+Death:+A+Meta-Analysis+of+Observational+Studies&author=A+Mantovani&author=CD+Byrne&author=MH+Zheng&author=G+Targher&volume=30&issue=(8)&publication_year=2020&pages=1236-48&pmid=32571616&", "/pmc/articles/PMC4390759/", "https://pubmed.ncbi.nlm.nih.gov/26064849", "https://scholar.google.com/scholar_lookup?journal=J+Lifestyle+Med&title=Immunological+Profiling+of+Obesity&author=RM+Ignacio&author=CS+Kim&author=SK+Kim&volume=4&publication_year=2014&pages=1-7&pmid=26064849&", "/pmc/articles/PMC7275979/", "https://pubmed.ncbi.nlm.nih.gov/32593459", "https://scholar.google.com/scholar_lookup?journal=Br+J+Anaesth&title=Potential+pathophysiology+of+COVID-19+in+patients+with+obesity.+Comment+on+Br+J+Anaesth+2020;+125:+e262-e263&author=B+Lui&author=JD+Samuels&author=RS+White&volume=125&publication_year=2020&pages=e283-4&pmid=32593459&", "/pmc/articles/PMC7264681/", "https://pubmed.ncbi.nlm.nih.gov/32314455", "https://scholar.google.com/scholar_lookup?journal=Diabetes+Obes+Metab&title=COVID-19+Infection+may+Cause+Ketosis+and+Ketoacidosis&author=J+Li&author=X+Wang&author=J+Chen&author=X+Zuo&author=H+Zhang&volume=22&publication_year=2020&pages=1935-41&pmid=32314455&", "/pmc/articles/PMC7360473/", "https://pubmed.ncbi.nlm.nih.gov/32664879", "https://scholar.google.com/scholar_lookup?journal=BMC+Med&title=New+Insights+Into+Genetic+Susceptibility+of+COVID-19:+An+ACE2+and+TMPRSS2+Polymorphism+Analysis&author=Y+Hou&author=J+Zhao&author=W+Martin&author=A+Kallianpur&author=MK+Chung&volume=18&publication_year=2020&pages=216&pmid=32664879&", "/pmc/articles/PMC7709597/", "https://pubmed.ncbi.nlm.nih.gov/33278516", "https://scholar.google.com/scholar_lookup?journal=Microb+Pathog&title=ACE2+and+TMPRSS2+Polymorphisms+in+Various+Diseases+With+Special+Reference+to+Its+Impact+on+COVID-19+Disease&author=H+Singh&author=R+Choudhari&author=V+Nema&author=AA+Khan&volume=150&publication_year=2020&pages=104621&pmid=33278516&", "/pmc/articles/PMC4100901/", "https://pubmed.ncbi.nlm.nih.gov/25029565", "https://scholar.google.com/scholar_lookup?journal=PloS+One&title=Type+II+Transmembrane+Serine+Protease+Gene+Variants+Associate+With+Breast+Cancer&author=K+Luostari&author=JM+Hartikainen&author=M+Tengstr\u00f6m&author=JJ+Palvimo&author=V+Kataja&volume=9&publication_year=2014&pages=e102519&pmid=25029565&", "/pmc/articles/PMC7857407/", "https://pubmed.ncbi.nlm.nih.gov/32972995", "https://scholar.google.com/scholar_lookup?journal=Science&title=Inborn+Errors+of+Type+I+IFN+Immunity+in+Patients+With+Life-Threatening+COVID-19&author=Q+Zhang&author=P+Bastard&author=Z+Liu&author=J+Le+Pen&author=M+Moncada-Velez&volume=370&publication_year=2020&pages=eabd4570&pmid=32972995&", "/pmc/articles/PMC8674144/", "https://pubmed.ncbi.nlm.nih.gov/34237774", "https://scholar.google.com/scholar_lookup?journal=Nature&title=Mapping+the+Human+Genetic+Architecture+of+COVID-19&volume=2021&publication_year=2021&pages=1-8&", "https://pubmed.ncbi.nlm.nih.gov/32998156", "https://scholar.google.com/scholar_lookup?journal=Nature&title=The+Major+Genetic+Risk+Factor+for+Severe+COVID-19+is+Inherited+From+Neanderthals&author=H+Zeberg&author=S+P\u00e4\u00e4bo&volume=587&issue=(7835)&publication_year=2020&pages=610-2&pmid=32998156&", "/pmc/articles/PMC7936282/", "https://pubmed.ncbi.nlm.nih.gov/33593941", "https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&title=A+Genomic+Region+Associated+With+Protection+Against+Severe+COVID-19+is+Inherited+From+Neandertals&author=H+Zeberg&author=S+P\u00e4\u00e4bo&volume=118&issue=(9)&publication_year=2021&pages=e2026309118&pmid=33593941&", "/pmc/articles/PMC7214856/", "https://pubmed.ncbi.nlm.nih.gov/32398162", "https://scholar.google.com/scholar_lookup?journal=Hum+Genomics&title=COVID-19+Vulnerability:+The+Potential+Impact+of+Genetic+Susceptibility+and+Airborne+Transmission&author=KJ+Godri+Pollitt&author=J+Peccia&author=AI+Ko&author=N+Kaminski&author=CS+Dela+Cruz&volume=14&publication_year=2020&pages=17&pmid=32398162&", "/pmc/articles/PMC7574718/", "https://pubmed.ncbi.nlm.nih.gov/33147444", "https://scholar.google.com/scholar_lookup?journal=Cell&title=Genome-Wide+CRISPR+Screens+Reveal+Host+Factors+Critical+for+SARS-CoV-2+Infection&author=J+Wei&author=MM+Alfajaro&author=PC+DeWeirdt&author=RE+Hanna&author=WJ+Lu-Culligan&volume=184&publication_year=2020&pages=1-16&", "/pmc/articles/PMC7594382/", "https://pubmed.ncbi.nlm.nih.gov/33057631", "https://scholar.google.com/scholar_lookup?journal=Blood+Adv&title=Reduced+Prevalence+of+SARS-CoV-2+Infection+in+ABO+Blood+Group+O.&author=MB+Barnkob&author=A+Potteg\u00e5rd&author=H+St\u00f8vring&author=TM+Haunstrup&author=K+Homburg&volume=4&publication_year=2020&pages=4990-3&pmid=33057631&", "/pmc/articles/PMC7594392/", "https://pubmed.ncbi.nlm.nih.gov/33057633", "https://scholar.google.com/scholar_lookup?journal=Blood+Adv&title=The+Association+of+ABO+Blood+Group+With+Indices+of+Disease+Severity+and+Multiorgan+Dysfunction+in+COVID-19&author=RL+Hoiland&author=NA+Fergusson&author=AR+Mitra&author=DEG+Griesdale&author=DV+Devine&volume=4&publication_year=2020&pages=4981-9&pmid=33057633&", "/pmc/articles/PMC7354354/", "https://pubmed.ncbi.nlm.nih.gov/32656591", "https://scholar.google.com/scholar_lookup?journal=Ann+Hematol&title=Blood+Type+and+Outcomes+in+Patients+With+COVID-19&author=CA+Latz&author=C+DeCarlo&author=L+Boitano&author=CYM+Png&author=R+Patell&volume=99&publication_year=2020&pages=2113-8&pmid=32656591&", "/pmc/articles/PMC8022215/", "https://pubmed.ncbi.nlm.nih.gov/33818622", "https://scholar.google.com/scholar_lookup?journal=JAMA+Netw+Open&title=Association+of+Sociodemographic+Factors+and+Blood+Group+Type+With+Risk+of+COVID-19+in+a+US+Population&author=JL+Anderson&author=HT+May&author=S+Knight&author=TL+Bair&author=JB+Muhlestein&volume=4&publication_year=2021&pages=e217429&pmid=33818622&", "/pmc/articles/PMC7724273/", "https://pubmed.ncbi.nlm.nih.gov/33139519", "https://scholar.google.com/scholar_lookup?journal=Sci+Transl+Med&title=Prothrombotic+Autoantibodies+in+Serum+From+Patients+Hospitalized+With+COVID-19&author=Y+Zuo&author=SK+Estes&author=RA+Ali&author=AA+Gandhi&author=S+Yalavarthi&volume=12&publication_year=2020&pages=eabd3876&pmid=33139519&", "/pmc/articles/PMC7361253/", "https://pubmed.ncbi.nlm.nih.gov/32619328", "https://scholar.google.com/scholar_lookup?journal=J+Thromb+Haemost&title=Antiphospholipid+Antibodies+in+Patients+With+COVID-19:+A+Relevant+Observation?&author=KMJ+Devreese&author=EA+Linskens&author=D+Benoit&author=H+Peperstraete&volume=18&publication_year=2020&pages=2191-201&pmid=32619328&", "/pmc/articles/PMC7161262/", "https://pubmed.ncbi.nlm.nih.gov/32268022", "https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&title=Coagulopathy+and+Antiphospholipid+Antibodies+in+Patients+With+Covid-19&author=Y+Zhang&author=M+Xiao&author=S+Zhang&author=P+Xia&author=W+Cao&volume=382&publication_year=2020&pages=e38&pmid=32268022&", "/pmc/articles/PMC7593765/", "https://pubmed.ncbi.nlm.nih.gov/33178218", "https://scholar.google.com/scholar_lookup?journal=Front+Immunol&title=Anti-Phospholipid+Antibodies+in+COVID-19+Are+Different+From+Those+Detectable+in+the+Anti-Phospholipid+Syndrome&author=MO+Borghi&author=A+Beltagy&author=E+Garrafa&author=D+Curreli&author=G+Cecchini&volume=11&publication_year=2020&pages=584241&pmid=33178218&", "/pmc/articles/PMC7217790/", "https://pubmed.ncbi.nlm.nih.gov/32430279", "https://scholar.google.com/scholar_lookup?journal=Virus+Res&title=Gut+Microbiota+and+Covid-19-+Possible+Link+and+Implications&author=D+Dhar&author=A+Mohanty&volume=285&publication_year=2020&pages=198018&pmid=32430279&", "/pmc/articles/PMC7237927/", "https://pubmed.ncbi.nlm.nih.gov/32442562", "https://scholar.google.com/scholar_lookup?journal=Gastroenterology&title=Alterations+in+Gut+Microbiota+of+Patients+With+COVID-19+During+Time+of+Hospitalization&author=T+Zuo&author=F+Zhang&author=GCY+Lui&author=YK+Yeoh&author=AYL+Li&volume=159&publication_year=2020&pages=944-55.e8&pmid=32442562&", "/pmc/articles/PMC7832617/", "https://pubmed.ncbi.nlm.nih.gov/34173452", "https://scholar.google.com/scholar_lookup?journal=Med+Microecol&title=Analysis+of+the+Intestinal+Microbiota+in+COVID-19+Patients+and+Its+Correlation+With+the+Inflammatory+Factor+IL-18&author=W+Tao&author=G+Zhang&author=X+Wang&author=M+Guo&author=W+Zeng&volume=5&publication_year=2020&pages=100023&pmid=34173452&", "/pmc/articles/PMC7857411/", "https://pubmed.ncbi.nlm.nih.gov/33159009", "https://scholar.google.com/scholar_lookup?journal=Science+(80-&title=Preexisting+and+De+Novo+Humoral+Immunity+to+SARS-CoV-2+in+Humans&author=KW+Ng&author=N+Faulkner&author=GH+Cornish&author=A+Rosa&author=R+Harvey&publication_year=2020&pages=1339-43&", "/pmc/articles/PMC7574914/", "https://pubmed.ncbi.nlm.nih.gov/32753554", "https://scholar.google.com/scholar_lookup?journal=Science+(80\u2212)&title=Selective+and+Cross-Reactive+SARS-CoV-2+T+Cell+Epitopes+in+Unexposed+Humans&author=J+Mateus&author=A+Grifoni&author=A+Tarke&author=J+Sidney&author=SI+Ramirez&volume=370&publication_year=2020&pages=89-94&", "/pmc/articles/PMC7773342/", "https://pubmed.ncbi.nlm.nih.gov/32997649", "https://scholar.google.com/scholar_lookup?journal=J+Clin+Invest&title=Recent+Endemic+Coronavirus+Infection+Is+Associated+With+Less+Severe+COVID-19&author=M+Sagar&author=K+Reifler&author=M+Rossi&author=NS+Miller&author=P+Sinha&volume=131&publication_year=2020&pages=e143380&", "/pmc/articles/PMC7304316/", "https://pubmed.ncbi.nlm.nih.gov/32561657", "https://scholar.google.com/scholar_lookup?journal=MBio&title=Could+an+Unrelated+Live+Attenuated+Vaccine+Serve+as+a+Preventive+Measure+to+Dampen+Septic+Inflammation+Associated+With+Covid-19+Infection?&author=PL+Fidel&author=MC+Noverr&volume=11&publication_year=2020&pages=1-4&", "https://pubmed.ncbi.nlm.nih.gov/33310766", "https://scholar.google.com/scholar_lookup?journal=BMJ+Evid+Based+Med&title=Inactivated+Trivalent+Influenza+Vaccination+is+Associated+With+Lower+Mortality+Among+Patients+With+COVID-19+in+Brazil&author=G+Fink&author=N+Orlova-Fink&author=T+Schindler&author=S+Grisi&author=APS+Ferrer&publication_year=2020&", "/pmc/articles/PMC7686805/", "https://pubmed.ncbi.nlm.nih.gov/33219096", "https://scholar.google.com/scholar_lookup?journal=MBio&title=Analysis+of+Measles-Mumps-Rubella+(MMR)+Titers+of+Recovered+COVID-19+Patients&author=JE+Gold&author=WH+Baumgartl&author=RA+Okyay&author=WE+Licht&author=PL+Fidel&volume=11&publication_year=2020&pages=e02628-20&pmid=33219096&", "/pmc/articles/PMC7655788/", "https://pubmed.ncbi.nlm.nih.gov/33194993", "https://scholar.google.com/scholar_lookup?journal=Front+Public+Health&title=Childhood+Immunization+and+COVID-19:+An+Early+Narrative+Review&author=B+Beric-Stojsic&author=J+Kalabalik-Hoganson&author=D+Rizzolo&author=S+Roy&volume=8&publication_year=2020&pages=587007&pmid=33194993&", "https://pubmed.ncbi.nlm.nih.gov/32169166", "https://scholar.google.com/scholar_lookup?journal=Cell+Stem+Cell&title=C/Ebp\u03b2-Dependent+Epigenetic+Memory+Induces+Trained+Immunity+in+Hematopoietic+Stem+Cells&author=B+de+Laval&author=J+Maurizio&author=PK+Kandalla&author=G+Brisou&author=L+Simonnet&volume=26&publication_year=2020&pages=657-74.e8&pmid=32169166&", "/pmc/articles/PMC7584442/", "https://pubmed.ncbi.nlm.nih.gov/33134901", "https://scholar.google.com/scholar_lookup?journal=EClinicalMedicine&title=Impaired+Spermatogenesis+in+COVID-19+Patients&author=H+Li&author=X+Xiao&author=J+Zhang&author=MI+Zafar&author=C+Wu&volume=28&publication_year=2020&pages=100604&pmid=33134901&", "/pmc/articles/PMC7857397/", "https://pubmed.ncbi.nlm.nih.gov/32972996", "https://scholar.google.com/scholar_lookup?journal=Science&title=Autoantibodies+Against+Type+I+IFNs+in+Patients+With+Life-Threatening+COVID-19&author=P+Bastard&author=LB+Rosen&author=Q+Zhang&author=E+Michailidis&author=HH+Hoffmann&volume=370&publication_year=2020&pages=eabd4585&pmid=32972996&", "/pmc/articles/PMC7556454/", "https://pubmed.ncbi.nlm.nih.gov/33052920", "https://scholar.google.com/scholar_lookup?journal=PloS+One&title=Residual+Clinical+Damage+After+COVID-19:+A+Retrospective+and+Prospective+Observational+Cohort+Study&author=R+De+Lorenzo&author=C+Conte&author=C+Lanzani&author=F+Benedetti&author=L+Roveri&volume=15&publication_year=2020&pages=e0239570&pmid=33052920&", "/pmc/articles/PMC7892867/", "https://pubmed.ncbi.nlm.nih.gov/33603008", "https://scholar.google.com/scholar_lookup?journal=Sci+Rep&title=Years+of+Life+Lost+to+COVID-19+in+81+Countries&author=H+Pifarr\u00e9+i+Arolas&author=E+Acosta&author=G+L\u00f3pez-Casasnovas&author=A+Lo&author=C+Nicodemo&volume=11&publication_year=2021&pages=3504&pmid=33603008&", "/pmc/articles/PMC8500096/", "https://pubmed.ncbi.nlm.nih.gov/34564730", "https://scholar.google.com/scholar_lookup?journal=Int+J+Epidemiol&title=Quantifying+Impacts+of+the+COVID-19+Pandemic+Through+Life-Expectancy+Losses:+A+Population-Level+Study+of+29+Countries&author=JM+Aburto&author=J+Sch\u00f6ley&author=I+Kashnitsky&author=L+Zhang&author=C+Rahal&publication_year=2021&pages=dyab207&", "/pmc/articles/PMC7850177/", "https://pubmed.ncbi.nlm.nih.gov/33144403", "https://scholar.google.com/scholar_lookup?journal=Clin+Med&title=Long-Term+Sequelae+Following+Previous+Coronavirus+Epidemics&author=O+O'Sullivan&volume=21&publication_year=2021&pages=e68-70&", "/pmc/articles/PMC8139423/", "https://pubmed.ncbi.nlm.nih.gov/33853970", "https://scholar.google.com/scholar_lookup?journal=Science+(80-)&title=Genomics+and+Epidemiology+of+the+P.1+SARS-CoV-2+Lineage+in+Manaus,+Brazil&author=NR+Faria&author=TA+Mellan&author=C+Whittaker&author=IM+Claro&author=DS+Candidoda&volume=372&publication_year=2021&pages=815-21&", "https://scholar.google.com/scholar_lookup?journal=medRxiv&title=Second+Wave+of+COVID-19+in+India+Could+be+Predicted+With+Genomic+Surveillance+of+SARS-CoV-2+Variants+Coupled+With+Epidemiological+Data:+A+Tool+for+Future&author=A+Kumar&author=P+Dwivedi&author=G+Kumar&author=RK+Narayan&author=RK+Jha&publication_year=2021&", "/pmc/articles/PMC9011477/", "https://pubmed.ncbi.nlm.nih.gov/34811761", "https://scholar.google.com/scholar_lookup?journal=SSRN+Electron+J&title=Emerging+SARS-CoV-2+Variants+Can+Potentially+Break+Set+Epidemiological+Barriers+in+COVID-19&author=A+Kumar&author=R+Parashar&author=MA+Faiq&author=S+Kumar&author=C+Kumari&publication_year=2021&", "https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/", "https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html", "/pmc/articles/PMC8397301/", "https://pubmed.ncbi.nlm.nih.gov/34461056", "https://scholar.google.com/scholar_lookup?journal=Lancet+Infect+Dis&title=Hospital+Admission+and+Emergency+Care+Attendance+Risk+for+SARS-CoV-2+Delta+(B.1.617.2)+Compared+With+Alpha+(B.1.1.7)+Variants+of+Concern:+A+Cohort+Study&author=KA+Twohig&author=T+Nyberg&author=A+Zaidi&author=S+Thelwall&author=MA+Sinnathamby&volume=S1473\u20133099&issue=(21)&publication_year=2021&pages=00475-8&", "https://pubmed.ncbi.nlm.nih.gov/33834772", "https://scholar.google.com/scholar_lookup?journal=J+Med+Chem&title=Insights+Into+SARS-CoV-2's+Mutations+for+Evading+Human+Antibodies:+Sacrifice+and+Survival&author=B+Luan&author=T+Huynh&publication_year=2021&", "/pmc/articles/PMC8167834/", "https://pubmed.ncbi.nlm.nih.gov/34075212", "https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Microbiol&title=SARS-CoV-2+Variants,+Spike+Mutations+and+Immune+Escape&author=WT+Harvey&author=AM+Carabelli&author=B+Jackson&author=RK+Gupta&author=EC+Thomson&volume=19&publication_year=2021&pages=409-24&pmid=34075212&", "https://scholar.google.com/scholar_lookup?journal=bioRxiv+Prepr+Serv+Biol&title=SARS-CoV-2+B.1.1.7+and+B.1.351+Variants+of+Concern+Induce+Lethal+Disease+in+K18-Hace2+Transgenic+Mice+Despite+Convalescent+Plasma+Therapy&author=AM+Horspool&author=C+Ye&author=TY+Wong&author=BP+Russ&author=KS+Lee&publication_year=2021&", "https://scholar.google.com/scholar_lookup?journal=bioRxiv&title=SARS+CoV-2+Variant+B.1.617.1+is+Highly+Pathogenic+in+Hamsters+Than+B.1+Variant&author=PD+Yadav&author=S+Mohandas&author=AM+Shete&author=DA+Nyayanit&author=N+Gupta&publication_year=2021&", "/pmc/articles/PMC8786931/", "https://pubmed.ncbi.nlm.nih.gov/35075154", "https://scholar.google.com/scholar_lookup?journal=medRxiv&title=Viral+Infection+and+Transmission+in+a+Large,+Well-Traced+Outbreak+Caused+by+the+SARS-CoV-2+Delta+Variant&author=B+Li&author=A+Deng&author=K+Li&author=Y+Hu&author=Z+Li&publication_year=2021&", "https://scholar.google.com/scholar_lookup?journal=bioRxiv&title=The+B1.351+and+P.1+Variants+Extend+SARS-CoV-2+Host+Range+to+Mice&author=X+Montagutelli&author=M+Prot&author=L+Levillayer&author=EB+Salazar&author=G+Jouvion&publication_year=2021&", "https://outbreak.info/situation-reports?pango=AY.1&loc=IND&loc=GBR&loc=USA", "/pmc/articles/PMC7194065/", "https://pubmed.ncbi.nlm.nih.gov/32362314", "https://scholar.google.com/scholar_lookup?journal=Mol+Cell&title=A+Multibasic+Cleavage+Site+in+the+Spike+Protein+of+SARS-CoV-2+Is+Essential+for+Infection+of+Human+Lung+Cells&author=M+Hoffmann&author=H+Kleine-Weber&author=S+P\u00f6hlmann&volume=78&publication_year=2020&pages=779-e5&pmid=32362314&", "/pmc/articles/PMC7194977/", "https://pubmed.ncbi.nlm.nih.gov/32272173", "https://scholar.google.com/scholar_lookup?journal=Antiviral+Res&title=Coronavirus+Membrane+Fusion+Mechanism+Offers+a+Potential+Target+for+Antiviral+Development&author=T+Tang&author=M+Bidon&author=JA+Jaimes&author=GR+Whittaker&author=S+Daniel&volume=178&publication_year=2020&pages=104792&pmid=32272173&", "https://pubmed.ncbi.nlm.nih.gov/34237773", "https://scholar.google.com/scholar_lookup?journal=Nature&title=Reduced+Sensitivity+of+SARS-CoV-2+Variant+Delta+to+Antibody+Neutralization&author=D+Planas&author=D+Veyer&author=A+Baidaliuk&author=I+Staropoli&author=F+Guivel-Benhassine&volume=2021&publication_year=2021&pages=1-7&", "/pmc/articles/PMC8117968/", "https://pubmed.ncbi.nlm.nih.gov/33882219", "https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&title=Vaccine+Breakthrough+Infections+With+SARS-CoV-2+Variants&author=E+Hacisuleyman&author=C+Hale&author=Y+Saito&author=NE+Blachere&author=M+Bergh&volume=384&publication_year=2021&pages=2212-8&pmid=33882219&", "/pmc/articles/PMC8363499/", "https://pubmed.ncbi.nlm.nih.gov/34127854", "https://scholar.google.com/scholar_lookup?journal=Nat+Med&title=Evidence+for+Increased+Breakthrough+Rates+of+SARS-CoV-2+Variants+of+Concern+in+BNT162b2-mRNA-Vaccinated+Individuals&author=T+Kustin&author=N+Harel&author=U+Finkel&author=S+Perchik&author=S+Harari&volume=27&publication_year=2021&pages=1-6&pmid=33442018&", "https://scholar.google.com/scholar_lookup?journal=bioRxiv&title=Computational+Assessment+of+the+Spike+Protein+Antigenicity+Reveals+Diversity+in+B+Cell+Epitopes+But+Stability+in+T+Cell+Epitopes+Across+SARS-CoV-2+Variants&author=A+Ge&author=M+Rioux&author=AA+Kelvin&author=AK+Ca&author=A+Kelvin&publication_year=2021&", "/pmc/articles/PMC9059041/?report=reader", "/pmc/articles/PMC9059041/pdf/kxn-0001.pdf", "#", "https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9059041%2F&text=Mecanismos%20del%20COVID-19%20en%20el%20cuerpo%20humano%3A%20Lo%20que%20sabemos%20hasta%20ahora", "https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9059041%2F", "#", "https://twitter.com/ncbi", "https://www.facebook.com/ncbi.nlm", "https://www.linkedin.com/company/ncbinlm", "https://github.com/ncbi", "https://ncbiinsights.ncbi.nlm.nih.gov/", "https://www.nlm.nih.gov/socialmedia/index.html", "https://twitter.com/NLM_NIH", "https://www.facebook.com/nationallibraryofmedicine", "https://www.youtube.com/user/NLMNIH", "https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323", "https://www.nlm.nih.gov/web_policies.html", "https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office", "https://www.hhs.gov/vulnerability-disclosure-policy/index.html", "https://support.nlm.nih.gov/", "https://www.nlm.nih.gov/accessibility.html", "https://www.nlm.nih.gov/careers/careers.html", "//www.nlm.nih.gov/", "https://www.nih.gov/", "https://www.hhs.gov/", "https://www.usa.gov/"]}